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	Voorwoord 	In	1994	begon	ik	in	Gouda	als	huisarts	te	werken	en	het	duurde	niet	lang	of	ik	werd	geconfronteerd	met	een	probleem	waarover	ik	niets	had	geleerd	in	mijn	opleiding.	Een	jonge	vrouw	had	al	een	tijd	pijn	bij	de	gemeenschap	en	mijn	collega	huisarts	noch	de	gynaecoloog	kon	een	lichamelijke	oorzaak	vinden.	Misschien	kon	ik	als	psychosomatisch	opgeleid	huisarts	(Nijmegen!)	daar	wel	iets	mee?	De	vrouw	deed	een	dringend	appel	op	mij:	er	moest	iets	gebeuren	want	seks	vond	zij	prettig	en	belangrijk.	Ik	hakkelde	en	struikelde	mij	door	het	consult	en	ging	voor	haar	op	zoek	naar	een	seksuoloog,	nog	niet	wetende	dat	daarmee	mijn	professionele	lot	werd	bezegeld.	Via	het	RIAGG	(want	als	dokters	het	niet	meer	weten	…,	dacht	ik	naïef)	en	veel,	heel	veel	bellen	(internet	was	er	nog	niet),	bleek	voor	haar	uiteindelijk	een	verwijzing	naar	een	Rutgershuis	in	Den	Haag	of	Rotterdam	de	enige	optie.		Mijn	verwondering	en	frustratie	over	de	deplorabele	stand	van	de	seksuologische	zorg	in	onze	regio	vonden	weerklank	bij	Jan	Schraag,	de	toenmalige	hoofdopleider	van	de	seksuologieopleiding	in	Rotterdam	die	ik	op	mijn	zoektocht	tegenkwam.	Waarom	dan	niet	mezelf	scholen	als	er	niets	in	de	regio	te	halen	viel?	Hij	verleidde	mij	met	zijn	opleiding	(‘je	kunt	er	na	een	paar	lessen	ook	weer	uit	stappen	als	je	denkt	genoeg	te	hebben	geleerd	als	huisarts’)	en	bracht	me	in	contact	met	zijn	buurman,	die	als	hoofd	van	de	poli	gynaecologie	in	het	Goudse	ziekenhuis	verlegen	zat	om	seksuologische	expertise.	En	zo	kon	ik	in	1998	met	de	start	van	de	polikliniek	seksuologie	in	datzelfde	ziekenhuis	aan	een	behoefte	voldoen.	Daarmee	diende	zich	nieuwe	verwondering	bij	me	aan.	Elke	week	zag	ik	op	de	poli	vrouwen	met	pijn	bij	de	gemeenschap	die	al	jaren	in	de	weer	waren	met	allerlei	crèmepjes,	glijmiddelen	en	dokters.	Als	huisarts	snapte	ik	goed	dat	je	eens	wat	probeert	en	zoekt,	maar	zolang?	En	waarom	dachten	de	meeste	vrouwen	en	huisartsen	dat	ze	een	chronische	schimmelinfectie	hadden?	En	toen	eenmaal	bleek	dat	met	eenvoudige	interventies	een	aantal	vrouwen	goed	geholpen	waren,	vroeg	ik	mij	af	waarom	de	huisarts	een	deel	dan	zelf	niet	kon	behandelen?	En	hoeveel	vrouwen	zag	ik	niet	op	de	poli	en	hoe	gingen	huisartsen	daar	mee	om?	Voelden	deze	vrouwen	zich	gehoord	en	geholpen	door	de	huisarts?	Er	bleek	uiteindelijk	maar	één	manier	om	antwoord	op	die	vragen	te	krijgen	en	over	die	zoektocht	doe	ik	in	dit	proefschrift	verslag.	Terugkijkend	heb	ik	wel	enige	antwoorden	
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gekregen,	maar	des	te	meer	nieuwe	vragen.	En	nieuwe	verbazing.	Bij	een	gerenommeerd	wetenschappelijk	tijdschrift	duurde	het	negen	maanden	voordat	twee	geschikte	referenten	voor	mijn	artikel	waren	gevonden	en	bij	een	ander	tijdschrift	gaf	de	hoofdredacteur	aan	dat	mijn	artikel	weinig	prioriteit	had	aangezien	hij	in	zijn	25-jarige	carrière	als	huisarts	het	probleem	maar	1x	had	gezien.	Kennelijk	voorzag	mijn	onderzoek	dus	niet	in	een	behoefte	–	en/of	ontbeerde	het	kwaliteit.	Maar	was	door	de	redactionele	belemmeringen	de	noodzaak	van	onderzoek	naar	vulvodynie	er	juist	niet	mee	aangetoond?	Want	hoe	kun	je	kennis	en	belangstelling	bij	redacteuren	en	referenten	vermeerderen	anders	dan	door	te	onderzoeken	en	publiceren?	Hoe	doorbreek	je	een	catch	22?	Er	resteert	niets	anders	dan	verder	te	gaan,	zeg	ik	met	huisarts	en	schrijver	Toon	Tellegen.		
Een	streep		Ik	trok	een	streep;	tot	hier,	nooit	ga	ik	verder	dan	hier.		Toen	ik	verder	ging	trok	ik	een	nieuwe	streep,	en	nog	een	streep.		De	zon	scheen	en	overal	zag	ik	mensen,		haastig	en	ernstig,		en	iedereen	trok	een	streep	iedereen	ging	verder.			
	
Chapter 1
General Introduction
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The	focus	of	this	thesis	is	the	diagnostic	management	of	provoked	vulvodynia	(PVD)	in	general	practice.	I	will	give	an	overview	of	the	definition,	epidemiology,	the	clinical	presentation	and	the	context	of	PVD,	after	which	I	will	give	a	description	of	the	unmet	needs	and	impeding	factors	of	women	seeking	help	regarding	their	PVD.	Also,	I	will	describe	the	role	of	the	general	practitioner	(GP)	concerning	diagnosis	and	management	of	PVD.	Finally,	I	will	give	an	outline	of	the	study	aims	and	research	questions	of	this	thesis.	
	
Definition From	the	late	19th	century	until	now,	many	different	terms	have	been	used	to	describe	idiopathic	vulvar	pain,	e.g.	burning	vulva	syndrome,	focal	vulvitis,	vulvar	vestibulitis	syndrome,	vulvar	dysesthesia.1	Recently,	vulvar	pain	was	classified	into	two	groups:	vulvar	pain	caused	by	a	specific	disorder	(e.g.	infection,	dermatoses,	neurological	disorder)	and	idiopathic	vulvar	pain	i.e.	vulvodynia.1	The	International	Society	for	the	Study	of	Vulvovaginal	Disease	(ISSVD)	defined	this	latter	condition	as	‘vulvar	pain	of	at	least	3	months	duration,	without	clearly	identifiable	cause,	which	may	have	potential	associated	factors.'	The	ISSVD	added	the	following	descriptors	to	the	terminology	in	order	to	specify	the	condition,	for	example,	localised	or	general,	primary	or	secondary,	provoked	or	spontaneous.1	The	current	definition	is	based	on	the	following	principles.	First	of	all,	regarding	causality,	the	misleading	suffix	of	‘–itis’	is	no	longer	used,	as	vulvodynia	showed	not	to	be	an	infection.2	Secondly,	it	is	recognized	that	various	potential	factors	are	associated	with	both	the	development	and	maintenance	of	vulvodynia,	e.g.	other	pain	syndromes,	inflammation,	musculoskeletal	conditions,	neurologic	mechanisms,	and	psychosocial	and	sexual	factors.1	Finally,	although	research	on	vulvodynia	is	intensified	and	evidence	is	mounting	that	different	subgroups	should	be	distinguished,	empirical	evidence	on	the	causal	mechanisms	is	largely	lacking,	which	asks	for	a	personalised	rather	than	a	‘one-size-fits-all'	approach.3,4	The	specification	of	the	type	of	vulvodynia	is	recommended	in	order	to	avoid	unwanted	uniformity	in	assessment	and	treatment.3	By	its	definition,	regarding	the	consensus	based	symptom	complex	and	the	lack	of	proven	pathological	or	pathophysiological	aetiology,	PVD	should	be	considerd	as	a	syndrome.		In	this	thesis,	PVD	refers	to	the	localised	type	of	provoked	vulvodynia,	be	it	primary	(started	from	sexarche)	or	secondary	(after	a	painless	period).	The	adjective	‘provoked’	
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addresses	the	condition	in	which	the	pain	is	elicited,	which	means	during	and	following	penetration	of	the	vagina	or	by	touching	the	vestibulum	and	the	introitus	of	the	vagina.	Because	PVD,	compared	with	unprovoked	vulvodynia,	is	the	most	prevalent	clinical	presentation	of	vulvodynia	in	primary	care,	the	focus	of	this	thesis	will	be	on	PVD.	In	this	thesis	the	concepts	PVD,	vulvodynia	and	vulvar	pain	are	used	interchangeably	as	some	referred	studies	did	not	specify	the	type	of	vulvodynia.	I	will	follow	the	nomenclature	of	the	original	referred	study	if	there	is	no	alternative,	but	the	aforementioned	ISSVD	definition	will	be	preferred	in	this	thesis.	For	the	GP	this	definition	is	sufficient	for	clinical	practice;	specification	of	the	type	of	vulvodynia	might	be	too	specific	and	only	necessary	in	the	context	of	research.		As	far	as	the	distinction	with	the	term	'dyspareunia'	is	concerned,	it	has	to	be	mentioned	that	women	with	PVD	will	experience	dyspareunia	when	having	intercourse,	but	not	every	woman	with	dyspareunia	will	have	PVD	as	dyspareunia	can	have	many	causes.			
Epidemiology  Because	of	the	various	definitions	of	PVD	being	used	in	the	past	decades,	a	broad	range	of	lifetime	prevalence	data	of	women	suffering	from	PVD	in	the	United	States	(US)	has	been	found	of	about	8-16%.5–8	The	annual	incidence	in	the	general	population	of	the	US	is	estimated	to	be	3.1-	4.7%.9–11	Almost	all	epidemiological	population	studies	are	conducted	in	the	US,	which	outcomes	may	not	be	representative	for	other	countries.	Other	population	studies	outside	the	US	are	not	very	useful	to	compare	with	because	PVD	was	not	defined	precisely	or	confused	with	‘dyspareunia’	or	these	studies	lacked	methodological	rigor.	In	the	Netherlands,	no	incidence	and	prevalence	data	of	PVD	are	known.	Yet,	a	Dutch	population	study	showed	that	5%	of	women	between	18-80	years	old	suffer	from	dyspareunia,	an	important	feature	of	PVD	but	not	sufficient	for	the	diagnosis.12	Another	Dutch	study	showed	that	of	women	younger	than	25	years	of	age,	about	25%	reported	dyspareunia	during	at	least	three	months	last	year,	and	7%	reported	regular	to	frequent	complaints	of	dyspareunia.13	However,	these	prevalence	and	incidence	data	do	not	illustrate	the	natural	course	of	PVD,	as	this	condition	is	characterised	by	remissions	and	relapses.7,9,14,15	Factors	associated	with	both	relapse	and	persistence	(compared	with	remission	alone)	include	increased	severity	of	pain	ever	or	pain	after	intercourse,	longer	duration	of	symptoms,	and	screening	positive	for	fibromyalgia.15	
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In	short,	population	based	epidemiological	data	show	that	PVD	is	not	rare,	and,	due	to	its	heterogeneous	character,	does	have	an	unstable	course.	For	a	better	understanding	of	its	heterogeneity,	a	closer	look	at	the	clinical	presentation	and	the	context	of	PVD	might	be	useful.		
Clinical presentation and examination Women	with	PVD	present	themselves	with	complaints	of	burning,	stinging	or	tearing	pain	at	the	entrance,	which	can	be	provoked	upon,	during	and	following	penetration	in	the	vagina	and	by	touching	the	vestibulum	and	the	introitus	of	the	vagina.	This	can	be	caused,	for	example,	by	sexual	intercourse,	insertion	of	a	tampon	or	a	finger,	a	gynaecologic	examination,	wearing	tight	pants	or	sitting	on	a	saddle.	The	pain	can	be	localised	on	one	spot	but	is	mostly	affecting	different	spots	in	the	vestibulum.	Often,	there	is	no	pain	in	the	absence	of	touch,	as	the	definition	of	PVD	requires,	although	burning	pain	or	dull	background	pain	can	continue	after	penetration	or	touch	and	can	last	from	minutes	to	days.	Despite	the	pain,	most	women	tend	to	persist	in	having	sexual	intercourse.16,17	Women	may	describe	a	feeling	that	something	is	blocking	their	vagina	when	they	attempt	to	have	sexual	intercourse,	a	symptom	of	pelvic	floor	overactivity.	Examination	of	the	vulva	by	a	physician	will	show	a	normal	aspect	of	the	vulva	that	is	tender	around	the	vestibulum	and/or	introitus	after	slight	pressure	with	a	cotton	swab	or	finger.	Recently,	however,	a	study	showed	that	a	positive	cotton	swab	test	cannot	be	considered	equivalent	to	PVD	as	women	without	PVD	also	can	have	painful	vestibular	spots	on	touch.18	There	might	be	localised	erythema	at	the	spots	with	maximal	tenderness,	but	this	is	a	non-specific	finding.1		The	pelvic	floor	muscles	are	typically	tense	and	tender	and	most	women	are	not	aware	how	to	control	their	pelvic	floor	muscles.	To	date,	there	is	no	gold	standard	to	diagnose	pelvic	floor	overactivity.	Any	further	investigation	should	be	directed	at	confirming	or	excluding	other	pathologies,	such	as	chronic	or	recurrent	candidiasis,	painful	dermatoses,	or	rarely,	pudendal	neuralgia.	A	bimanual	vaginal	or	speculum	examination	is	very	seldomly	needed,	as	there	is	no	pathology	of	the	internal	genital	organs	that	could	explain	the	superficial	vulvar	complaints.	Sometimes	it	could	be	useful	as	the	absence	of	pathology	might	reassure	the	woman.	Because	an	examination	is	not	indicated	to	establish	the	diagnosis	of	PVD	but	is	mainly	helpful	in	excluding	other	pathologies,	taking	a	thorough	history	should	be	the	main	
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focus	in	diagnosing	PVD.	However,	women	present	their	complaints	typically	not	in	the	way	they	are	defined.	In	a	population-based	case-control	study	in	the	US	of	women	meeting	self	reported	vulvodynia	criteria,	it	was	found	that,	although	the	most	frequent	pain	descriptors	were	"irritating",	"burning",	and	"raw",	27.8%	also	described	the	pain	as	"itchy".7	These	women	needed	an	average	of	2.5	descriptors	to	describe	their	pain.7	Besides	that	a	patient	might	feel	burning	pain	as	irritation	or	itch,	normal	physiological	vaginal	discharge	might	be	described	as	smelling	or	disgusting	or	falsely	interpreted	as	infectious.	Also,	women	themselves	are	mostly	not	able	to	determine	the	correct	diagnosis	of	vulvovaginal	candidiasis	accurately,	thus	prompting	a	physician	not	only	to	focus	on	the	assumption	of	the	women.19	Moreover,	as	studies	show,	the	physician	needs	to	be	aware	of	the	shame,	low	self-esteem	and	negative	genital	self-image	of	women	with	PVD	presenting	their	complaints.20,21	Therefore,	complaints	might	be	presented	as	compelling	or	neglectful	or	embedded	in	other	non-gynaecological	complaints,	making	it	difficult	to	establish	the	real	request	or	need	for	help.		In	summary,	a	woman	with	PVD	will	present	herself	to	a	GP	with	some	reluctance	and	describe	her	provoked	vulvar	pain	in	non-specific	terms.	During	the	examination	of	the	vulva	the	GP	will	find	a	normally	looking	vulva	that	is	tender	around	the	vestibulum	on	slight	pressure	and	also	may	find	an	overactive	pelvic	floor.	In	order	to	support	the	diagnosis	and	to	understand	the	need	for	help,	the	GP	should	involve	the	context	of	PVD	in	the	diagnostic	process.		
The context of PVD A	complaint	or	clinical	syndrome	like	PVD	is	not	limited	to	an	isolated	pathophysiological	phenomenon,	and	therefore	its	cause,	dynamics	and	clinical	presentation	should	be	understood	in	relation	to	other	bio-psycho-social	factors	like	age,	ethnicity,	comorbidity,	sexuality	and	partner	responses.	These	factors	are	considered	briefly.	
	
Age and ethnicity Although	PVD	occurs	in	women	of	all	ages,	it	is	mostly	affecting	premenopausal	women,	especially	women	between	the	age	of	20	and	40	years	old.22,23	Some	studies	in	which	data	were	adjusted	for	having	sexual	intercourse	showed	contrary	results.	Among	sexually	active	women,	the	prevalence	was	both	similar	at	all	ages	as	well	as	more	
		
	 	
 |	7	 	
prevalent	in	younger	women.7,24	The	women	in	both	studies	did	not	differ	in	ethnic	background	or	country	of	origin	(both	US).7,24	In	the	Netherlands,	three	studies	on	dyspareunia	(being	not	conclusive	for	PVD)	showed	a	higher	prevalence	in	young	women.12,25,26	Finally,	age	at	pain	onset	did	not	predict	remission,	relapse	or	persistence	of	PVD.15	 	Regarding	ethnicity,	one	web-based	survey	showed	that	the	prevalence	of	pain	was	similar	in	African	American	and	non-African	American	women23,	while	three	other	population-based	cross-sectional	studies	demonstrated	that	Hispanic	women	were	more	likely	to	experience	chronic	vulvar	pain	than	were	white	and	African	American	women.5,8,27	Race	had	no	significant	effect	on	pain	severity,	as	showed	one	study	after	adjusting	for	age,	educational	level,	pain	duration,	depression	and	functional	impairment.28	In	one	cross-sectional	study	black	and	white	women	visiting	vulvovaginal	speciality	clinics	showed	differences	in	the	clinical	presentation	of	PVD.	White	women	were	19	times	as	likely	to	report	their	pain	as	burning,	while	black	women	used	the	term	aching.29		To	date,	studies	are	ambiguous	about	the	influence	of	age	and	ethnicity	on	vulvodynia.	For	the	clinician	it	seems	more	worthwhile	to	ask	whether	one	is	sexually	active.				
	
Comorbidity 
Somatic comorbidity Women	with	PVD,	compared	to	women	without	PVD,	more	frequently	reported	comorbidities	with	moderate	to	high	Odds	ratios	(OR),	like	urinary	tract	infections	(OR	2.0-6.2)6,30,31,	candidiasis	(OR	2.1-9.9)6,30–32,	chronic	fatigue	syndrome	(OR	2.8-3.2)6,32,	fibromyalgia	(OR	2.2-9.2)6,15,30,32,	and	irritable	bowel	syndrome	(1.9-2.2).6,30	PVD	was	not	related	to	a	history	of	pregnancy	or	episiotomy,	menopausal	status,	history	or	currently	use	of	oral	contraceptive	or	IUD,	or	Premenstrual	Syndrome.6,30–32		One	study	analysed	the	pattern	of	comorbid	pain	clustering	in	a	convenience	sample	of	women	with	vulvodynia.33	Of	these	women	with	localised	vulvodynia,	58,5%	had	one	or	more	somatic	disorder	of	which	irritable	bowel	syndrome	and	fibromyalgia	were	the	most	common	comorbidities	regardless	of	the	type	of	vulvar	pain.33		Overactivity	of	the	pelvic	floor	is	another	important	physical	finding	in	vulvodynia.34	This	overactivity	could	be	perceived	as	a	guarding	mechanism,	an	initially	healthy	adaptive	and	protective	response	to	actual	or	perceived	vulvar	tissue	damage	
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(candidiasis,	unaroused	intercourse)	or	to	emotional	distress	(fear,	sexual	trauma,	PTSD),	becoming	maladaptive	over	time	for	unknown	reasons.35–37	Muscle	contractions	might	trigger	inflammatory	responses,	as	well	as	inflammation	of	the	vulvar	mucosa	may	sensitize	muscle	nociceptors	causing	contraction,	suggesting	a	vicious	cycle	of	inflammation	and	further	muscle	contraction.38	Furthermore,	it	is	hypothesized	that	repetitive	stimulation	of	pain	receptors	–	such	as	repetitive	allergic	reaction,	yeast	infections,	and	vulvovaginal	infections	–	can	result	in	chronic	local	inflammation	which	is	suggested	to	precede	the	onset	of	PVD.10,39–41	
Psychological comorbidity In	general,	chronic	pain	is	highly	comorbid	with	anxiety	and	depression,	as	pain	catastrophizing	and	a	lack	of	dispositional	optimism	are	risk	factors	for	increased	pain	perception,	especially	with	a	coexistent	depressed	mood.42–44	Women	with	PVD	reported	more	anxiety,	more	catastrophizing	thoughts,	hypervigilance	and	fear	of	pain	compared	with	controls.45,46	Moreover,	in	one	case-control	study	women	with	PVD	showed	ten	times	more	an	anxiety	disorder	and	three	times	more	a	depression	before	the	onset	of	PVD,	and,	vice	versa,	PVD	was	followed	by	new	or	recurrent	depressive	or	anxiety	disorders.47	Three	population-based	studies	(of	which	one	was	a	longitudinal	study)	also	showed	that	women	with	PVD	had	a	three	times	higher	risk	of	depression.6,15,30	Finally,	women	with	PVD	more	often	have	a	history	of	sexual	and	physical	abuse	and	of	social	trauma	(e.g.	bullying)	than	women	without	PVD.48		
Comorbidity: causal and maintaining factors in a vicious circle It	could	be	tempting	to	perceive	the	somatic	and	psychological	comorbidity	as	being	the	cause	of	PVD.	However,	the	direction	of	causality	is	not	clear	due	to	the	lack	of	prospective,	longitudinal	studies,	controlling	for	the	temporal	relation	of	the	various	complaints	and	symptoms.	Yet,	some	efforts	are	being	made	to	clarify	the	onset	and	time	course	of	PVD.		Three	longitudinal	population-based	studies,	prospectively	determining	probabilities	of	remission,	relapse,	and	persistence	among	women	screening	positive	for	PVD,	showed	that	onset	of	PVD	is	more	likely	among	those	with	pre-existing	sleep	disorder,	psychological	problems	(PTSD,	depression),	preceding	mild	vulvar	symptoms,	pain	history	(dyspareunia	and	pain	with	oral	sex	or	partner	touch),	and	comorbid	pain	disorders	(irritable	bowel	syndrome,	fibromyalgia).10,15,24	Furthermore,	women	with	chronic	vulvar	pain	were	two	to	eight	times	more	likely	to	report	difficulty	and	pain	
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with	their	first	tampon	use	than	were	women	without	chronic	vulvar	pain.5,11,22	It	was	suggested	that	PVD	is	an	episodic	condition	with	a	potentially	identifiable	prodromal	phase.24		Inflammatory	tissue	responses,	pelvic	floor	overactivity	and	emotional	distress	(by	catastrophizing	for	example)	are	all	–	in	the	end	-	maladaptive	mechanisms	interdependently	contributing	to	PVD	and	likely	acting	within	a	cyclical	model,	in	which	the	acute	nociceptive	pain	of	the	vulva	develops	into	chronic	pain,	as	a	result	of	central	sensitization	and	altered	descending	modulation	of	the	central	nervous	system,	maintained	by	emotional	distress	and	pelvic	floor	overactivity.10,31,39–41,45,49–51	Therefore	it	is	hypothesized	to	approach	PVD	as	a	multifactorial	chronic	pain	disorder.		As	sexual	behaviour	(including	relational	aspects	and	partner	responding	to	PVD)	might	play	an	important	role	in	maintaining	or	eliciting	this	maladaptive	process,	these	factors	need	to	be	explored	in	more	detail.3,16,45	
	
Sexuality In	general,	PVD	is	associated	with	decreased	sexual	satisfaction	and	with	significantly	lower	levels	of	sexual	desire	and	arousal.6,32,52,53	One	might	assume	that	these	sexual	problems	in	women	with	PVD	are	due	to	a	predisposing	pathophysiological	condition	leading	to	an	inadequate	genital	sexual	response	i.e.	lack	of	lubrication.	However,	this	has	not	been	proven.	Research	conducted	in	laboratory	settings	indicates	that	there	are	no	significant	differences	between	women	with	vulvovaginal	pain	and	asymptomatic	women	in	their	genital	responsiveness;	there	was	no	evidence	for	impaired	genital	responsiveness	associated	with	dyspareunia.54–56	On	the	other	hand,	women	with	vulvovaginal	pain	experience	significantly	more	negative	affect,	due	to	a	negative	appraisal	of	sexual	stimuli.54	It	was	demonstrated	that	fair	of	pain	determines	genital	responsiveness	in	both	sexually	dysfunctional	and	functional	women.54	Moreover,	many	women	with	dyspareunia	mention	feelings	of	guilt,	shame,	embarrassment,	failure,	and	inadequacy.57–59	Also,	negative	self-image	cognitions	about	vaginal	penetration	and	feelings	and	beliefs	about	one's	own	body	and	genitals	are	associated	with	increased	pain	intensity,	sexual	dysfunction,	and	sexual	distress	in	women	with	dyspareunia.21,60			Contrary	to	what	might	be	presumed,	it	is	not	self-evident	that	women	with	vulvodynia	abstain	from	sexual	intercourse;	only	a	minority	of	the	women	stops	having	intercourse	due	to	their	vulvodynia.5–7,23,32	A	few	studies	explored	the	motives	why	women	do	
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persist	having	intercourse	despite	the	pain.	A	qualitative	study	showed	that	a	perceived	ideal	woman	had	several	distinct	characteristics,	such	as	being	perceptive	of	her	partner’s	sexual	needs,	and	being	able	to	satisfy	her	partner.61	Also,	having	sexual	intercourse	per	se	was	considered	to	be	an	affirmation	of	being	a	normal	woman,	irrespective	of	pain	or	discomfort.61	This	was	confirmed	by	a	recent	study	in	which	the	high	pain	group	reported	more	pain,	fear	of	pain,	and	a	stronger	tendency	to	continue	with	sex	despite	the	pain	when	perceiving	themselves	as	sexually	less	competent	and	when	this	perception	did	not	match	their	ideal	self.62	This	‘task	persistence’	and	maladaptive	beliefs	were	also	seen	in	a	questionnaire	study	among	women	with	superficial	dyspareunia.16	They	exhibited	more	mate	guarding	and	duty/pressure	motives	for	intercourse	and	were	less	sexually	autonomous	than	controls.	Furthermore,	symptomatic	women	had	more	maladaptive	penetration-related	beliefs	than	controls,	for	example	about	genital	incompatibility	and	catastrophic	beliefs.16	Women	experienced	intercourse	as	an	obligation	during	the	period	they	suffer	pain,	and	77%	reported	fearing	that	vulvar	pain	would	ruin	their	relationship.63		Heterosexual	women	who	experienced	sexual	desire	loss	or	vulvar	pain,	negotiated	sexual	contact	in	the	context	of	a	relationship	by	avoiding	potentially	intimate	situations,	engaging	in	intercourse	although	it	was	painful	or	sexual	desire	was	absent,	and	mentally	planning	and	preparing	themselves	for	sex.	Other	sexual	activities	were	almost	always	regarded	as	a	prelude	to	intercourse,	yet	around	half	of	the	sample	had	adapted	their	sexual	repertoire	to	compensate	for	an	absence	of	intercourse.64	One	qualitative	study	demonstrated	the	relevance	of	the	loss	of	femininity/sexual	identity,	and	the	centrality	of	sex	within	relationships.65	The	participants	in	this	study	did	not	report	the	actual	pain	as	being	the	central	issue	of	PVD,	rather	they	emphasized	the	meaning	the	vulvar	pain	had	for	their	identity	and	relationships	as	the	central	concern	in	coping	with	this	condition.65	In	summary,	the	sexual	impairment	due	to	PVD	can	be	seen	on	the	level	of	sexual	experience,	sexual	identity	and	sexual	behaviour,	and	cannot	be	understood	without	involving	the	relationship	with	the	sexual	partner	as	this	involvement	requires	her	to	be	a	‘normal’	woman	for	herself.	
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Partner relationship Findings	of	a	systematic	review	that	examined	relationship	adjustment	and	sexual	satisfaction	among	women	with	vulvar	pain,	indicate	that	though	PVD	is	associated	with	reduced	sexual	satisfaction,	women	and	their	partners	do	not	necessarily	experience	general	relationship	maladjustment.52	Apparently,	the	aforementioned	strategy	in	negotiating	sexual	contact	in	the	context	of	a	relationship	seems	to	have	benefit	for	women	regarding	their	relationship,	though	at	the	expense	of	sexual	satisfaction.64		Facilitating	male	partner	responses,	i.e.	showing	encouragement	of	adaptive	coping,	for	example	engaging	in	non-painful	sexual	behaviour,	may	improve	sexual	functioning.66	Solicitous	responses	(i.e.	showing	too	much	attention	and	sympathy,	suggesting	to	stop	engaging	in	all	sexual	activity)	and	negative	responses	(showing	hostility	and	frustration)	may	be	detrimental.66	This	association	between	perceived	facilitating	partner	responses	and	their	improved	sexual	function	and	satisfaction,	was	greater	when	women	were	more	sexually	assertive.67	Also,	a	collaborative	sexual	communication	pattern	such	as	mutually	expressing	feelings	or	problem	solving	was	found	to	benefit	couples’	sexual	and	relational	well-being.	A	negative	sexual	communication	pattern	e.g.	withdrawing	or	criticising,	was	found	to	impede	sexual	and	relational	adjustment	to	PVD.68		Male	partners	as	well	may	experience	negative	consequences	of	the	painful	condition	of	their	partner	with	PVD.	Almost	73%	of	partners	reported	a	negative	relational	impact	of	vulvar	pain.69	Partners	reported	significantly	poorer	sexual	communication	and	erectile	function,	and	less	sexual	satisfaction	compared	with	controls.	They	also	reported	significantly	less	expression	of	affection	within	their	relationships	and	were	more	likely	than	controls	to	report	a	discrepancy	between	their	relationship	and	their	idea	of	a	satisfying	relationship.69	Moreover,	partners	might	develop	attributions	about	the	condition	of	PVD,	for	example,	thinking	that	the	pain	is	their	fault,	thinking	that	the	pain	will	never	vanish,	feelings	of	inadequacy	of	being	a	good	lover	or	insecurity	whether	they	might	be	partly	responsible	for	the	pain.70	These	attributions	were	related	to	lower	relationship	and	sexual	satisfaction.70		Recently,	a	study	examined	characteristics	of	vulvar	pain	in	lesbian,	bisexual,	and	heterosexual	women	and	investigated	associations	between	relationship	qualities	with	participants’	perceptions	of	pain’s	influence	on	relationships.71	Characteristics	of	vulvar	pain	were	similar	across	groups.	Groups	differed	in	how	they	perceived	pain	to	impact	
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their	relationships,	such	that	better	communication	for	same-sex	couples	and	greater	romantic	love	for	mixed-sex	couples	was	associated	with	the	perception	of	their	pain	as	having	less	of	an	effect	on	their	relationship	functioning.71	Summarizing	the	factors	a	woman	and	her	partner	are	faced	with	once	PVD	is	involved,	one	can	conclude	that	the	kind	of	attribution	and	communication	patterns	of	the	male	partner,	his	facilitating	role,	as	well	as	different	relationship	qualities	in	same-sex	or	mixed-sex	couples,	are	important	in	maintaining	a	good	relationship	in	order	to	cope	with	PVD.		All	together,	taking	into	account	the	complexity	of	the	physical	complaints	of	PVD,	elicited	and	maintained	by	its	bio-psycho-social	context	(age,	ethnicity,	comorbidity,	sexuality,	partner	responses,	shame,	low	self-esteem,	negative	genital	self-image	and	problems	to	recognize	and	present	the	complaints),	some	women	will	be	asking	themselves	on	a	certain	point:	“what	is	going	on	and	who	can	offer	me	a	solution	for	my	problem?”	In	other	words,	for	some	women	the	next	step	might	be	to	seek	health	care.		
Health care seeking of women with PVD A	population	study	in	two	distinct	geographic	regions	in	the	US	demonstrated	that	43%	of	women	with	self-reported	PVD	never	sought	treatment,	41%	had	seen	three	or	more	clinicians	and	52%	who	sought	care	received	no	diagnosis.8	Accordingly,	these	data	were	confirmed	in	other	population	based	studies	in	the	US.5,7		As	these	studies	show,	searching	for	help	does	not	guarantee	a	fast	and	definite	diagnosis.	Most	of	the	women	had	been	diagnosed	with	oestrogen	deficiency	(39.5%	of	those	given	one	or	more	diagnoses),	or	a	yeast	infection	(36.9%),	but	nevertheless,	despite	treatment	directed	at	the	supposed	cause,	they	still	reported	symptoms	consistent	with	vulvodynia.	Only	5.7%	of	those	given	a	diagnosis	had	been	given	the	diagnosis	of	vulvodynia.7	The	mean	duration	of	the	current	pain	-	due	to	both	delay	in	seeking	for	care	and	failure	of	the	management	by	physicians	-	was	12.4	years	with	a	range	of	0.5	to	48	years,	and	a	median	of	8.0	years.7		One	prospective	study	found	an	average	duration	of	symptoms	of	38	months	before	consulting	a	health	care	provider	for	the	first	time.72	Women	with	clinically	confirmed	PVD	who	were	seeking	treatment	through	a	multidisciplinary	program	of	a	tertiary	centre	in	Canada,	reported	a	mean	duration	of	vulvar	pain	symptoms	of	59	months.73	
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Moreover,	illustrating	both	the	difficulty	in	establishing	a	correct	diagnosis	and	the	poor	state	of	evidence	based	treatment	of	PVD,	one	prospective	study	reported	that	the	most	common	therapeutic	interventions	previously	tried	by	patients,	were	antifungal	medication	(54%),	antibiotics	(45%),	topical	corticosteroids	(43%)	and	oestrogen	cream	(27%).72	These	women	stated	that	more	than	64%	of	the	time	these	interventions	made	their	symptoms	worse	or	no	better.72	Apparently,	knowledge	of	diagnosis	and	treatment	of	PVD	is	poor	in	GPs	and	gynaecologists.74	Obviously,	many	women	with	vulvodynia	are	not	seeking	care,	and	of	those	who	did	seek	care	the	complaints	on	average	lasted	three	to	five	years	before	a	correct	diagnosis	was	established.	So,	there	is	a	doctor's	delay	and	a	patient's	delay.	Women	reported	that	the	delay	in	diagnosis	adversely	affected	them	and	increased	the	severity	of	their	symptoms.75	Only	after	receiving	a	diagnosis,	they	took	the	first	step	on	a	path	toward	the	acceptance	of	a	chronic	condition	and	a	commitment	to	a	management	program.75		What	do	women	with	PVD	tell	us	about	their	own	role	in	the	delay	of	and	the	process	towards	the	correct	diagnosis?	In	a	systematic	review	regarding	treatment-seeking	decisions	in	women	with	vulvodynia,	it	was	found	that	women’s	delay	in	seeking	treatment	for	vulvar	pain	was	associated	with	believing	that	the	pain	is	normal	and	will	disappear	by	itself	or	cannot	be	cured,	with	doubts	about	the	effectiveness	of	medical	assistance,	with	fears	that	the	severity	of	the	condition	might	represent	a	disease,	or	with	the	stigma	of	having	a	sexual	problem.76	Also,	a	phenomenological	analysis	of	interviews	with	women	showed	that	uncertainty	surrounding	the	diagnosis	was	an	important	theme.	Women	expressed	disappointment	about	the	lack	of	a	somatic	cause	for	their	pain	and	the	suggestion	that	psychological	factors	may	explain	their	complaints	raised	feelings	of	distress	and	shame	or	failure	and	rejection.76–78	Some	authors	emphasise	the	important	role	of	the	social	context	in	which	this	physician-patient	relationship	takes	place.58,79,80	They	indicate	that	women	who	experience	sexual	pain	have	been	eager	for	medicalization	as	a	path	to	minimising	pain	during	sexual	activity	and	reinstating	normative	heterosexual	practices	(‘the	coital	imperative’)	and	identities.	These	goals,	as	the	authors	state,	have	been	lobbied	for	by	patient	advocacy	groups	and	noted	by	professionals	in	the	field.	Although	there	are	some	clear	benefits	to	this	case	for	medicalization,	the	desire	for	profit	may	conceal	understandings	and	approaches	to	treatment,	downplaying	the	social	context	in	which	women’s	sexual	experiences	take	place,	as	the	authors	conclude.79,80		
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In	short,	health	care	seeking	of	women	with	PVD	is	not	as	self-evident	as	one	might	expect.	Quantitative	and	qualitative	research	demonstrates	barriers	to	both	physicians	and	patients.	In	the	Dutch	health	care	system,	in	her	role	as	gatekeeper,	the	general	practitioner	(GP)	would	be	the	most	obvious	health	care	provider	to	identify	the	woman’s	problem,	to	put	it	in	the	right	context	in	providing	her	psycho-education,	and,	if	needed,	to	refer	her	to	a	sexologist	or	gynecologist.	Therefore,	it	is	necessary	to	look	to	what	extent	GPs	are	familiar	with	PVD	and	how	they	cope	with	it.			
PVD in primary care In	the	past,	vulvodynia	probably	was	occasionally	described	by	GPs,	although	vulvodynia	was	not	defined	and	the	term	PVD	or	focal	vulvitis	was	not	coined	as	such.	In	an	article	from	1948,	the	histories	of	a	unselected	series	of	349	cases	of	dyspareunia	among	women	with	“neuroses	and	psychosomatic	symptoms”	were	reviewed	and	the	most	remarkable	in	reading	this,	was	that	after	70	years	nothing	is	new.81	In	1993,	two	Dutch	GPs	studied	the	factors	associated	with	‘microbiologically	unexplained’	vaginal	symptoms,	the	course	of	symptoms	and	signs	in	these	cases,	and	factors	modifying	this	course.	It	seems	very	likely	that	the	authors	in	this	study	unknowingly	were	describing	vulvar	vestibulitis	syndrome/PVD.82	Vulvovaginal	complaints	are	frequently	presented	in	general	practice.	About	25-30%	of	women	with	vulvovaginal	complaints	remains	without	a	microbiologically	explained	diagnosis,	even	after	careful	evaluation.82–85	Approximately	25	per	1000	female	patients	per	year	visit	their	general	practitioner	(GP)	with	vulvovaginal	candidiasis,	the	most	frequent	cause	of	vulvovaginal	complaints.86	Dutch	GPs	reported	106	consultations	concerning	vaginal	candidiasis	per	practice	per	year.87	In	the	Netherlands,	as	well	as	in	other	countries,	no	incidence	and	prevalence	data	of	PVD	are	known,	mainly	due	to	the	fact	that	PVD	is	not	included	in	the	International	Classification	of	Primary	Care.	Though	dyspareunia	is	an	important	but	not	conclusive	feature	of	PVD,	research	on	PVD	in	general	practice	might	be	illustrated	by	using	studies	on	dyspareunia.	In	Dutch	family	practices,	the	incidence	of	dyspareunia	(ICPC-code	X04)	is	about	1.0	/	1000,	especially	in	young	women	(incidence	of	3.4	/	1000	in	the	age	cohort	of	20-24	years).88	This	incidence	is	much	lower	than	the	incidence	in	the	Dutch	population.12,13	Although	this	phenomenon	(high	prevalence	and	incidence	in	the	population	versus	low	prevalence	and	incidence	in	general	practice)	is	common	for	all	
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kinds	of	complaints,	it	is	also	compelling,	because	women	may	suffer	unnecessary	from	their	complaints.	An	overview	of	research	demonstrates	that	an	unfulfilled	need	for	help	is	not	related	to	the	subject	PVD	itself,	but	to	sexual	problems	in	general.88–93		A	systematic	review	of	qualitative	studies	in	the	period	2003-2013	explored	GPs'	experiences	of	discussing	sexuality	with	adult	service	users.	The	most	important	themes	in	the	eight	included	articles	were	fear	about	"opening	up	a	can	of	worms",	lack	of	time,	resources,	and	training,	concern	about	knowledge	and	abilities,	worry	about	causing	offence,	personal	discomfort,	and	a	lack	of	awareness	about	sexual	issues.90	Some	themes	were	particularly	marked	relating	to	the	sexuality	of	the	opposite-gender,	black	and	ethnic	minority	groups,	older	and	non-heterosexual	service	users,	and	those	with	intellectual	disabilities.90	Other	studies	among	GPs	in	Europe	confirm	these	results.91–93	In	a	survey	that	was	directed	at	GPs	to	assess	the	extent	of	vulvodynia	in	the	primary	health	care	setting	in	North-West	of	England,	the	authors	concluded	that	women	with	vulvar	complaints	commonly	attended	their	GP	but	were	inadequately	investigated	and	inappropriately	managed.94	There	are	indications	that	offering	support	to	GPs,	for	example	by	using	a	short	questionnaire	or	following	a	training,	can	help	them	discuss	sexual	issues	with	their	patients,	although	the	real	impact	of	these	interventions	on	physician-patient	contact	and	patient	satisfaction	was	not	considered.95–97		What	may	be	expected	from	the	Dutch	GP	regarding	diagnosis	and	management	of	PVD?	In	2009,	the	‘Werkgroep	Actualisering	Eindtermen	en	Competenties’,	establishing	goals	and	competencies	for	GP	trainees,	was	very	clear	in	its	statement	regarding	sexual	and	vulvar	complaints.98	The	Werkgroep	stated	that	the	GP	should	be	able	"to	identify	sexual	problems	and	identify	the	main	causes	thereof,	and	to	conduct	an	adequate	diagnostic	and	therapeutic	policy	independently	or	by	referring	to	the	specialised	care."	The	GP	should	also	be	able	“to	identify	the	causes	of	vaginal	secretion,	other	vaginal	complaints,	and	vulvar	diseases,	and	to	conduct	an	adequate	diagnostic	and	therapeutic	policy	independently,	and	to	refer	if	indicated."98	In	2015	the	subject	of	PVD	was	included	in	the	Dutch	GPs	Guideline	on	Sexual	Complaints	which	provides	recommendations	on	diagnostics	and	management.99			
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In	short,	studies	in	general	practice	show	that	PVD	is	present	in	general	practice,	and	that	women	may	suffer	from	it	although	at	times	hidden	as	recurrent	or	unexplained	vulvo-vaginal	symptoms.	Moreover,	in	general	GPs	lack	the	knowledge	and	skills	to	diagnose	and	manage	this	problem.		
Study aim and research questions The	main	aim	of	this	PhD	project	is	to	gain	insight	about	whether	and	how	GPs	could	involve	PVD	in	their	diagnostic	process	when	women	present	themselves	with	vulvovaginal	complaints.	Improvement	of	the	competencies	of	the	GP	on	this	issue	might	lead	to	improvement	of	the	quality	of	health	care	for	these	women,	as	an	early	diagnosis	and	an	adequate	management	are	necessary	to	break	the	vicious	circle	of	both	the	chronic	pain	and	the	medicalization.		To	achieve	these	goals	the	following	research	questions	with	their	rationale	are	briefly	formulated:	1. Do	women	between	15-50	years	old,	who	are	visiting	a	GP	with	specific	vulvovaginal	complaints	suggestive	of	PVD,	have	a	higher	probability	of	certain	specified	comorbidities	than	women	of	a	similar	age	without	PVD?	Rationale:	Although	studies	in	the	population	and	in	tertiary	centres	show	that	there	are	associations	between	PVD	and	other	conditions,	it	is	not	yet	clear	which	comorbidities	are	associated	with	PVD	in	women	visiting	a	GP.	The	presence	of	these	specific	vulvovaginal	symptoms	in	the	context	of	these	comorbidities	could	assist	GPs	to	recognise	and	identify	PVD	at	an	earlier	stage.	The	results	of	this	study,	a	retrospective	cohort	analysis,	collecting	data	in	a	research	database	of	family	practices,	are	presented	in	Chapter	2:	Comorbidities	among	
women	with	vulvovaginal	complaints	in	family	practice.	2. Do	women	with	uncertain	vulvovaginal	candidiasis	(VVC)	differ	from	women	with	certain	VVC	with	respect	to	characteristics	associated	with	PVD	and	–	given	the	doctor’s	delay	-	do	GPs	differently	manage	certain	or	uncertain	VVC,	and	if	so,	how?		Rationale:	The	aim	of	this	study	was	to	investigate	whether	the	relationship	found	between	VVC	and	PVD	in	many	studies,	might	also	be	explained	by	the	fact	that	women	with	VVC	possibly	are	diagnosed	incorrectly,	in	fact	covering	a	subgroup	of	women	with	PVD.			
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The	results	of	a	study	with	data	prospectively	collected	in	2014	in	Dutch	family	practices	of	the	NIVEL	Primary	Care	Database,	are	presented	in	Chapter	3:	Is	
uncertain	vulvovaginal	candidiasis	a	marker	of	vulvodynia?	A	study	in	a	general	
practice	research	database.	3. What	is	the	state	of	the	art	of	the	exact	relationship	between	VVC	and	PVD?	Rationale:	The	relationship	of	Candida	infections	in	PVD	has	remained	unclear	but	often	confirmed,	which	might	maintain	medicalization	of	the	problem.	In	case	the	relationship	is	causal,	then	it	might	be	relevant	for	how	GPs	treat	VVC.	The	results	of	a	systematic	review	are	presented	in	Chapter	4:	The	relationship	
between	provoked	vulvodynia	and	vulvovaginal	candidiasis,	a	systematic	review.	4. Which	barriers	and	facilitators	are	affecting	the	diagnostic	process	of	GPs	who	are	confronted	with	(persistent	and	recurrent)	vulvovaginal	complaints?	Rationale:	In	order	to	improve	the	recognition	of	PVD,	it	is	important	to	know	more	precisely	the	diagnostic	considerations	of	GPs	when	consulted	by	women	with	vulvovaginal	complaints.	The	results	of	a	qualitative	focus	group	study	in	GPs	are	presented	in	Chapter	5:	
Facilitators	and	barriers	in	the	diagnostic	process	of	vulvodynia	in	general	practice:	a	
qualitative	study.	5. Which	barriers	and	facilitators	affect	women	with	PVD	and	what	do	they	expect	and	experience	when	they	consulted	a	GP?		Rationale:	By	investigating	women’s	consultation	experiences,	it	will	be	possible	to	determine	whether	all	the	necessary	components	for	making	a	correct	diagnosis,	like	taking	a	sexual	history,	performing	a	vulvovaginal	examination,	discussion	of	possible	treatment	options	and	referral,	are	addressed.	An	overview	of	the	unmet	needs	and	the	facilitating	factors	in	their	consultation	by	their	GP	may	help	improve	both	the	diagnostic	as	well	as	the	management	of	vulvovaginal	complaints	in	primary	care.	The	results	of	in	depth	interviews	are	presented	in	Chapter	6:	Women’s	opinions	of	
the	diagnostic	management	of	vulvovaginal	symptoms	by	their	general	practitioner.			
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Abstract 
Background:	The	lifetime-prevalence	of	women	suffering	from	provoked	vestibulodynia	(PVD)	is	estimated	to	be	approximately	15%.	The	etiology	of	PVD	is	not	yet	clear.	Recent	studies	approach	PVD	as	a	chronic	multifactorial	sexual	pain	disorder.	PVD	is	associated	with	pain	syndromes,	genital	infections	and	mental	disorders,	which	are	common	diseases	in	family	practice.	PVD,	however,	is	not	included	in	the	International	Classification	of	Primary	Care.	Hence,	the	vulvovaginal	symptoms,	which	could	be	suggestive	of	PVD,	are	likely	to	be	missed.	
Aim:	To	explore	the	relationship	between	specific	vulvovaginal	symptoms	which	could	be	suggestive	of	PVD	(genital	pain,	painful	intercourse,	other	symptoms/complaints	vagina/vulva)	and	related	diseases	such	as	pain	syndromes,	psychological	symptom	diagnoses	and	genital	infections	in	family	practice.	
Methods:	A	retrospective	analysis	of	all	episodes	from	1995-2008	in	784	women	between	15-49	years	were	used	in	order	to	determine	the	posterior	probability	of	a	selected	diagnosis	in	the	presence	of	specific	vulvovaginal	symptoms	suggestive	of	PVD	expressed	in	an	odds	ratio	(OR).	Selected	comorbidities	were	pain	syndromes	(muscle	pain,	general	weakness,	irritable	bowel	syndrome	(IBS)),	psychological	symptom	diagnoses	(anxiety,	depression,	insomnia),	vulvovaginal	candidiasis	and	sexual	and	physical	abuse.		
Results:	Women	with	symptoms	suggestive	of	PVD	were	4	to	7	times	more	likely	to	be	diagnosed	with	vulvovaginal	candidiasis	and	2	to	4	times	more	likely	to	be	diagnosed	with	IBS.	Some	symptoms	suggestive	of	PVD	were	1	to	3	times	more	likely	to	be	diagnosed	with	complaints	of	muscle	pain,	general	weakness,	insomnia,	depressive	disorder	and	feeling	anxious.		
Conclusion:	Data	from	daily	family	practice	showed	a	clear	relationship	between	symptoms	suggestive	of	PVD	and	the	diagnoses	of	vulvovaginal	candidiasis	and	IBS	in	premenopausal	women.	Possibly,	family	doctors	make	a	diagnosis	of	vulvovaginal	candidiasis	or	IBS,	of	which	the	diagnosis	is	only	based	upon	clinical	manifestations,	in	many	women	in	whom	a	diagnosis	of	PVD	would	be	more	appropriate.	
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Introduction Although	infections	and	dermatoses	are	well-known	causes	of	vulvar	pain,	in	most	cases	vulvar	pain	is	unexplained.1	The	International	Society	for	the	Study	of	Vulvar	Disease	defines	provoked	vestibulodynia	(PVD)	as	‘vulvar	discomfort,	most	often	described	as	burning	pain,	occurring	in	the	absence	of	relevant	visible	findings	or	a	specific,	clinically	identifiable,	disorder’.2	The	unexplained	pain	can	be	provoked	upon,	during	and	following	penetration	of	the	vagina	and	by	touching	the	vestibulum	and	the	introitus	of	the	vagina.	Dyspareunia,	pain	during	sexual	intercourse,	or	during	other	forms	of	vaginal	penetration	with	sexual	activity,	is	the	most	common	symptom	experienced	by	women	with	PVD.	Although	sometimes	present,	erythema,	warts,	naevi,	and	cysts	are	usually	normal	findings,	and	therefore	they	are	neither	relevant	for	diagnosticating	PVD	nor	responsible	for	vulvar	discomfort.	Other	names	used	in	the	past	to	describe	PVD	included	vulvar	vestibulitis	syndrome	and	focal	vulvitis,	both	with	the	misleading	suffix	of	–itis.	PVD	is,	however,	not	an	inflammation.2	The	lifetime	prevalence	of	women	suffering	from	PVD	has	been	estimated	at	8-16%.1	It	occurs	in	women	of	all	ages,	but	especially	women	between	the	age	of	20	and	40	years	old	are	affected.1	A	Dutch	population	study	showed	that	4.9%	of	women	between	18-70	years	old	suffer	from	dyspareunia	and	11%	of	women	younger	than	25	years	of	age	report	regular	to	frequent	complaints	of	dyspareunia.3,4	Recent	studies	approach	PVD	as	a	chronic	pain	disorder,	which	is	likely	multifactorial.	The	pain	is	explained	as	an	abnormal	pain	perception,	where	peripheral	pain	turns	into	neuropathic	pain.5-8	PVD	is	associated	with	pain	syndromes	such	as	fibromyalgia,	fatigue,	sleep	disorders,	interstitial	cystitis	and	irritable	bowel	syndrome	(IBS).9-11	Dysmenorrhea	is	common	in	women	with	pelvic	pain	and	PVD.12	In	addition,	compared	to	women	without	PVD,	women	with	PVD	experience	more	pain	during	intercourse	and	they	experience	a	reduced	sexual	response	with	loss	of	sexual	satisfaction	and	desire	and	they	report	more	anxiety,	in	addition	to	more	catastrophizing,	hypervigilance	and	fear	of	pain.13.14	Vulvodynia	may	lead	to	new	or	recurrent	depressive	or	anxiety	disorders	and	vice	versa.15	Women	with	PVD	more	often	have	a	history	of	sexual	and	physical	abuse	than	women	without	PVD.16	PVD	is	not	included	in	the	International	Classification	of	Primary	Care	(ICPC),	nor	were	the	terms	vulvar	vestibulitis	syndrome	or	focal	vulvitis.	Hence,	the	multifactorial	nature	of	vulvovaginal	symptoms,	which	could	be	suggestive	of	PVD,	is	likely	to	be	missed	in	
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family	practice.	In	Dutch	family	practices	the	incidence	of	painful	intercourse	is	about	1.0	/	1000,	especially	in	young	women	(incidence	of	3.4	in	age	cohort	of	20-24	years).17	About	half	of	the	women	with	vulvar	pain	seek	medical	care,	visiting	multiple	health	care	providers.18	Not	all	of	these	providers	are	familiar	with	the	symptoms	of	PVD.	This	lack	of	knowledge	may	lead	to	the	delay	in	diagnosis	and	management,	as	one	study	found	an	average	duration	of	symptoms	before	consulting	a	health	care	provider	for	the	first	time	of	38	months.19	It	also	may	explain	the	gap	between	the	relatively	high	prevalence	of	these	complaints	in	the	general	population	and	the	low	incidence	in	Dutch	family	practice.		
Aims Although	some	studies	show	that	there	are	associations	between	PVD	and	other	conditions	like	genital	infections	and	pain	syndromes,	it	is	not	yet	clear	which	comorbidities	are	associated	with	PVD	in	women	visiting	a	Family	Practitioner	(FP).	The	aim	of	this	study	was	to	examine	comorbidities	of	women	with	specific	vulvovaginal	symptoms	(which	could	be	suggestive	of	PVD)	between	15-50	years	old	in	family	practice.	The	presence	of	these	specific	vulvovaginal	symptoms	in	the	context	of	these	comorbidities	could	assist	FPs	to	recognize	and	treat	PVD	in	an	earlier	stage.	Therefore	we	formulated	the	following	research	question:	do	women	between	15-50	years	old,	who	are	visiting	a	FP	with	specific	vulvovaginal	complaints	suggestive	of	PVD,	have	a	higher	probability	of	certain	specified	comorbidities	than	women	of	a	similar	age	without	PVD?		
 
Methods 
Study design  In	this	retrospective	cohort	analysis,	the	collected	data	were	based	upon	a	set	of	specific	diagnoses	registered	in	a	research	database	of	family	practices,	the	‘Transition	project’.20	Therefore	we	selected	a	broad	range	of	diagnoses	that	seem	most	likely	to	be	associated	with	PVD	and	some	symptoms	suggestive	of	PVD.	The	episodes	of	comorbidities	should	at	least	comprise	10	episodes	to	achieve	reliable	data-analysis.	Otherwise	the	Odds	will	have	very	broad	confidence	intervals	with	no	clinical	importance.	
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Data source All	encounters	between	1995	and	2008	recorded	in	the	dataset	of	the	‘Transhis	recording’	system	(electronic	medical	recording	in	family	practice),	representing	48,959	patient-years	in	the	age	group	15-49	years,	were	used.	Because	the	dataset	should	be	considered	as	an	open	cohort	(some	patients	are	included	only	for	some	months),	a	patient-year	is	a	better	epidemiological	variable	than	a	patient.	The	family	practices	participating	in	the	project	recorded	details	of	all	their	patient	encounters	in	the	electronic	medical	record.	The	urban	(n=4)	and	rural	practices	(n=3)	participating	in	the	Transition	project	are	situated	in	the	western	and	northern	part	of	the	Netherlands.	All	encounters	were	documented	according	to	the	ICPC.21	The	diagnoses	were	stored	in	“episodes	of	care”,	which	are	followed	longitudinally.	An	“episode	of	care”	is	defined	as	a	health	problem	in	an	individual	from	the	first	encounter	until	the	completion	of	the	last	encounter	with	a	health	care	provider.	During	the	“episodes	of	care”	the	episode	title	(the	diagnosis)	can	be	modified,	for	example	when	vulvar	pain	has	been	caused	by	a	candida	infection.	During	each	visit	a	patient’s	reason	for	encounter	is	documented	and	coded	as	well	as	the	episode	title,	treatment	and	referral.	The	reliability	of	the	registration	and	coding	preciseness	of	this	recording	system	is	estimated	to	be	higher	than	usual	for	family	practices,	because	of	the	use	of	well-defined	diagnostic	criteria	and	a	warning	system	in	case	of	errors	or	inconsistencies.21		
	
PVD The	ICPC	system	does	not	provide	a	specific	code	for	PVD.	X-codes	present	in	the	ICPC	system	were	examined	to	identify	codes	representing	or	suggesting	PVD.	The	following	codes	were	included	to	approximate	the	diagnosis	PVD:	X01	(Genital	pain),	X04	(Painful	intercourse),	X15	(Other	symptoms/complaints	vagina,	excluding	an	infection)	and	X16	(Other	symptoms/complaints	vulva,	excluding	an	infection).		
	
Comorbidities Based	on	the	literature	a	selection	of	comorbidities	associated	with	PVD	was	made,	including	pain	syndromes,	mental	disorders,	vulvovaginal	candidiasis,	and	sexual	and	physical	abuse.7-16	The	following	episode	titles	(described	by	their	ICPC	code)	were	included:	
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1. Pain	syndromes:	Muscle	pain	(L18),	General	weakness/tiredness	(A04),	Irritable	bowel	syndrome	(D93),	Painful	period	(X02).	2. Mental	disorders	and	symptom	diagnoses:	Feeling	anxious/nervous/tense	(P01),	Feeling	depressed	(P03),	Disturbances	of	sleep/insomnia	(P06),	Anxiety	disorder/anxiety	state	(P74),	Depressive	disorder	(P76).	3. Vulvovaginal	candidiasis	(X72).	4. Sexual	and	physical	abuse	(Z12,	Z16,	Z25).	
Data analysis The	unit	of	analysis	was	a	group	of	female	patients	between	15-49	years	with	episode	titles	X01,	X04,	X15	and	X16.	For	the	analysis	in	the	population	sample,	episode	titles	per	year	for	the	various	comorbidities	were	compared	between	women	with	and	without	these	selected	codes	in	the	period	1995-2008.	To	determine	whether	the	simultaneous	occurrence	of	two	syndromes	or	diseases	(specific	vulvovaginal	complaint	and	a	comorbidity)	was	clinically	relevant	or	a	coincidental	finding,	the	posterior	probability	of	a	selected	diagnosis	in	the	presence	of	PVD	expressed	in	an	odds	ratio	(OR)	according	to	Bayes	theorem	was	calculated.	The	OR	indicates	how	many	times	more	often	comorbidity	is	diagnosed	in	women	with	symptoms	suggestive	of	PVD	compared	to	women	of	similar	age	without	symptoms	suggestive	of	PVD.	A	particular	feature	of	the	Bayes	theorem	is	that	the	posterior	probability	not	only	depends	on	the	extent	to	which	a	comorbidity	is	characteristic	for	a	disease,	but	also	on	the	incidence	of	the	diagnosis	in	the	practice	population	sample	(prior	probability).	ORs,	confidence	intervals	(CI)	and	pre-	and	posttest	probability	were	calculated.	Prevalence	rates	were	obtained	for	the	selected	diagnoses.	The	different	X-codes	could	not	be	compared	together	with	the	comorbidities,	so	the	comorbidities	were	compared	with	every	single	code	episode	title.		The	codes	that	were	scored	for	fewer	than	100	patients	were	excluded	in	order	to	prevent	a	very	broad	confidence	interval.	Using	this	criterion,	codes	X17	(other	symptoms/complaints	pelvis,	N=43)	and	X29	(Other	symptoms/complaints	genital	system,	N=71)	were	not	used.	We	focused	on	episode	titles	with	an	odds	ratio	≥	3.48	to	establish	an	association	of	a	relevant	effect	size	between	the	comorbidity	and	the	X-code.	An	OR	≥1	and	≤	1.68,	an	OR	≥	1.69	and	≤	3.47	and	an	OR	≥	3.48	and	≤	6.71	is	indicative	of	a	small,	medium	and	large	effect	size,	respectively.22	
	32	|		
Results Between	1995	and	2008	a	total	of	959	relevant	episodes	were	coded	for	784	female	patients	between	15-49	years.	The	prevalence	of	these	episodes	in	this	age	group	is	19.6	(959/48,959)	per	1000	women	per	year.	The	relationship	between	the	selected	comorbidities	and	the	symptoms	suggestive	of	PVD	is	denoted	in	Table	1,	2	and	3.		
 
Pain syndromes Women	with	the	four	symptoms	suggestive	of	PVD	were	2.6	to	4.3	times	more	likely	to	suffer	from	IBS	compared	to	women	without	any	symptom	suggestive	of	PVD	(Table	1).	Women	with	genital	pain	were	3.9	times	more	likely	to	suffer	from	muscle	pain	than	women	without	genital	pain.	Genital	pain	and	painful	intercourse	were	most	strongly	associated	with	general	weakness/tiredness.	Complaints	such	as	genital	pain	and	painful	intercourse	increased	the	probability	of	general	weakness	from	6%	to	15%	and	from	6%	to	18%,	respectively.			
Table	1.	Symptoms	suggestive	of	PVD	in	relation	to	Pain	syndromes		 	 Muscle	pain		n=729	 General	weakness/tiredness	n=2697	 IBS		n=1188	Genital	pain	n=200	 Odds	 3.89**	 2.58*	 4.27**	CI	95%	 2.11-7.18	 1.70-3.90	 2.65-6.88	n	 11	 26	 19	Pretest	 0.02	 0.06	 0.02	Posttest	 0.06	 0.15	 0.10		 	 	 	 	Painful	intercourse	n=117	 Odds	 0.57	 3.13*	 2.57*	CI	95%	 0.08-4.08	 1.89-5.18	 1.19-5.53	n	 1	 18	 7	Pretest	 0.02	 0.06	 0.02	Posttest	 0.01	 0.18	 0.06		 	 	 	 	Other	symptoms/complaints	vagina	n=291	
Odds	 0.92	 1.83*	 4.01**	CI	95%	 0.34-2.48	 1.24-2.71	 2.67-6.03	n	 4	 28	 26	Pretest	 0.02	 0.06	 0.02	Posttest	 0.01	 0.11	 0.10		 	 	 	 	Other	symptoms/complaints	vulva	n=351	
Odds	 1.35	 2.48*	 3.83**	CI	95%	 0.64-2.86	 1.81-3.41	 2.62-5.59	n	 7	 44	 30	Pretest	 0.02	 0.06	 0.02	Posttest	 0.02	 0.14	 0.09	
Note		 *			effect	size	medium	(OR	≥	1.69	and	≤	3.47)		 **		effect	size	large	(OR	≥	3.48	and	≤	6.71)	
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Mental disorders and psychological symptom diagnoses  Women	with	genital	pain	and	other	symptoms/complaints	of	the	vagina	were	2.7	and	2.5	times	more	likely	to	suffer	from	feeling	anxious	than	women	without	these	complaints	(Table	2).	Painful	intercourse	and	other	symptoms/complaints	of	the	vagina	were	most	strongly	associated	with	disturbances	of	sleep/insomnia.	Other	symptoms/complaints	of	the	vulva	were	most	strongly	associated	with	a	depressive	disorder	and	increased	the	probability	of	having	this	diagnosis	as	comorbidity	from	4%	to	12%.	
	
Table	2.	Symptoms	suggestive	of	PVD	in	relation	to	mental	disorders	and	psychological	symptom	diagnoses				 	 Feeling	anxious	/nervous/tense		n=1321	
Disturbances	of	sleep/insomnia	n=1787	
Depressive	disorder		n=2012	Genital	pain	n=200	 Odds	 2.73*	 2.15*	 2.18*	CI	95%	 1.58-4.72	 1.27-3.65	 1.32-3.59	n	 14	 15	 17	Pretest	 0.03	 0.04	 0.04	Posttest	 0.08	 0.08	 0.09		 	 	 	 	Painful	intercourse	n=117	 Odds	 1.28	 2.75*	 2.19*	CI	95%	 0.47-3.47	 1.48-5.13	 1.14-4.19	n	 4	 11	 10	Pretest	 0.03	 0.04	 0.04	Posttest	 0.04	 0.10	 0.09		 	 	 	 	Other	symptoms/complaints	vagina	n=291	
Odds	 2.54*	 2.50*	 1.54	CI	95%	 1.59-4.06	 1.66-3.78	 0.96-2.49	n	 19	 25	 18	Pretest	 0.03	 0.04	 0.04	Posttest	 0.07	 0.09	 0.07		 	 	 	 	Other	symptoms/complaints	vulva	n=351	
Odds	 2.44*	 1.52	 2.78*	CI	95%	 1.58-3.76	 0.95-2.41	 1.97-3.92	n	 22	 19	 37	Pretest	 0.03	 0.04	 0.04	Posttest	 0.07	 0.06	 0.12	
	
Note		 *			effect	size	medium	(OR	≥	1.69	and	≤	3.47)	
	
Vulvovaginal candidiasis Women	with	the	four	symptoms	suggestive	of	PVD	were	between	3.6	and	7.7	times	more	likely	to	suffer	from	vulvovaginal	candidiasis	in	relation	to	women	without	any	
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symptom	suggestive	of	PVD	(Table	3).	The	probability	of	vulvovaginal	candidiasis	in	women	with	all	four	symptoms	suggestive	of	PVD,	increased	between	18%	(genital	pain)	and	47%	(painful	intercourse)	relative	to	women	without	symptoms	suggestive	of	PVD.		 	
Table	3.	Symptoms	suggestive	of	PVD	in	relation	to	Vulvovaginal	candidiasis			 	 Vulvovaginal	candidiasis	n=3230	Genital	pain	n=200	 Odds	 3.57**	CI	95%	 2.52-5.06	N	 40	Pretest	 0.07	Posttest	 0.25		 	 	Painful	intercourse	n=117	 Odds	 7.72***	CI	95%	 5.27-11.31	N	 41	Pretest	 0.07	Posttest	 0.54		 	 	Other	symptoms/complaints	vagina	n=291	
Odds	 4.56**	CI	95%	 3.48-5.98	N	 70	Pretest	 0.07	Posttest	 0.32		 	 	Other	symptoms/complaints	vulva	n=351	
Odds	 5.54**	CI	95%	 4.37-7.02	N	 97	Pretest	 0.07	Posttest	 0.38		
Note		 **			effect	size	large	(OR	≥	3.48	and	≤	6.71)		 ***	effect	size	very	large	(OR	≥	6.72)		
	
Sexual and physical abuse Fewer	than	10	women	with	symptoms	suggestive	of	PVD	reported	having	experienced	sexual	and/or	physical	abuse;	therefore	our	inclusion	criterion	of	at	least	10	episodes	combined	with	both	codes	was	not	met.		
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Discussion This	is	one	of	the	first	studies	in	a	family	practice	population	to	examine	the	association	between	specific	vulvovaginal	symptoms,	which	could	be	suggestive	of	PVD,	and	comorbidities.	Due	to	the	lack	of	a	specific	ICPC-code	for	PVD,	the	FP	can	select	several	different	codes	to	code	PVD.	Women	diagnosed	with	all	four	symptoms	suggestive	of	PVD	are	found	to	be	four	to	seven	times	more	likely	to	also	receive	the	diagnosis	of	vulvovaginal	candidiasis	and	two	to	four	times	more	likely	to	also	receive	the	diagnosis	of	IBS	than	women	without	PVD	during	the	year.	All	effect	sizes	but	one	were	large.	This	study	also	reveals	significant	associations	between	some	symptoms	suggestive	of	PVD	and	general	weakness,	muscle	pain,	insomnia,	depressive	disorder	and	the	symptom	diagnosis	feeling	anxious,	although	these	effect	sizes	were	less	large.		
 
A comparison with existing literature  Our	study	supports	previous	findings	of	a	strong	relationship	between	symptoms	suggestive	of	PVD	and	vulvovaginal	candidiasis.7	The	high	odds	ratios	and	the	increase	of	the	posterior	probability	underline	this	relationship.	The	guideline	for	Dutch	FPs	for	diagnosing	vulvovaginal	candidiasis	states	that	this	condition	can	be	diagnosed	based	on	clinical	manifestations	without	taking	a	vaginal	culture	or	using	microscopy.23	Criteria	for	vulvovaginal	candidiasis	involve	vaginal	itching	and	the	appearance	of	redness	of	the	vulva.	Vaginal	burning	–	often	being	mistaken	for	itching	–	and	redness	of	the	vulva	appear	to	be	symptoms	of	PVD	as	well.	However,	by	making	a	diagnosis	only	based	upon	these	symptoms,	PVD	can	unfortunately	be	mistaken	for	candidiasis.	This	misinterpretation	may	contribute	to	the	strong	relationship	between	PVD	and	vulvovaginal	candidiasis.	A	diagnosis	of	recurrent	vulvovaginal	candidiasis	infections,	of	which	the	diagnosis	is	only	based	upon	clinical	manifestations,	is	possibly	made	in	many	women	in	whom	PVD	is	not	recognized.	Recent	findings	that	proinflammatory	response	to	Candida	albicans	can	contribute	to	the	induction	of	pain	in	PVD,	confirm	this	line	of	reasoning,	but	can	not	explain	why	and	in	whom	the	pain	persists.24	Another	possible	explanation	for	the	strong	relationship	between	candidiasis	and	PVD	could	be	that	women	with	a	vulvovaginal	candidiasis	continue	to	have	intercourse	despite	the	pain	they	experience	during	and	shortly	after	the	infection.	Some	women	with	dyspareunia	seem	to	continue	with	intercourse	despite	pain,	possible	leading	to	PVD.25	Until	now	
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there	has	not	been	any	satisfying	longitudinal	study	that	gives	insight	into	the	sexual	behavior	of	women	in	the	early	stages	of	a	vulvovaginal	candidiasis.	In	previous	studies	associations	were	found	between	PVD	and	general	pain	syndromes.	The	strongest	association	is	that	between	PVD	and	fibromyalgia	and	between	PVD	and	IBS,	with	ORs	greater	than	3.9-11	Our	study	in	a	FP-based	sample	reveals	a	similarly	strong	association	between	symptoms	suggestive	of	PVD	and	IBS.	In	both	syndromes,	pain	in	the	lower	pelvis	or	abdomen	is	a	central	symptom.26	Because	pelvic	pain	contains	also	symptoms	of	PVD,	the	model	of	a	chronic	pelvic	pain	disorder	could	explain	the	relationship	between	PVD	and	IBS.13,26		We	also	found	an	association	of	medium	effect	size	between	symptoms	suggestive	of	PVD	and	feelings	of	anxiety	and	symptoms	suggestive	of	PVD	and	a	depressive	disorder.	Women	with	PVD	also	visit	the	FP	more	often	with	sleep	problems.	These	results	are	in	line	with	the	literature.9,14	A	notable	finding	was	the	very	low	prevalence	of	sexual	and	physical	abuse	in	our	group	of	women	with	symptoms	suggestive	of	PVD.	This	is	contrary	to	previous	studies	and	may	be	indicative	of	FPs	low	likelihood	of	making	inquiries	about	sexual	and	physical	abuse.16,27		Our	findings	might	encourage	FPs,	who	are	faced	with	specific	vulvovaginal	symptoms,	to	inquire	after	episodes	of	previous	vulvovaginal	candidiasis,	symptoms	of	IBS,	symptoms	of	pelvic	pain,	feelings	of	anxiety,	depression	and	a	history	of	sexual	or	physical	abuse,	in	order	to	increase	the	probability	of	diagnosing	PVD.	
	
Strengths and limitations The	most	important	strength	of	our	study	is	that	its	data	are	retrieved	from	a	large	dataset	with	large	numbers	of	patient	encounters.	The	reliability	of	the	registration	and	coding	preciseness	of	the	participants	in	this	system	is	estimated	to	be	higher	than	usual	for	family	practices.20	Another	strength	is	that	the	study	was	performed	in	a	family	practice	population,	which	means	there	was	less	pre-selection	of	patients	than	in	a	specialized	population.	There	are	also	limitations	of	our	study.	The	first	limitation	is	that	there	is	no	ICPC	code	for	PVD.	We	decided	to	include	four	X-codes,	which	contain	some	of	the	features	of	PVD,	but	these	codes	also	contain	other	complaints	of	the	vulva	or	vagina.	Secondly,	the	comorbidities	fibromyalgia,	chronic	fatigue	syndrome	and	physical	and	sexual	abuse	are	only	described	in	a	sub	code.	In	the	research	database	we	only	were	able	to	select	main	
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ICPC	codes	and	not	the	sub	codes.	Therefore,	the	main	symptoms	of	these	comorbidities	are	provided,	leading	to	overestimating	the	group	of	women	with	these	comorbidities.	For	example,	not	ICPC	Z12.02	(Assault/sexual	abuse	by	partner)	was	used,	but	the	maincode	Z12	(Relationship	problem	with	partner),	also	including	Z12.01	(Divorce	of	partner).	Using	the	sub	codes	may	have	led	to	stronger	associations	between	these	comorbidities	and	symptoms	suggestive	of	PVD.	Lastly,	the	low	numbers	of	episodes	may	have	resulted	in	inaccurate	outcomes	with	broad	CIs.		
Conclusion In	conclusion,	four	vulvovaginal	symptoms	which	could	be	suggestive	of	PVD	in	women	in	family	practice	are	strongly	associated	with	vulvovaginal	candidiasis	and	IBS.	Possibly,	in	a	family	practice,	a	diagnosis	of	vulvovaginal	candidiasis	infections	or	IBS	of	which	the	diagnosis	is	only	based	upon	clinical	manifestations,	is	made	in	many	women	in	whom	PVD	is	not	recognized.	We	found	less	strong	relationships	between	PVD	and	general	weakness,	muscle	pain	and	depressive	disorder	and	psychological	symptom	diagnoses.	Our	study	demonstrates	that	previous	findings	of	associations	between	PVD	and	vulvovaginal	candidiasis,	pain	syndromes	and	mental	disorders,	which	are	common	in	a	sexual	medicine	setting,	are	also	applicable	to	a	family	practice	population.	Therefore	FPs	should	improve	diagnosis	and	management	of	vulvar	pain.			
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Chapter 3
Is uncertain vulvovaginal candidiasis a marker of vulvodynia? 
A study in a Dutch general practice research database
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Abstract 
Background:	A	recent	Dutch	study	in	general	practice	showed	a	clear	relationship	between	the	diagnosis	of	vulvovaginal	candidiasis	(VVC)	and	symptoms	suggestive	of	provoked	vulvodynia	(PVD).	PVD	accounts	for	the	largest	group	of	vulvar	pains,	but	is	often	not	recognized	by	general	practitioners	(GPs).	
Aims:	To	investigate	whether	diagnostic	uncertainty	about	VVC	in	general	practice	could	also	point	to	the	diagnosis	of	PVD,	and	whether	and	how	this	diagnostic	uncertainty	affects	management.	
Design	and	Setting:	An	observational	study	in	2014	in	Dutch	general	practices	of	the	NIVEL	Primary	Care	Database.	
Methods:	Women	with	an	uncertain	diagnosis	of	VVC	were	distinguished	from	women	with	certain	VVC	based	on	the	occurrence	of	recurrent	episodes	and	persisting	complaints,	despite	treatment.	Factors	known	to	be	associated	with	PVD	were	hypothesized	to	be	more	prevalent	in	women	with	uncertain	VVC.	Data	on	symptom	management	by	GPs	were	collected.	
Results:	In	total	7,066	women	with	VVC	or	uncertain	VVC	were	included.	Uncertain	VVC	was	found	to	account	for	28%	of	these	patients.	Compared	to	VVC,	the	group	uncertain	VVC	included	significantly	more	women	with	female	genital	symptoms,	tiredness,	irritable	bowel	syndrome	(all	p<0.001),	feeling	anxious,	reduced	sexual	desire,	depressive	disorder,	relationship	problems,	and	micturition	symptoms	(all	p<0.05).	Compared	to	VVC,	the	group	uncertain	VVC	included	significantly	higher	mean	numbers	of	telephone	consultations	(p<0.001),	more	referrals	to	gynaecology	(p=0.009),	and	higher	mean	numbers	of	prescriptions	per	patient	(p<0.001).		
Conclusion:	Our	findings	indicate	that	uncertain	vulvovaginal	candidiasis	could	be	a	marker	of	PVD.	GPs	might	reconsider	their	diagnostics	and	management	when	women	present	recurrent	and	persistent	vulvovaginal	complaints,	especially	if	accompanied	by	dyspareunia,	functional	syndromes,	micturition	symptoms	and	psychological	conditions.				
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Introduction Vulvovaginal	complaints	are	frequently	presented	in	general	practice.	Approximately	25	per	1000	female	patients	per	year	visit	their	general	practitioner	(GP)	with	vulvovaginal	candidiasis	(VVC).1	Dutch	GPs	reported	106	consultations	concerning	vaginal	candidiasis	per	practice	per	year.2	About	25-30%	of	women	with	vulvovaginal	complaints	remains	without	a	microbiologically	explained	diagnosis,	even	after	careful	evaluation.3-6	One	reason	may	be	that	most	GPs	find	it	difficult	to	diagnose	vulvovaginal	complaints,	perhaps	leading	to	an	overestimation	of	VVC.	A	Dutch	study	showed	that	GPs	do	not	perform	the	examinations	required	to	confirm	their	putative	diagnosis,	despite	the	recommendations	given	by	the	Dutch	GPs	Guideline	of	Vaginal	Discharge.1,2	Another	reason	for	the	apparently	difficulty	in	diagnosing	of	VVC	might	be	confusion	with	another	diagnosis,	e.g.	provoked	vulvodynia	(PVD).			PVD	is	the	most	common	cause	of	vulvar	pain,	which	is	defined	as	‘vulvar	pain	of	at	least	3	months	duration,	without	clear	identifiable	cause,	which	may	have	potential	associated	factors.’7	PVD	and	VVC	have	partially	cohering	symptoms.	Besides	white	crumbling	discharge,	criteria	for	VVC	involve	vaginal	itching	and	the	appearance	of	redness	of	the	vulva.	Vaginal	burning	–	often	being	mistaken	for	itching	–	and	redness	of	the	vulva	–	although	not	obligatory	-	appear	to	be	symptoms	of	PVD	as	well.	Both	VVC	and	PVD	can	produce	symptoms	of	irritation	and	tenderness	in	the	vestibule.	Women	often	describe	their	discomfort	in	other	phrases	than	‘pain’,	including	itching,	burning	and	a	swelling	sensation.8	Previous	vaginal	infections	such	as	VVC	and	vaginosis	have	been	identified	as	important	triggers	and	risk	factors	for	PVD	because	of	changes	in	the	vaginal	flora	and	immunological	response,	leading	to	neuropathic	pain	conditions	of	the	vulva.8-12	Also,	the	strong	relationship	between	VVC	and	PVD	may	be	explained	by	the	possibility	that	women	with	VVC	continue	to	have	intercourse	despite	the	vulvovaginal	pain	they	experience	during	and	shortly	after	the	infection,	possible	leading	to	a	vicious	circle	that	maintains	PVD.13A	recent	retrospective	cohort	analysis	in	Dutch	general	practices	showed	a	clear	relationship	between	VVC	and	symptoms	suggestive	of	PVD.14	It	was	hypothesized	that	the	strong	relation	between	VVC	and	PVD	could	be	explained	as	well	by	the	possibility	that	VVC	was	misdiagnosed,	actually	covering	a	subgroup	of	women	with	PVD.	The	prevalence	of	PVD	in	the	general	population	is	estimated	to	be	between	3.1%	and	15%,	mostly	affecting	women	under	50	years	of	age.15,16	The	annual	incidence	in	the	general	population	is	estimated	to	be	3.1%.17		
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Since	little	is	known	about	PVD	in	primary	care	and	since	PVD	is	not	included	in	the	International	Classification	of	Primary	Care	(ICPC),	vulvovaginal	symptoms	suggestive	of	PVD	may	not	be	recognized	by	the	GP	and	consequently	be	registered	as	VVC.	A	lack	of	training	in	recognising	PVD	among	physicians	could	also	play	a	role	in	this	doctor’s	delay.18,19	Another	important	factor	is	patient	delay:	in	a	large	prospective	study	in	300	patients	it	took	an	average	of	38	months	after	symptom-onset	before	women	with	PVD	consulted	a	health	care	provider	for	the	first	time.20	PVD	is	associated	with	several	chronic	pain	conditions	and	mental	health	problems.14,	21-24		Moreover,	in	existing	literature	PVD	is	found	to	be	associated	with	medically	unexplained	physical	symptoms	(MUPS)	as	is	seen	in	fibromyalgia,	chronic	fatigue,	sleep	disorders,	and	irritable	bowel	syndrome.20,21,25	A	timely	diagnosis	of	PVD	may	be	helpful	in	improving	the	impaired	quality	of	life	of	patients	and	the	consumption	of	extra	medical	care	that	is	associated	with	PVD.26		The	aim	of	this	study	was	to	investigate	whether	diagnostic	uncertainty	about	VVC	is	a	marker	of	PVD.	Our	research	questions	are:	do	women	with	uncertain	VVC	differ	from	women	with	certain	VVC	with	respect	to	characteristics	associated	with	PVD	and	–	given	the	doctor’s	delay	-	do	GPs	differently	manage	certain	or	uncertain	VVC,	and	if	so,	how?			
Methods We	performed	a	retrospective	analysis	of	women	with	VVC	and	uncertain	VVC	in	a	representative	primary	care	database.	We	analysed	differences	between	these	groups	in	characteristics	that	according	to	the	literature	were	associated	with	PVD:	female	genital	symptoms,	psychological	symptoms,	medically	unexplained	symptoms,	relationship	problems	with	partner,	and	micturition	symptoms.	14,	21-24		
Data collection Data	were	collected	from	NIVEL,	a	nationally	representative	Primary	Care	Database,	which	uses	routinely	recorded	data	from	GPs	to	monitor	health	and	utilisation	of	health	services	in	a	representative	sample	of	the	Dutch	population.	In	this	database	GPs	record	all	diagnoses	and	proceedings	according	to	the	ICPC	classification,	during	or	immediately	after	the	consultation.	Diagnostic	and	management	data	were	used	of	women	between	ages	10	and	50	who	were	seen	for	vulvovaginal	complaints	by	their	GP	between	January	1,	2014	and	January	1,	2015.	The	following	information	was	extracted	
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from	the	electronic	medical	record:	relevant	diagnoses	and	symptoms,	additional	tests,	prescriptions,	type	of	contact,	and	referrals.			
VVC and uncertain VVC VVC	and	uncertain	VVC	were	defined	as	follows.	1. VVC	According	to	the	Dutch	Guideline	on	Vaginal	Discharge,	a	VVC	(ICPC	code	X72)	is	considered	very	likely,	when	the	patients	history	and	physical	exam	display	itching	and	non-smelling,	white	crumbling	discharge	in	combination	with	a	red	swollen	vulva	or	vaginal	wall.1	According	to	this	Guideline	a	physical	exam	can	be	omitted	if	the	patient	recognizes	the	complaints	from	an	earlier	episode	of	VVC.	In	case	of	doubt,	a	positive	yeast	culture	or	KOH	preparation	showing	hyphae	is	indicated	to	establish	a	definite	diagnosis.		2. Uncertain	VVC,	as	is	defined	by	us:	a) Recurrent	VVC	(RVVC):	when	a	patient	presents	with	3	or	more	episodes	of	VVC	within	a	year,	of	which	at	least	one	is	confirmed	by	the	GP	in	a	face-to-face	consultation.	The	frequent	recurrence	of	a	VVC	might	be	an	indication	that	in	one	way	or	another	the	policy	of	the	GP	was	insufficient.	To	prevent	missing	patients	with	RVVC	in	2014,	we	traced	patients	with	VVC	once	or	twice	in	2014,	back	to	2013.		b) Persisting	VVC	(PVVC):	when	a	patient	returns	for	a	second	consultation	within	one	episode	of	VVC,	suggesting	that	the	previous	consultation	was	insufficient.	Episodes,	used	in	the	NIVEL	Primary	Care	Database,	are	constructed	periods	for	a	specific	diagnosis.	Because	a	symptom-free	period	for	VVC	lasts	eight	weeks	before	a	new	episode	of	VVC	can	be	started,	a	complaint	was	considered	persistent	when	a	patient	had	consulted	the	GP	at	least	two	times	with	the	same	complaint	within	a	time	period	of	eight	weeks.				
Variables associated with PVD Symptoms	associated	with	PVD	were	selected	based	on	the	literature.14,25	These	included	Female	genital	symptoms	(Painful	intercourse	(X04),	Other	symptoms/complaints	vagina	(X15),	Other	symptoms/complaints	vulva	(X16),	Vaginitis	/	vulvitis	NOS	(X84)),	Pain	symptoms	(Muscle	pain	(L18),	Irritable	bowel	syndrome	(D93)),	General	weakness/tiredness	(A04),	Psychological	conditions	(Feeling	
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anxious/nervous/tense	(P01),	Feeling	depressed	(P03),	Reduced	sexual	desire	(P07),	Depressive	disorder	(P76)),	Relationship	problems	(Z12),	and	Micturition	symptoms	(Dysuria/painful	urination	(U01),	Urinary	frequency/urgency	(U02),	Urination	problems	other	(U05),	Cystitis/other	infection	(U71))	(Tables	1	and	2).		
Analysis Data	were	analysed	of	women	diagnosed	with	VVC	that	were	registered	between	1	January	2014	and	1	January	2015	using	the	Statistical	Product	and	Service	Solutions	(SPSS),	version	22.	It	was	investigated	whether	factors	associated	with	PVD	and	whether	medical	activities	were	more	prevalent	in	women	with	uncertain	VVC	relative	to	VVC.	Statistical	significance	will	be	computed	using	the	chi-squared	test	in	which	p	<	0.05	is	considered	significant.			
Results 
Population Of	379,190	women	aged	10-50,	representing	data	collected	by	227	GPs,	7,066	women	were	diagnosed	with	VVC	(1.8%).	The	mean	age	of	these	women	was	35.1	(SD=11.4)	years	old.	
	
Uncertain VVC Of	the	patients	that	initially	received	the	diagnosis	VVC,	28%	had	uncertain	VVC.	Table	1	lists	comorbidities	associated	with	PVD	for	VVC	and	uncertain	VVC.	Compared	to	certain	VVC,	patients	with	uncertain	VVC	were	diagnosed	significantly	more	often	with	female	genital	symptoms	(p<0.001),	especially	dyspareunia,	vaginal	symptoms/complaints,	and	not	otherwise	specified	vaginitis/vulvitis.	Also,	patients	with	uncertain	VVC	showed	a	significantly	higher	incidence	of	general	tiredness,	irritable	bowel	syndrome,	reduced	sexual	desire,	depressive	disorder,	relationship	problems,	and	micturition	symptoms	(Table	1).							
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Table	1.	Factors	associated	with	provoked	vulvodynia	for	vulvovaginal	candidiasis	(VVC)	and	uncertain	VVC	(in	%)			 VVC			(n=5,088)	 Uncertain	VVC	(n=1,978)	 P-value	
Female	genital	symptoms	 	 	 	 	Dyspareunia	 1.1	 2.1	 <0.001	 ***	Vaginal	symptom	/	complaint	other	 6.9	 10.3	 <0.001	 ***	Vulva	symptom	/	complaint	 2.3	 3.1	 0.019		 *	Vaginitis	/	vulvitis	NOS	 12.6	 16.9	 <0.001	 ***						 	 	 	 	
Medical	unexplained	
symptoms	
	 	 	 	Weakness	/	tiredness	in	general	 16.3	 19.4	 <0.001	 ***	Muscle	pain	 4.2	 4.8	 0.186	 	Irritable	bowel	syndrome	 5.3	 6.9	 0.001		 **		 	 	 	 	
Psychological	conditions	 	 	 	 	Feeling	anxious	/	nervous	/	tense	 5.3	 6.3	 0.047	 *	Feeling	depressed	 4.0	 4.7	 0.107	 	Sexual	desire	reduced	 0.1	 0.3	 0.012	 *	Depressive	disorder	 5.1	 6.7	 0.002	 **						 	 	 	 	
Relationship	problem	
partner	
3.5	 4.4	 0.029	 *		 	 	 	 	
Micturition	symptoms	 	 	 	 	Dysuria/painful	urination	 5.1	 5.8	 0.148	 	Urinary	frequency/urgency	 5.8	 6.9	 0.046	 *	Urination	problems	other	 2.3	 3.5	 0.001	 **	Cystitis/other	infection	 27.3	 29.6	 0.015	 *		*	p	<0.05			**	p<0.01			***p<0.001		
 
Management by the GP Mean	number	of	consultations	per	patient	with	certain	VVC	was	4.3	(SD=4.9).	Patients	that	were	classified	as	having	uncertain	VVC	had	almost	three	times	as	many	consultations,	i.e.	11.3	(SD=11.9,	p<0.001)	(not	shown	in	Table).	For	uncertain	VVC	the	mean	number	per	patient	of	telephone	consultations	as	well	as	face-to-face	consultations,	was	significantly	higher	(Table	2).	Patients	with	uncertain	VVC	were	four	
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times	as	likely	to	be	referred	to	a	gynaecologist	(p<0.001),	and	received	twice	as	many	prescriptions	per	patient.	Table	2	lists	consultations,	referrals,	and	prescriptions	in	patients	with	VVC	and	uncertain	VVC.			
Table	2.	Consultations,	referrals,	and	prescriptions,	related	to	the	disorder,	in	patients	with	vulvovaginal	candidiasis	(VVC)	and	uncertain	VVC	(in	number	and	%	of	total)		
	 VVC	(n=5,088)	 Uncertain	VVC	(n=1,978)	 P-value	
Telephone	consultation	 	 	 	 	Patients	 2,898	(57.0%)	 1,643	(83.1%)	 <0.001	 ***	Consultations	per	patient	 M=1.2	(SD=1.7)	 M=3.1	(SD=4.1)	 <0.001	 ***	
	 	 	 	 	
Face-to-face	consultation	 	 	 	 	Patients	 3,524	(69.3%)	 1,801	(91.1%)	 <0.001	 ***	Consultations	per	patient	 M=1.5	(SD=2.0)	 M=3.9	(SD=4.6)	 <0.001	 ***	
	 	 	 	 	
Referrals	 	 	 	 	Patients	referred	to	gynaecology	 222	(4.4%)	 351	(17.7%)	 0.009	 **	Patients	referred	for	diagnostics	 156	(3.1%)	 241	(12.2%)	 <0.001	 ***	Patients	with	one	or	more	referrals	 1,246	(24.5%)	 995	(50.3%)	 0.006	 **	
	 	 	 	 	
Prescriptions	 	 	 	 	Patients	that	received	local	treatment	 2,956	(58.1%)	 1,130	(57.1%)	 0.002	 **	Patients	that	received	oral	treatment	 579	(11.4%)	 442	(22.3%)	 0.673	 	Prescription	per	patient		 M=1.9	(SD=1.5)	 M=4.1(SD=3.2)	 <0.001	 ***		**	p<0.01				***p<0.001		
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Discussion  
Summary Many	factors	known	to	be	associated	with	PVD,	especially	dyspareunia,	functional	syndromes,	micturition	symptoms	and	psychological	conditions,	were	found	to	be	significantly	more	prevalent	in	2014-2015	in	the	uncertain	VVC	group	i.e.	women	presenting	recurrent	and	persistent	vulvovaginal	complaints.	This	reinforces	our	hypothesis	that	uncertain	VVC	could	be	a	marker	of	PVD.	As	well,	the	number	of	face-to-face	and	telephone	consultation	and	the	number	of	referrals,	related	to	VVC	or	uncertain	VVC,	were	found	to	be	significantly	higher	in	the	women	with	uncertain	VVC.	Because	uncertain	VVC	was	found	to	account	for	a	substantial	part	of	28%	of	all	patients	initially	diagnosed	with	VVC,	our	findings	may	point	–	after	excluding	infections	and	dermatoses	–	to	the	existence	of	a	subgroup	of	women	with	PVD	within	the	group	of	women	with	uncertain	VVC.		
Strengths and limitations A	strength	of	our	study	is	that	the	data	included	a	large	number	of	patients	and	their	episodes,	and	that	the	study	was	performed	in	a	GP	population	representative	of	the	general	Dutch	population.27	The	GPs	affiliated	with	NIVEL	Primary	Care	Database	are	motivated	to	perform	adequate	ICPC	coding.		However,	as	no	ICPC	code	for	PVD	is	available,	only	indirect	measures	of	PVD	were	available	of	complaints	or	disorders	known	to	be	related	to	PVD.	They	lack	specificity,	however,	as	some	of	these	nonspecific	complaints	may	also	occur	in	case	of	lichen	sclerosus	or	eczema,	therefore	possibly	overestimating	the	hypothesized	relation	between	uncertain	VVC	and	PVD.		Using	RVVC	as	a	subtype	of	uncertain	VVC	might	overestimate	this	relation	as	well	because	RVVC	can	in	fact	be	caused	by	a	candida-infection,	especially	in	case	of	comorbidity	such	as	diabetes	mellitus,	reduced	immunity	status	and	use	of	immunity	decreasing	drugs,	for	example	antirheumatic	and	chemotherapeutic	drugs,	corticosteroids	and	antibiotics.	Nevertheless,	it	should	be	emphasized	that	one-third	to	one-half	of	RVVC	cases	have	no	clear	cause.28		On	the	other	hand,	the	existence	of	a	subgroup	of	PVD	in	the	group	VVC	may	also	be	underestimated	rather	than	overestimated.	Our	data	show	a	very	low	number	of	women	with	sexual	complaints,	contrary	to	robust	findings	in	the	literature	showing	that	in	
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women	with	PVD	reduced	sexual	desire	and	response	is	common.25	This	might	indicate	that	GPs	probably	didn’t	take	a	sexual	history	adequately.	In	the	past	PVD	was	described	as	vulvar	vestibulitis	syndrome	or	focal	vulvitis,	both	with	the	misleading	suffix	of	–itis.	It	is	possible	that	PVD	was	registered	by	GPs	under	the	ICPC	code	vaginitis/vulvitis	(NOS),	which	in	this	study	indeed	was	found	to	be	significantly	more	prevalent	in	the	group	of	uncertain	VVC.	Since	only	general	ICPC	codes	were	accessible	for	research	and	subcodes	were	not,	this	cannot	be	stated	with	certainty.	
	
Comparison with existing literature Women	with	uncertain	VVC	were	twice	more	likely	to	have	dyspareunia	and	three	times	more	likely	to	have	reduced	sexual	desire,	both	found	to	be	important	characteristics	of	PVD.10,14,20,23,25	Our	findings	that	women	with	uncertain	VVC	showed	a	significantly	higher	incidence	of	micturition	symptoms	and	of	irritable	bowel	syndrome,	are	in	line	with	findings	related	to	chronic	pelvic	pain	as	one	of	the	maintaining	factors	in	PVD.12,17,21,25	Also,	psychological	conditions	and	relationship	problems	with	a	partner,	known	to	be	associated	with	PVD,	are	more	prevalent	in	women	with	uncertain	VVC.24,29		Uncertain	VVC	was	found	to	account	for	28%	of	all	patients	diagnosed	with	VVC,	which	high	number	does	correspond	to	the	findings	of	a	Dutch	study	on	the	factors	associated	with	microbiologically	unexplained	vaginal	symptoms,	which	showed	that	25%	of	all	the	women	had	symptoms	of	unknown	aetiology.6	It	shows	the	difficulty	of	diagnosing	vulvovaginal	complaints	by	GPs,	as	was	demonstrated	previously	among	Dutch	GPs.2	This	difficulty	has	apparently	repercussions	for	the	management	of	VVC	by	GPs	as	is	seen	in	the	significantly	higher	health	care	use	in	women	with	uncertain	VVC.	While	these	findings	may	be	the	consequence	of	the	definition	of	uncertain	VVC	itself,	it	also	could	be	an	expression	of	the	well-known	association	between	MUPS	and	high	health	care	use.30	Given	the	higher	number	of	MUPS	in	the	uncertain	VVC	group,	and	the	difficulty	in	diagnosing	PVD	as	a	chronic	pain	disorder	without	clear	identifiable	cause,	the	higher	number	of	consultations	and	referrals	may	reflect	the	association	between	PVD	and	MUPS.	A	recent	study	showed	that	GPs	take	various	characteristics	like	multiple	MUPS,	frequent	and	long	consultations	and	many	referrals	into	account	when	recognizing	MUPS	in	their	patients.31	Equally,	in	case	of	uncertain	VVC,	GPs	should	be	
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aware	that	the	increasing	number	of	consultations	and	comorbidity	of	MUPS	could	point	to	PVD.		It	is	unknown	whether	GPs	ever	consider	PVD	as	an	alternative	diagnosis.	Given	the	significantly	higher	mean	number	of	prescriptions	received	per	patient	in	the	women	with	uncertain	VVC	(twice	as	many),	GPs	seem	hold	on	to	their	initial	diagnosis	of	VVC.	This	is	in	line	with	research	that	was	conducted	among	a	group	of	Dutch	GPs,	some	years	after	the	introduction	of	the	Dutch	GPs	Guideline	on	Vaginal	Discharge,	showing	that	GPs	did	not	perform	the	examinations	required	to	confirm	their	putative	diagnosis	of	VVC,	leading	to	wrong	diagnoses	and	maltreatment	with	antimycotics.2		Our	results	also	demonstrate	that	despite	requesting	for	diagnostics	more	often	among	women	with	uncertain	VVC,	GPs	referred	more	often	to	a	gynaecologist	as	well.	This	is	in	line	with	a	study	in	patients	with	sexual	complaints	attending	Dutch	general	practitioners,	showing	that	women	with	a	sexual	dysfunction	were	more	often	referred	to	secondary	care	services	than	were	male	patients	with	a	sexual	dysfunction.32	If	PVD	were	to	be	considered	as	a	diagnosis,	a	referral	to	a	pelvic	floor	physical	therapist	or	sexologist	(or	sexual	and	relationship	therapist)	rather	than	a	gynaecologist	would	be	indicated,	as	is	stated	by	the	Dutch	GPs	Guideline	on	Sexual	complaints.33	Own	national	guidelines	might	be	consulted	in	applying	referring	policy	correctly.	Does	the	referral	policy	of	the	GPs	in	this	study	suggest	that	they	do	not	consider	any	alternative	diagnosis	when	women’s	vulvovaginal	complaints	persist?	This	hypothesis	would	be	consistent	with	studies	that	show	that	vulvodynia	is	underestimated	and	not	recognized	by	GPs.30,	34			
Implications and future perspective  It	is	important	for	GPs	to	evaluate	their	diagnostics	and	management	when	persisting	genital	complaints,	dyspareunia,	and	PVD	associated	factors	are	present	in	a	patient	initially	diagnosed	as	VVC.	Rather	than	doing	more	of	the	same,	in	case	of	uncertainty	about	VVC	–	after	excluding	infections	and	dermatoses	-	the	GP	might	consider	PVD,	especially	in	situations	of	RVVC	and	PVVC.		Since	an	adequate	diagnostic	approach	is	needed	for	recognizing	PVD,	more	insight	into	the	facilitating	and	limiting	factors	in	the	diagnostic	process	of	GPs	dealing	with	women	with	vulvovaginal	complaints,	is	recommended.	Learning	from	the	way	GPs	diagnose	and	manage	MUPS	could	be	helpful.	
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Conclusion Many	factors	known	to	be	associated	with	PVD	were	found	to	be	significantly	more	prevalent	in	the	uncertain	VVC	group.	Diagnostic	uncertainty	about	VVC	could	point	to	the	diagnosis	PVD.	GPs	might	reconsider	their	diagnostics	and	management	when	persistent	and	recurrent	genital	complaints,	dyspareunia,	medical	unexplained	symptoms,	micturition	symptoms	and	psychological	conditions	are	present	in	a	patient	initially	diagnosed	as	VVC.				
Additional information 
Funding Expert	Group	on	Sexual	Health	of	the	Dutch	College	of	General	Practitioners	
Ethical approval The	data	collected	by	the	NIVEL	Primary	Care	Database	from	the	GPs’	electronic	medical	record	system	are	‘pseudonymized’,	which	implies	that	personal	data	are	converted	to	a	non-traceable	code.	These	conversions	are	irreversible,	protecting	the	patient’s	privacy.	Given	that	the	Medical	Research	Involving	Human	Subjects	Act	of	the	Netherlands	does	not	apply	to	data	already	present	in	the	NIVEL	Primary	Care	Database,	official	approval	of	a	Medical	Ethics	Committee	was	not	required.		
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Abstract 
Background:	Provoked	vulvodynia	is	a	chronic	vulvar	pain	condition	affecting	up	to	8.3%	of	the	female	population.	Despite	many	years	of	research	no	clear	cause	for	provoked	vulvodynia	has	been	identified.	Several	risk	factors	have	been	studied,	including	vulvovaginal	candidiasis.	However,	to	date,	the	role	of	Candida	infections	in	provoked	vulvodynia	has	remained	unclear.	Vulvovaginal	candidiasis	and	provoked	vulvodynia	have	an	overlap	of	symptoms,	which	may	contribute	to	diagnostic	inaccuracy	and	mistreatment.	
Objective:	To	systematically	review	the	literature	on	the	relationship	between	vulvovaginal	candidiasis	and	provoked	vulvodynia.	
Data	sources:	We	searched	CINAHL,	the	Cochrane	Library,	EMBASE,	MEDLINE,	PsycINFO,	Pubmed	and	Web	of	Science	for	relevant	studies	published	over	the	last	fifteen	years.		
Study	eligibility	criteria:	Cohort	and	case-control	studies	were	included	that	compared	women	with	provoked	vulvodynia	with	healthy	controls	with	respect	to	the	presence	of	a	history	of	Candida	vulvovaginitis.	Provoked	vulvodynia	had	to	be	diagnosed	by	Friedrich’s	criteria	or	ISSVD	criteria.	
Study	appraisal	method:	The	inclusion	process	as	well	as	the	quality	appraisal	of	the	studies,	using	the	Newcastle-Ottawa	quality	assessment	Scale,	were	performed	independently	by	two	authors.	
Results:	We	included	a	total	number	of	fourteen	studies,	both	population	and	clinic-based	case-control,	and	pathophysiological	research.	Seven	studies	were	of	low	and	seven	studies	were	of	medium	methodological	quality.	The	population-based	case-control	studies	showed	a	significantly	increased	OR	for	self-reported	vulvovaginal	candidiasis	in	provoked	vulvodynia	cases	compared	to	controls.	The	pathophysiological	studies	revealed	a	tendency	of	an	increased	local	pro-inflammatory	response	on	Candida	
in	vitro	in	patients	with	provoked	vulvodynia.		
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Conclusions:	This	systematic	review	is	unable	to	draw	conclusions	regarding	a	relationship	between	actual	vulvovaginal	candidiasis	and	provoked	vulvodynia	since	studies	were	based	on	self-reported	vulvovaginal	candidiasis.	Until	new	evidence	becomes	available,	we	advocate	that	provoked	vulvodynia	should	be	considered	as	an	unexplained	chronic	pain	condition.	In	women	with	recurrent	or	persistent	vulvovaginal	candidiasis-like	complaints,	physicians	should	consider	a	diagnosis	of	provoked	vulvodynia.	
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Introduction  The	International	Society	for	the	Study	of	Vulvovaginal	Disease	(ISSVD)	defines	vulvodynia	as	“vulvar	pain	of	at	least	three	months	duration	without	a	clear	identifiable	cause	which	may	have	potential	associated	factors”.1	Provoked	vulvodynia	(PVD)	comprises	a	subgroup	of	vulvodynia	characterized	by	a	localized	vulvar	pain,	provoked	by,	for	example,	sexual	penetration,	tampon	insertion	and/or	tight	clothing.2	Estimated	prevalence	varies	from	3.8	-	8.3%.3–6	Women	with	PVD	describe	their	pain	as	burning,	itching	or	stinging,7	and	report	lower	quality	of	life,3	reduced	sexual	satisfaction,8–10	and	higher	depression	rates.8,11–13		Remarkable	is	the	association	of	PVD	with	medically	unexplained	physical	symptoms	such	as	fibromyalgia,	irritable	bowel	disease,	chronic	fatigue	syndrome	and	tension	headaches,	as	was	found	in	outpatients	departments	and	specialized	clinics	as	well	as	in	primary	care.2,12,14		To	date,	no	single	cause	has	been	identified	in	either	the	onset	or	the	maintenance	of	PVD,	which	therefore	is	likely	of	multifactorial	origin.15,16	Over	the	last	years,	many	potential	risk	factors	have	been	studied,	including	hormonal	factors,17–24	genetic	factors,25–30	psychological	factors,31–34	HPV	infections,35–38	allergic	factors,39	pelvic	muscle	floor	dysfunction,40–43	and	sexual	and	relationship	factors.44,45		The	most	extensively	studied	risk	factor	is	vulvovaginal	candidiasis	(VVC).	As	several	studies	state,	inflammation,	induced	by	a	(repeated)	vulvovaginal	Candida	infection,	could	alter	the	equilibrium	in	the	peripheral	vulvar	vestibular	skin,	which	may	result	in	local	allodynia	and	hyperesthesia.16,46–48	An	observational	study	in	general	practice	has	demonstrated	that	patients	with	an	uncertain	diagnosis	of	VVC,	which	was	defined	as	recurrent	or	persistent	vulvovaginal	complaints	despite	treatment	for	VVC,	showed	an	increased	prevalence	of	factors	known	to	be	associated	with	PVD:	dyspareunia,	medically	unexplained	physical	symptoms	and	higher	health	care	consumption.49	Therefore	it	was	hypothesized	that	in	some	patients,	PVD	complaints	are	unintentionally	mistaken	for	VVC	due	to	overlapping	symptoms.49	Women	with	PVD	may	thus	be	misdiagnosed,	leading	to	under	treatment.	Studies	show	that	one-third	to	one-half	of	recurrent	VVC	cases	have	no	clear	cause50	and	that	about	20-25%	of	women	with	vulvovaginal	complaints	remain	without	a	microbiologically	explained	diagnosis,	even	after	careful	evaluation.51–54	PVD	also	poses	a	diagnostic	challenge	for	many	general	practitioners	(GPs).	Diagnostic	delay	is	common,	
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caused	by	both	patients’	avoidance	to	seek	help	and	reluctance	among	their	GPs	to	perform	adequate	sexual	history	and	examination.5,37,55	Since	there	is	no	diagnostic	tool	to	confirm	PVD,	it	is	merely	a	diagnosis	of	exclusion.	Improved	knowledge	of	the	exact	relationship	between	PVD	and	VVC	could	lead	to	better	identification	of	women	with	PVD	and	a	more	directed	diagnostic	approach.	Improved	insight,	should	VVC	be	of	relevance	for	the	onset	of	PVD,	could	contribute	to	new	therapeutic	options	and	rational	allocation	of	current	treatment	strategies.	Only	one	systematic	review	on	PVD	is	available,	addressing	the	relationship	between	PVD	and	inflammatory	biomarkers.56	To	date,	no	systematic	review	has	been	performed	specifically	aimed	at	the	relationship	between	VVC	and	PVD.	Therefore,	we	conducted	a	systematic	review	addressing	the	following	research	question:	Do	women	with	provoked	vulvodynia	have	a	greater	likelihood	of	having	had	a	history	of	vulvovaginal	candidiasis	compared	to	healthy	controls?	
	
Methods 
Eligibility criteria, information sources and search strategy We	included	all	cohort	and	case-control	studies	that	compared	women	with	PVD	to	healthy	controls	with	respect	to	the	presence	of	a	history	of	Candida	vulvovaginitis.	Only	studies	that	were	published	over	the	last	15	years	and	with	full	text	available	in	English,	Dutch,	German	or	French	were	included.	Conference	abstracts,	reviews,	and	editorials	were	excluded.	Subjects	had	to	be	women	with	strictly	defined	complaints	of	PVD,	preferably	according	to	the	ISSVD	criteria.1	The	2003	ISSVD	revision	of	PVD	terminology	does	no	longer	include	erythema	in	the	definition	as	erythema	is	not	present	in	all	PVD	cases,	can	occur	in	many	other	vulvar	disorders	and	may	even	be	physiological.57	However,	we	took	into	account	that	it	may	take	several	years	before	a	new	definition	is	applied	to	studies.	Therefore	studies	using	different	criteria,	such	as	Friedrich’s	criteria,58	also	were	included.	The	literature	search	was	performed	with	the	assistance	of	an	information	specialist	from	the	Radboud	University	Library	of	Medical	Sciences.	We	defined	two	search	groups:	PVD	and	VVC,	each	comprised	of	Medical	Subject	Headings	(MeSH	terms)	and	free	text	synonyms.	Searches	were	executed	in	CINAHL,	the	Cochrane	Library,	EMBASE,	MEDLINE,	PsycINFO,	PubMed	and	Web	of	Science	and	took	place	on	September	26,	2017.	The	search	results	were	filtered	by	date,	including	studies	after	September	2002.	
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The	complete	search	strategy	can	be	found	in	Appendix	A.	The	search	result	was	loaded	in	an	EndNote	X8.0.1	(Clarivate	Analytics)	library.		
 
Study selection After	removing	the	duplicates	of	the	identified	records,	title	and	abstracts	were	screened	for	relevance	by	two	researchers	(PL	and	SvdP)	independently	(Figure	1).	When	there	was	disagreement	the	researchers	discussed	until	consensus	was	reached;	if	necessary	a	third	researcher	was	available	(TLJ)	to	reach	consensus.	The	included	articles	were	read	full-text	by	the	same	two	researchers	(PL	and	SvdP)	independently	and	judged	on	our	eligibility	criteria.	Results	were	again	discussed	until	consensus	was	reached,	with	a	third	researcher	(TLJ)	available	in	case	of	persisting	debate.	The	references	of	the	included	articles	were	manually	screened	for	other	possibly	eligible	studies.	
 
Quality assessment Quality	appraisal	was	performed	using	the	Newcastle-Ottawa	Quality	Assessment	Scales	on	the	reported	methodology	and	data,	available	online	supplements,	in	the	cohort	studies	and	case-control	studies.59	This	tool	is	recommended	by	the	Cochrane	Institute	for	the	assessment	of	case-control	and	cohort	studies60,61	and	has	been	used	in	several	other	systematic	reviews	on	chronic	unexplained	pain	conditions.62–65	Both	the	case	control	and	cohort	study	checklists	are	comprised	of	eight	items	with	a	maximum	score	of	nine.	Prior	to	assessment,	all	items	were	discussed	to	ensure	unambiguous	interpretation	of	possible	answers.	Rated	on	a	0–9	scale,	studies	with	scores	8	or	9	were	considered	high	quality,	studies	with	scores	6	or	7	out	of	9	were	considered	medium	quality,	and	all	other	studies	were	considered	low	quality.63	Studies	with	low	quality	were	not	included	in	the	synthesis	of	results.62,65	Quality	appraisal	was	performed	independently	by	two	authors	(PL	and	SvdP).	Any	differences	were	discussed	until	consensus	was	reached.		
 
Data extraction The	following	data	were	extracted	from	identified	studies:	publication	date,	study	design,	sample	size,	diagnostic	criteria	for	PVD,	patient	and	control	selection	procedures,	response	or	participation	rate,	inclusion	and	exclusion	criteria	for	cases	and	controls,	age	of	population,	outcome	measure	(VVC	history,	self-reported	or	confirmed	with	pathophysiological	findings).	Whenever	possible,	outcomes	were	listed	as	odds	
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ratio	(OR),	including	the	95%	confidence	interval	and	p-values.	Heterogeneity	of	results	was	calculated	using	Higgins	I2	test	for	heterogeneity	using	the	Review	Manager	5.3	software	of	the	Cochrane	Library.	66–68	Heterogeneity	was	considered	high	if	I2≥50%.61		
Results 
Study selection Our	search	strategy	yielded	284	results,	as	presented	in	Figure	1.	After	title	and	abstract	screening,	the	full-text	version	of	twenty	articles	was	studied,	plus	two	additional	studies	found	through	reference	screening.	No	studies	had	to	be	excluded	based	on	language	alone.	Based	on	full-text	reviews,	eight	articles	were	excluded	for	the	lack	of	a	control	group	26,39,69–72	and/or	otherwise	not	meeting	the	eligibility	criteria.9,39,69–71,73	An	overview	of	all	excluded	studies	can	be	found	in	Appendix	B.	Finally,	we	included	fourteen	articles.			
Figure	1.	Flowchart	
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Study characteristics Quality	appraisal	was	performed	on	the	fourteen	included	studies	and	their	elaborated	results	are	displayed	in	Appendix	C.	Seven	studies	scored	less	than	five	points	and	were	therefore	not	considered	further	in	the	synthesis	of	results.	6,7,14,29,74–76	In	this	synthesis	we	consider	population	and	clinic-based	studies	(n=4)7,37,77,78	and	pathophysiological	studies	(n=3).16,46,48	All	were	case-control	studies.	Study	data,	in	order	of	methodological	quality,	of	the	population	and	clinic-based	case-control	and	pathophysiological	studies	are	shown	in	Table	1	and	Table	2,	respectively.		
 
Synthesis of results: population and clinic-based case-control studies All	included	population	and	clinic-based	case-control	studies	assessed	possible	PVD	risk	factors,	including	VVC	history,	using	questionnaires,	telephone	interviews,	or	chart	reviews.	Participants	were	women	with	PVD	or	healthy	controls	with	no	history	of	PVD,	recruited	from	a	random	sample	of	the	population	or	from	tertiary	health	care	centers.	Overall,	553	cases	and	668	controls	participated.	All	studies	showed	a	greater	likelihood	for	patients	diagnosed	with	PVD	to	have	a	self-reported	history	of	VVC	(ORs	2.1-6.1).			
Table	1.	Overview	of	results	of	population	based	case-control	studies	
First	author		Year	of	publication	NOS-score*	
Research	question	 Study	population	 Measurements	 Results	
Harlow	et	al.	201778	Score=7	
Are	self-reported	new	or	recurrent	yeast	infections	a	risk	factor	for	and/or	consequence	of	vulvodynia?	
Population:	visitors	of	community	health	clinics	in	the	Minneapolis/Saint	Paul	metropolitan	area	Age:	18–40	yrs	Cases:	n=	216		Controls:	n=	224		Case	definition:	ISSVD	criteria	Clinically	confirmed	case:	yes	
Questionnaire	and	chart	review		Outcome	measures:	(1)	History	of	candidiasis	(self-reported	and	self-reported	as	clinically	confirmed)	(a)	5-10	yeast	infections	(b)	>10	yeast	infections	(2)	New	or	recurrent	post-onset	yeast	infections	subsequent	to	vulvodynia	
(1a)	OR	1.6	(95%	CI:	0.76–3.5,	p	N/A)	(1b)	OR	5.5	(95%	CI:	1.7–17.8,	p	N/A)	(2)	RR	2.1	(95%	CI:	1.5–2.9,	p	N/A)	
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Nguyen	et	al.	200977	Score=7	
Are	pathologic	vaginal	microbial	and	viral	agents	risk	factors	for	VVS	among	women	diagnosed	in	a	vulvar	disease	clinic	as	compared	to	controls?	
Population:	random	selection	from	Boston	population	Age:	18-64	yrs	Cases:	n=191	Controls:	n=171	Case	definition:	ISSVD	criteria	Clinically	confirmed	case:	yes	
Questionnaire		Outcome	measure:	Previous	yeast	infection	(self-reported)	
OR	2.1	(95%	CI:	1.3-3.3,	p	N/A)	
Arnold	et	al.	20067	Score=6	
Are	previous	STIs,	UTIs	or	yeast	infections	associated	with	vulvodynia	onset?	
Population:	tertiary	centre	New	Jersey		Age:	18-80	yrs	Cases:	n=77	Controls:	n=208	Case	definition:	Friedrich’s	criteria	Clinically	confirmed	case:	yes	
Questionnaire		Outcome	measure:	>3	yeast	infections/year	(self-reported)	
OR	6.1	(95%	CI:	2.5-18.7,	p<0.001)	
Smith	et	al.	200237	Score=5	
Is	there	a	difference	in	health	history	and	health	care	use	habits	of	women	diagnosed	with	vulvodynia	compared	to	asymptomatic	controls?		
Population:	tertiary	centre	Iowa		Age:	18-65	yrs	Cases:	n=69	Controls:	n=65	Case	definition:	Friedrich’s	criteria	Clinically	confirmed	case:	yes	
Questionnaire,	medical	chart	review		Outcome	measures:	History	of	candidiasis	(self-reported	and	medical	records)	
OR	5.7	(95%	CI:	1.5-21,	p<0.01)	
*NOS	=	Newcastle-Ottawa	quality	assessment	Scale,	maximum	score=9	ISSVD	=	International	Society	for	the	Study	of	Vulvovaginal	Disorders,	N/A	=	not	available,	STI	=	sexually	transmitted	infection,	UTI	=	urinary	tract	infection		
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Table	2.	Overview	of	results	of	pathophysiological	studies	
First	author	Year	of	publication	NOS-score*	
Research	question	 Study	population	 Measurements	 Results	
Foster	et	al.	201516	Score=6		
Is	there	a	difference	in	site-specific	responsiveness	to	live	yeast	species	compared	with	yeast	byproducts	in	PVD	cases	and	pain-free	controls?	
Population:	tertiary	centre,	Rochester	Age:	N/A	Cases:	n=4	Controls:	n=4	Case	definition:	Friedrich’s	criteria	Clinically	confirmed	case:	yes	
Two	strains	of	fibroblasts	derived	from	vestibular	en	vulvar	region	of	lower	genital	tract	per	patient,	challenged	with	live	yeast	species,	yeast	extract	or	inactive	vehicle		Outcome	measure:		IL-6	and	PGE2	production	
Enhanced	IL-6	and	PGE2	production	upon	live	yeast	stimulation	in	cases	versus	controls	
Falsetta	et	al.	201546	Score=6	
Does	Dectin-1	expression	in	vulvar	and	vestibular	fibroblasts	differ	between	PVD	cases	and	controls	in	reponse	to	challenge	with	zymosan	of	live	yeast?	
Population:	tertiary	centre,	Rochester	Age:	N/A	Cases:	n=4	Controls:	n=4	Case	definition:	Friedrich’s	criteria	Clinically	confirmed	case:	yes	
Two	strains	of	fibroblasts	derived	from	vestibular	and	vulvar	region	of	lower	genital	tract	per	patient		Outcome	measure:	Dectin-1	expression	(binds	C.	albicans	cell	wall	glucan)	
Dectin-1	receptor	was	expression	elevated	in	cases	versus	controls	(p<0.05)	
	66	|		
Foster	et	al.	200748	Score=5	
Is	there	a	higher	pro-inflammatory	cytokine	production	upon	C.	albicans	stimulation	in	fibroblasts	from	PVD	patients	compared	to	controls?	
Population:	tertiary	centre,	Rochester	Age:	N/A	Cases:	n=5	Controls:	n=5	Case	definition:	NA	Clinically	confirmed	case:	yes	
Two	strains	of	fibroblasts	derived	from	vestibular	en	vulvar	region	of	lower	genital	tract	per	patient,	challenged	with	yeast,	αMSH,	αMSH	plus	yeast,	IL-1ß	or	nothing		Outcome	measure:		IL-1ß,	IL-6,	and	IL-8	production	
Vestibular	fibroblasts	from	VVS	patients	produced	the	highest	relative	levels	of	IL-1ß	(NS),	IL-6	(NS)	and	IL-8	(p<0.05)	at	baseline	an	following	yeast	alone	stimulation.	
*NOS	=	Newcastle-Ottawa	quality	assessment	Scale,	maximum	score=9	N/A=	not	available,	NS	=	not	significant,	PVD	=	provoked	vulvodynia 
 One	study	used	both	self-report	and	medical	chart	review	to	diagnose	VVC	but	the	share	of	each	is	not	reported.37	Study	groups	and	outcome	measures	(i.e.	number	of	Candida	infections)	showed	considerable	variance.	Heterogeneity	was	calculated	as	I2	=	85%,	corresponding	with	substantial	heterogeneity,61	although	the	reliability	of	I2	is	poor	with	this	small	number	of	included	studies.79		
 
Synthesis of results: pathophysiological studies One	study	group	performed	all	three	selected	pathophysiological	studies,	two	of	which	used	the	same	patient	material.16,46	Vulvar	and	vestibular	fibroblasts	were	derived	from	women	with	PVD	and	age-	and	race-matched	controls,	which	were	candidates	for	vestibulectomy	or	unrelated	vulvar	surgery,	respectively.	Cytokine	production	upon	different	regimens	was	measured,	as	cytokine	may	act	directly	or	indirectly	on	sensory	neurons	and	therefore	induce	hyperalgesia.48,80	Following	yeast	stimulation	in	vitro,	two	studies	showed	an	increased	pro-inflammatory	cytokine	production	in	patient	cells	as	compared	to	controls.16,48	Furthermore,	Dectin-1	expression	was	significantly	elevated	in	patients	versus	controls.46	As	dectin-1	is	a	receptor	that	binds	C.	albicans	cell	wall	glucan,	it	plays	a	pivotal	role	in	immunological	defense	against	VVC.81	Given	that	dectin-1	blockage	resulted	in	a	decreased	cytokine	production	the	authors	suggested	that	the	elevated	expression	of	Dectin-1	in	PVD	patients	results	in	an	increase	in	pro-inflammatory	cytokines.46		
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Discussion 
Main findings Our	systematic	review	shows	that	women	with	PVD	are	more	likely	to	have	a	self-reported	history	of	VVC	and	greater	local	pro-inflammatory	responses	than	women	with	no	history	of	PVD.	This	might	suggest	that	VVC	might	induce	an	inflammation	of	the	vulva,	causing	PVD	at	some	point.	However,	due	to	the	unclear	diagnosis	of	an	actual	VVC	in	the	included	studies	and	uncertainty	about	the	significance	of	the	pro-inflammatory	responses,	the	implications	of	these	findings	for	the	relationship	between	PVD	and	VVC	are	unclear.	Especially	since	no	included	study	was	of	high	quality,	their	conclusions	must	be	interpreted	with	some	caution.	Although	the	appraised	studies	had	a	NOS	score	of	five	or	more	out	of	nine,	overall,	their	study	quality	was	medium.	Only	two	studies	had	a	NOS	score	of	seven,	three	others	were	rated	a	six	and	two	were	rated	a	five.	The	main	methodological	limitations	were	related	to	the	selection	of	the	controls	(the	control	group	did	not	derive	from	the	same	population	as	the	cases),	to	the	ascertainment	of	the	exposure	(self-diagnosis	of	VVC	rather	than	clinically	confirmed	VVC),	to	the	non-response	(rate	not	known	or	characteristics	not	compared),	to	the	retrospective	character	of	the	design	(recall	bias	and	lack	of	exact	time	course),	and	to	the	comparability	of	cases	and	controls	(no	adjustments	for	potential	confounders	were	made).	Moreover,	of	the	seven	studies,	only	two	used	the	2003	ISSVD	criteria	of	PVD.	Using	the	obsolete	Friedrich’s	criteria	may	have	confounded	the	results,	as	local	vulvar	erythema	is	not	a	specific	feature	of	PVD.57,82	In	addition,	as	most	studies	were	carried	out	in	tertiary	health	care	centers,	the	results	may	not	be	representative	of	the	average	PVD	population.	Finally,	reliability	can	be	questioned	as	two	of	the	three	pathophysiological	studies	were	based	upon	the	same	4	cases,	one	was	based	upon	5	cases,	and	all	cases	were	selected	from	patients	previously	scheduled	for	gynecologic	surgery	(reasons	and	comorbidity	were	not	mentioned).		The	included	pathophysiological	studies	report	differences	between	human	fibroblasts	of	women	with	PVD	as	compared	to	healthy	controls	in	local	cytokine	response	on	yeast	species	in	vitro16,48	and	in	the	expression	of	Dectin-1,	a	yeast-specific	recognition	receptor.46	It	can	be	debated	whether	these	excessive	pro-inflammatory	responses	are	the	result	of	a	Candida	infection,	or	whether	other	PVD	characteristics,	such	as	inadequate	pain	coping,	low	lubrication	and	pelvic	floor	hyperactivity83,	all	resulting	in	
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fragile	vulvar	tissue,	are	accountable	for	this	altered	cytokine	reaction.	None	of	the	appraised	studies	made	adjustments	for	sexual	behavior	as	a	possible	confounder.		
Comparison with existing literature 
Significance of the pathophysiological studies for the relationship between PVD and VVC The	hypothesis	of	PVD	being	an	inflammatory	condition	has	been	adopted	58,84–86	and	rejected	87–90	several	times,	and	debate	is	still	ongoing.	It	was	shown	that	long-lasting	vulvar	hypersensitivity	could	be	induced	by	both	single	and	repeated	C.	albicans	infection	in	mice.47	Furthermore,	several	polymorphisms	in	components	of	inflammatory	pathways	have	been	shown	to	occur	more	frequently	in	PVD	patients	as	compared	to	controls,	which	may	suggest	immunologic	engagement	in	the	pathophysiology	of	PVD.25,26,28,29,91	The	findings	in	the	included	pathophysiological	studies	are	in	line	with	these	hypotheses.	Nevertheless,	it	remains	unclear	what	is	the	initial	cause	of	this	immunologic	response.	Does	the	provocative	agent	have	to	be	infectious,	or	may,	for	example,	friction	of	the	penis	during	unaroused	intercourse	in	a	non-lubricated	vagina,	lead	to	immunologic	responses	as	well?	For	example,	it	has	been	shown	that	mechanical	stretch	enhances	cytokines	production	in	different	tissues	(lung,	heart,	skin),	even	though	this	has	yet	to	be	demonstrated	in	vulvar	tissue.92,93		Furthermore,	all	included	population	studies	show	that	about	25-50%	of	the	women	with	PVD	were	found	not	to	have	a	history	of	self-diagnosed	VVC	7,37,77,78	Inversely,	nearly	75%	of	women	report	an	episode	of	self-diagnosed	VVC	at	some	point	in	their	life	while	never	developing	PVD.94	Thus,	even	if	future	studies	unequivocally	demonstrate	that	VVC	is	related	to	PVD,	it	should	not	be	considered	its	sole	causative	agent.	
Self-diagnosed VVC versus actual VVC The	lack	of	proven	VVC	in	our	appraised	population	and	clinic-based	studies	raises	the	question	of	whether	self-diagnosed	VVC	predicts	an	actual	diagnosed	VVC.	Unfortunately,	all	publications	show	that	the	accuracy	of	self-diagnosed	VVC	is	very	poor.95–98	In	this	perspective,	we	would	like	to	mention	the	study	by	Harlow	and	colleagues,	which	reports	positive	associations	between	PVD	and	self-reported	Candida	infections.78	However,	the	proportion	of	yeast	infections	diagnosed	by	a	clinician	did	not	differ	among	those	with	and	without	vulvodynia	before	onset	of	vulvar	pain	(36.5%	vs.	39.8%)	or	subsequent	to	onset	of	vulvar	pain	(31.7%	vs.	30.5%).78	The	researchers	argued	that	these	findings	may	be	explained	by	the	risk	of	recall	bias,	meaning	that	
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women	with	PVD	may	be	more	likely	to	remember	or	overestimate	their	history	of	self-reported	yeast	infections	as	compared	to	controls.78		The	association	between	self-reported	VVC	and	PVD	in	the	studies	included	in	this	review,	rather	than	being	indicative	of	a	true	relationship,	may	actually	represent	the	complex	pattern	of	complaints	women	seek	help	with.	For	instance,	one	population-based	study	in	over	2,200	women	showed	that	women’s	pain	descriptions	are	not	limited	to	vulvar	burning,	but	also	include	rawness,	irritation,	and	itching,	descriptors	that	may	lead	to	misdiagnosis	if	not	further	pursued.5	Another	study	showed	that	women	who	buy	over-the-counter	antifungal	drugs	are	generally	unable	to	correctly	self-diagnose	VVC,	leading	to	drug	misuse.	96	Yet,	as	is	also	demonstrated	in	the	present	review,	VVC	prevalence	studies	and	pathophysiological	studies	studying	underlying	mechanisms	continue	to	be	based	on	self-diagnosis.		The	mechanism	behind	incorrect	self-diagnosis	of	VVC	may	be	partly	due	to	women’s	own	views	regarding	the	origin	of	their	complaints.	An	analysis	of	interviews	with	women	with	PVD	showed	their	disappointment	concerning	the	lack	of	a	somatic	cause	for	their	pain	and	the	suggestion	that	psychological	factors	may	be	associated	with	their	complaints.99	A	qualitative	study	in	32	women	with	sexual	pain	complaints	revealed	mechanisms	that	may	explain	why	women	continue	to	seek	medical	legitimation	of	their	pain.100	Among	those	reasons	were	fear	that	the	absence	of	a	medical	cause	implied	that	they	were	exaggerating	the	pain	or	represented	evidence	of	a	factitious	disorder	in	order	to	seek	privileges	associated	with	the	sick	role	(such	as	permission	to	avoid	painful	sexual	activity	if	considered	a	perceived	obligation).	The	authors	concluded	that	“women	may	use	validation	from	medical	providers	as	evidence	of	illness	that	may	carry	more	weight	than	their	subjective	claims	of	incapacity	due	to	pain”.100	Probably,	this	mechanism	is	maintained	by	a	conspiracy	of	silence	between	women	and	their	physician.		
Is PVD a multifactorial pain condition? In	a	systematic	review	in	2016	on	the	relationship	between	PVD	and	inflammatory	biomarkers,	the	authors	concluded	that	“there	is	limited	and	contradictory	evidence	regarding	the	characteristics	of	local	and	systemic	inflammation	in	women	with	localized,	provoked	vestibulodynia”.56	The	findings	of	our	systematic	review	also	do	not	provide	clear-cut	support	for	this	inflammation	hypothesis.	As	suggested	earlier,	perhaps	PVD	should	be	considered	as	a	(unexplained)	chronic	pain	condition.44	As	in	
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other	medically	unexplained	syndromes,	with	which	PVD	is	strongly	associated,14	women	with	PVD	are	more	likely	to	have	a	maladaptive	immune	response	and	have	been	found	to	be	more	sensitive	to	pain	at	distant	locations.101,102	Psychological	therapies	currently	applied	for	other	medically	unexplained	symptoms,	such	as	(mindfulness-based)	cognitive	behavioral	therapy,103,104	also	result	in	symptom	relief	for	PVD	patients.105–108	Apparently,	medically	unexplained	syndromes	and	PVD	share	common	causative	or	sustaining	biopsychosocial	factors.	Acceptance	of	an	integrative	model	where	PVD	is	seen	as	a	pain	condition	with	biomedical	and	psychological	associated	factors	that	do	not	dismiss	women’s	experience	of	pain	may	ultimately	be	more	beneficial	than	a	continued	sole	focus	on	medical	causes.					
Strengths and limitations To	our	knowledge,	this	is	the	first	systematic	review	that	attempts	to	address	the	relationship	between	VVC	and	PVD.	We	consider	the	strengths	of	our	study	our	systematic,	elaborate	search	strategy	and	the	exclusion	of	studies	of	insufficient	methodological	quality.	With	an	independently	performed	in-	and	exclusion	process	and	quality	appraisal,	we	ensured	optimal	internal	validity.	However,	even	after	excluding	studies	of	poor	methodological	quality,	there	were	still	important	methodological	limitations.	The	size	of	heterogeneity	prevented	us	to	establish	a	meta-analysis,	due	to	the	methodological	and	clinical	diversity	of	the	included	studies.	
	
Practical implications Firstly,	although	a	relationship	between	self-reported	VVC	and	the	occurrence	of	PVD	is	doubtful,	it	may	be	very	useful	to	physicians	to	consider	a	diagnosis	of	PVD	in	women	with	self-reported	VVC,	and	to	act	on	this	properly.49	Additionally,	recurrence	and	persistence	of	VVC-like	vulvar	complaints	should	make	physicians	reconsider	the	diagnosis.	This	is	highly	relevant	since	the	incidence	of	VVC	(including	recurrent	and	persistent	VVC)	is	24,2	per	1000	women	in	Dutch	primary	care,	with,	on	average,	two	consultations	concerning	vaginal	candidiasis	per	practice	per	week.109,110	Probably,	20-25%	of	them	do	not	have	VVC.49–54		Secondly,	given	that	antimycotic	treatment	of	VVC	is	highly	effective111,	persistent	VCC-like	symptoms	may	indicate	that	the	complaints	are	actually	not	indicative	of	VVC	and	may	point	to	PVD.	In	such	cases,	reiteration	of	antifungal	prescriptions	by	physicians	
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without	a	decent	diagnosis,	will	lead	to	mistreatment.	Also,	the	repetitive	use	of	over	the	counter	antifungal	drugs	may	leave	other	complaints,	like	PVD,	untreated.	Physicians	and	their	assistants	should	be	aware	of	this	during	telephone	triage	and	in-office	and	have	to	adapt	their	management	of	vulvovaginal	complaints	accordingly.	Thirdly,	as	VVC	might	induce	immunological	reactions	of	the	vulva	and	vagina,	women	should	be	informed	by	their	physician	that	intercourse	during	(or	shortly	after)	the	treatment	of	VVC	might	worsen	the	vulnerability	of	the	vulvar	skin,	should	be	done	only	when	sufficiently	sexually	aroused,	and	should	be	postponed	preferably	until	all	symptoms	have	subsided.			
Future research Ideally,	in	order	to	determine	the	relationship	between	VVC	and	PVD,	we	would	suggest	a	large	prospective	population-based	cohort	study	in	women	with	an	established	diagnosis	of	VVC,	assessing	the	incidence	of	PVD.	As	this	may	pose	many	practical	implications,	the	development	of	a	database	comprised	of	women	with	PVD	could	also	be	an	interesting	cohort	to	follow	up,	as	PVD	might	remit	and	relapse.112	Moreover,	for	the	ongoing	debate	of	immunological	involvement,	it	would	be	interesting	to	assess	PVD	prevalence	in	immunocompromised	patients	and	in	women	without	any	history	of	VVC.	Also,	immunological	response	may	be	measured	in	women	with	PVD	who	have	no	history	of	any	vulvovaginal	infection.	Furthermore,	we	would	like	to	encourage	to	include	sexual	behavior	parameters	in	pathophysiological	studies	to	adjust	for	confounders.83	Finally,	it	would	be	very	worthwhile	to	investigate	the	help	seeking	behavior	of	women:	how	do	they	express	their	vulvovaginal	complaints	in	a	medical	context	and	how	might	this	influence	the	final	diagnosis?		
Conclusion The	results	of	our	systematic	review	show	that	the	suggestion	of	a	relationship	between	actual	vulvovaginal	candidiasis	and	PVD	remains	controversial	due	to	problems	associated	with	self-reported	VVC.	Until	new	evidence	becomes	available,	we	advocate	that	PVD	should	be	regarded	as	an	unexplained	chronic	pain	condition.	Physicians	should	consider	a	diagnosis	of	PVD	in	women	with	recurrent	or	persistent	VVC	like	complaints.	
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Appendix	A.	Search	strategy		 Database	 Search	terms†	 Results‡	PubMed	 (("Vulvar	Vestibulitis"[Mesh]	OR	Vulvar	Vestibulit*[tiab]	OR	vulvodynia[tiab]	OR	vestibulodynia[tiab]	OR	vulvar	pain	syndrome*[tiab]	OR	Clitorodynia[tiab]	OR	vulvar	dysesthesia[tiab])		AND		("Candidiasis,	Vulvovaginal"[Mesh]	OR	Vulvovaginal	candidiasis[tiab]	OR	Candid*[tiab]	OR	vaginal	yeast	infection*[tiab]	OR	vaginitis[tiab]	OR	fungus[tiab]	OR	fungal[tiab]	OR	Vulvovaginal	Candidias*[tiab]	OR	Vulvovaginal	Monilias*[tiab]	OR	Monilial	Vaginit*[tiab]))	
86	
EMBASE	 exp	vulvar	vestibulitis/	OR	(Vulvar	Vestibulit*	OR	vulvodynia	OR	vestibulodynia	OR	vulvar	pain	syndrome*	OR	Clitorodynia	OR	vulvar	dysesthesia).ti,ab.		AND	exp	vagina	candidiasis/	OR	(Vulvovaginal	candidiasis	OR	Candid*	OR	vaginal	yeast	infection*	OR	vaginitis	OR	fungus	OR	fungal	OR	Vulvovaginal	Candidias*	OR	Vulvovaginal	Monilias*	OR	Monilial	Vaginit*).ti,ab.	
141	
MEDLINE	 exp	Vulvar	Vestibulitis/	OR	(Vulvar	Vestibulit*	OR	vulvodynia	OR	vestibulodynia	OR	vulvar	pain	syndrome*	OR	Clitorodynia	OR	vulvar	dysesthesia).ti,ab.	AND	exp	Candidiasis,	Vulvovaginal/	OR	(Vulvovaginal	candidiasis	OR	Candid*	OR	vaginal	yeast	infection*	OR	vaginitis	OR	fungus	OR	fungal	OR	Vulvovaginal	Candidias*	OR	Vulvovaginal	Monilias*	OR	Monilial	Vaginit*).ti,ab.	
89	
PsycINFO	 (Vulvar	Vestibulit*	OR	vulvodynia	OR	vestibulodynia	OR	vulvar	pain	syndrome*	OR	Clitorodynia	OR	vulvar	dysesthesia).ti,ab.	AND	(Vulvovaginal	candidiasis	OR	Candid*	OR	vaginal	yeast	infection*	OR	vaginitis	OR	fungus	OR	fungal	OR	Vulvovaginal	Candidias*	OR	Vulvovaginal	Monilias*	OR	Monilial	Vaginit*).ti,ab.	
6	
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The	Cochrane	Library	 (Vulvar	Vestibulit*	OR	vulvodynia	OR	vestibulodynia	OR	vulvar	pain	syndrome*	OR	Clitorodynia	OR	vulvar	dysesthesia)	AND	(Vulvovaginal	candidiasis	OR	Candid*	OR	vaginal	yeast	infection*	OR	vaginitis	OR	fungus	OR	fungal	OR	Vulvovaginal	Candidias*	OR	Vulvovaginal	Monilias*	OR	Monilial	Vaginit*)	
8	
CINAHL	 (MH	"Vulvar	Vestibulitis")	OR	TI	(	Vulvar	Vestibulit*	OR	vulvodynia	OR	vestibulodynia	OR	vulvar	pain	syndrome*	OR	Clitorodynia	OR	vulvar	dysesthesia	)	OR	AB	(	Vulvar	Vestibulit*	OR	vulvodynia	OR	vestibulodynia	OR	vulvar	pain	syndrome*	OR	Clitorodynia	OR	vulvar	dysesthesia	)	OR	TX	(	(Vulvar	Vestibulit*	OR	vulvodynia	OR	vestibulodynia	OR	vulvar	pain	syndrome*	OR	Clitorodynia	OR	vulvar	dysesthesia)	)		AND	(MH	"Candidiasis,	Vulvovaginal")	OR	TI	(	Vulvovaginal	candidiasis	OR	Candid*	OR	vaginal	yeast	infection*	OR	vaginitis	OR	fungus	OR	fungal	OR	Vulvovaginal	Candidias*	OR	Vulvovaginal	Monilias*	OR	Monilial	Vaginit*	)	OR	AB	(	Vulvovaginal	candidiasis	OR	Candid*	OR	vaginal	yeast	infection*	OR	vaginitis	OR	fungus	OR	fungal	OR	Vulvovaginal	Candidias*	OR	Vulvovaginal	Monilias*	OR	Monilial	Vaginit*	)	OR	TX	(	Vulvovaginal	candidiasis	OR	Candid*	OR	vaginal	yeast	infection*	OR	vaginitis	OR	fungus	OR	fungal	OR	Vulvovaginal	Candidias*	OR	Vulvovaginal	Monilias*	OR	Monilial	Vaginit*	)	
27	
Web	of	Science	 (Vulvar	Vestibulit*	OR	vulvodynia	OR	vestibulodynia	OR	vulvar	pain	syndrome*	OR	Clitorodynia	OR	vulvar	dysesthesia)	AND	(Vulvovaginal	candidiasis	OR	Candid*	OR	vaginal	yeast	infection*	OR	vaginitis	OR	fungus	OR	fungal	OR	Vulvovaginal	Candidias*	OR	Vulvovaginal	Monilias*	OR	Monilial	Vaginit*)	
90	
	†	Publication	dates	were	filtered	excluding	studies	before	September	1,	2002		‡	Searches	executed	on	September	26,	2017		 	
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Appendix	B.	Excluded	studies	after	full-text	revision	
First	author	Year	of	publication	 Relevant	 Control	group	 Commentary	Babula	et	al.,	2008	 yes	 no	 Comparison	between	PVD	subjects,	no	control	group.	Dennerstein,	2008	 no	 no	 Study	describes	microscopic	examination	of	a	vaginal	smear	and	therefore	does	not	provide	an	answer	to	our	research	question.	Falsetta	et	al.,	2016	 no	 yes	 Study	looks	at	the	role	of	bradykinin	in	pain	experience	in	people	with	PVD.	The	relationship	of	bradykinin	and	Candida	vaginitis	was	not	clear	from	the	study	and	it	was	therefore	excluded.	
Giraldo	et	al.,	2012	 no	 yes	 Sexual	function	assessment	in	both	PVD	and	VVC	separately.	This	provides	no	answer	to	the	research	question.	Pagano,	2007	 no	 no	 Study	addresses	vulvodynia	in	general	and	only	addresses	the	value	of	colposcopy	in	vulvodynia	patients.	This	provides	no	answer	to	our	research	question.	
Saunders	et	al.,	2008	 no	 no	 Assessment	and	comparison	of	pain	scores	in	vulvodynia	and	Candida	vaginitis.	This	provides	no	answer	to	our	research	question.	Theodoropoulos	et	al.,	2016	 no	 no	 Study	looks	at	chronic	vaginitis	syndrome,	which	consists	of	many	vulvar	diagnosis	(such	as	lichen	sclerosis	and	atrophic	vaginitis).	Witkin	et	al.,	2002	 yes	 no	 Comparison	between	PVD	subjects,	no	control	group.	
	PVD	=	Provoked	vulvodynia.	VVC	=	vulvovaginal	candidiasis	
		
	 	
 |	81	 	
Appendix	C.	Quality	assessment	with	the	Newcastle-Ottawa	quality	assessment	Scale	
First	author	and	year	of	publication	 Selection	of	case	and	controls	(max	score	4)	
Comparability	of	cases	and	controls	(max	score	2)	
Ascertainment	of	exposure	(max	score	3)	
Final	score		
Arnold	et	al.,	2006	 ***	 *	 **	 6	Arnold	et	al.,	2007	 **	 *	 *	 4‡	Edgardh	et	al.,	2007	 ***	 *	 	 4‡	Falsetta	et	al.,	2015	 **	 **	 **	 6	Foster	et	al.,	2007	 **	 *	 **	 5	Foster	et	al.,	2015	 **	 **	 **	 6	Harlow	et	al.,	2017	 ****	 **	 *	 7	Leusink	et	al.,	2016†	 **	 	 **	 4‡	Lev-Sagie	et	al.,	2009	 *	 	 *	 2‡	Nguyen	et	al.,	2009	 ***	 **	 **	 7	Ramirez	de	Knott	et	al.,	2005	 *	 	 **	 3‡	Smith	et	al.,	2002	 ***	 	 **	 5	Ventolini	et	al.,	2013	 *	 	 *	 2‡	Vieira-Baptista	et	al.,	2014	 **	 	 *	 3‡		†	Cohort	study	‡		Not	considered	in	the	synthesis	of	results		
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Facilitators and barriers in the diagnostic process of 
vulvovaginal complaints (vulvodynia) in general practice: a 
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Abstract 
Background:	The	gap	between	the	relatively	high	prevalence	of	provoked	vulvodynia	(PVD)	in	the	general	population	and	the	low	incidence	in	primary	care	can	partly	be	explained	by	physicians’	lack	of	knowledge	about	the	assessment	and	management	of	PVD.	
Objectives:		To	recognize	barriers	and	facilitators	of	GPs	in	the	diagnostic	process	of	women	presenting	with	recurrent	vulvovaginal	complaints.	
Methods:	A	qualitative	focus	group	study	in	17	Dutch	GPs,	five	men	and	twelve	women.	An	interview	guide,	based	on	the	scientific	literature	and	the	expertise	of	the	researchers,	including	a	vignette	of	a	patient,	was	used	to	direct	the	discussion	between	the	GPs.	The	interviews	were	audiotaped	and	transcribed	verbatim.	A	systematic	text	analysis	of	the	transcripts	was	performed	after	data	saturation	was	reached.		
Results:	Analysis	of	the	interviews	generated	three	major	themes:	Identifying	and	
discussing	sexual	complaints,	Importance	of	gender	in	professional	experience	and	Coping	
with	professional	uncertainty.	Within	these	themes,	the	reluctance	regarding	sexual	complaints,	male	gender,	negative	emotional	responses	when	faced	with	professional	uncertainty,	as	well	as	lack	of	education	were	barriers	for	the	diagnostic	process	and	management	of	PVD.	Female	gender	and	understanding	that	patients	can	profit	from	inquiring	about	sexual	health	issues	were	found	to	be	facilitating	factors.	
Conclusion:	In	order	to	improve	the	care	for	women	with	PVD,	attitude	and	skills	of	GPs	regarding	taking	a	sexual	history	and	performing	a	vulvovaginal	examination	should	be	addressed,	as	well	as	GPs’	coping	strategies	regarding	their	professional	uncertainty.			
Key	messages	•	 Female	and	certainly	male	GPs	should	be	better	supported	in	the	development	of	attitudes	and	skills	regarding	taking	a	sexual	history	in	women	and	performing	a	vulvovaginal	examination.		•	 GPs	should	be	trained	to	address	vulvodynia	like	other	medically	unexplained	physical	symptoms,	as	GPs	face	the	same	professional	uncertainty	about	it.		
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Introduction Vulvodynia	is	a	common	disorder	in	the	general	population	with	a	point	prevalence	of	8%	and	a	lifetime	prevalence	of	25%.1,2	Vulvodynia	is	defined	as	‘vulvar	pain	of	at	least	three	months	duration,	without	clear	identifiable	cause,	which	may	have	potential	associated	factors.’3	The	following	descriptors	are	used	to	specify	the	characteristics	of	vulvodynia:	Localized	(eg,	vestibulodynia,	clitorodynia)	or	generalized	or	mixed;	Provoked	(eg,	insertional,	contact)	or	spontaneous	or	mixed;	Onset	(primary	or	secondary);	and	Temporal	pattern	(intermittent,	persistent,	constant,	immediate,	delayed).3	As	provoked	vulvodynia	(PVD)	is	the	most	prevalent	and	studied	clinical	presentation	of	vulvodynia,	with	many	implications	on	an	individual	and	relational	level,	the	focus	in	this	article	will	be	on	PVD.	Studies	show	that	about	50%	of	women	with	PVD	never	sought	help	and	of	those	who	did,	more	than	50%	received	no	diagnosis.1,2	Only	5.7%	of	those	who	sought	help	were	diagnosed	with	vulvodynia.1	Accordingly,	in	Dutch	family	practices	the	registered	incidence	of	painful	intercourse,	an	essential	symptom	of	PVD,	is	very	low,	about	0.1%.4	More	precise	epidemiological	findings	of	PVD	in	primary	care	are	lacking,	since	PVD	is	not	included	in	the	International	Classification	of	Primary	Care	(ICPC).	The	gap	between	the	relatively	high	prevalence	of	PVD	in	the	general	population	and	the	low	incidence	in	primary	care	can	be	explained	by	patient	factors	as	well	as	by	physician	factors.5	As	was	demonstrated	in	a	number	of	studies,	physicians	lack	knowledge	about	the	assessment	and	management	of	PVD	6-8.	In	one	population	based	study,	60%	of	women	with	PVD	consulted	three	or	more	doctors,	many	of	whom	were	unable	to	provide	a	clear	diagnosis.6	In	a	qualitative,	in-depth	interview	study	women	with	PVD	consulted	between	three	and	fifteen	different	doctors,	and	often	had	endured	months	of	incorrect	treatment,	most	notably	for	vulvovaginal	candidiasis.7	Furthermore,	a	survey	among	junior	gynecologists	showed	that	most	of	them	did	not	receive	any	basic	training	about	the	condition,	even	after	having	reached	the	final	stages	of	specialism	training.8	Possibly,	physicians’	lack	of	competence	to	recognize	and	to	diagnose	PVD	maintains	the	negative	beliefs	of	women	regarding	the	benefit	of	seeking	help.	General	practitioners	(GPs)	deal	with	vulvovaginal	complaints	regularly	and	the	diagnostic	process	proves	to	be	complicated.9,10	In	a	retrospective	cohort	analysis,	we	found	that	in	a	general	practice	population	of	women	between	15-50	years,	symptoms	suggestive	of	PVD	were	strongly	associated	with	the	diagnosis	of	vulvovaginal	
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candidiasis	(odds	ratio	4-7).11	Moreover,	in	women	in	general	practice	who	presented	recurrent	and	persistent	vulvar	complaints	diagnosed	as	vulvovaginal	candidiasis,	concurrent	symptoms,	such	as	dyspareunia,	functional	syndromes,	micturition	symptoms	and	psychological	conditions,	may	possibly	point	to	the	diagnosis	of	PVD.12	GPs	might	reconsider	their	diagnostics	and	management	when	women	present	with	recurrent	and	persistent	vulvovaginal	complaints.	In	order	to	improve	the	recognition	of	PVD,	it	is	important	to	know	more	precisely	which	barriers	and	facilitators	are	affecting	the	diagnostic	process	for	GPs	who	are	confronted	with	recurrent	and	persistent	vulvovaginal	complaints.	The	present	study	reports	on	a	qualitative	focus	group	study	in	Dutch	GPs	investigating	their	diagnostic	considerations	when	consulted	by	women	with	vulvovaginal	complaints.			
Methods 
Study design Focus	group	interviews	were	carried	out	among	Dutch	GPs	during	the	first	half	of	2016.	Qualitative	data	were	collected	in	order	to	obtain	in-depth	insight	into	the	clinical	decision-making	process	concerning	vulvovaginal	complaints.	Group	interviews	rather	than	interviews	with	individual	GPs	were	carried	out	because	we	expected	that	the	exchange	of	ideas	and	experiences	between	focus	group	members	would	generate	more	relevant	information	than	individual	interviews.13			
Participants  Participants	were	recruited	among	400	randomly	selected	GPs	working	in	the	eastern	and	middle	region	of	the	Netherlands	through	an	invitational	letter.	Non-responders	were	contacted	two	weeks	later	through	e-mail	or	telephone.	Finally,	of	the	20	GPs	who	responded,	3	could	not	attend	the	scheduled	focus	group	meeting;	17	participated	in	four	focus	groups,	five	men	and	twelve	women.	Each	group	consisted	of	four	to	five	participants;	three	groups	contained	both	men	and	women,	one	focus	group	contained	five	female	GPs.	The	reason	for	the	low	participation	rate	is	not	known,	as	non-response	was	not	investigated.	Characteristics	of	participants	are	given	in	Table	1.	All	GPs	signed	an	informed	consent	form	prior	to	participating.	Anonymity	and	confidentiality	were	ensured.		
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According	to	Dutch	legislation,	no	approval	of	a	medical	ethics	committee	was	required	for	the	interviews.	Participants’	travel	expenses	were	reimbursed.		
Focus group interviews and data collection A	certified	sexologist	(and	former	GP)	moderated	two	focus	groups.	Due	to	practical	circumstances,	another	GP	moderated	the	other	two	focus	groups.	The	moderators	were	not	personally	or	professionally	related	to	the	participants.	An	interview	guide	was	used	to	direct	the	discussion	and	was	based	on	the	scientific	literature	and	the	expertise	of	the	researchers.	Emphasis	in	this	guide	was	placed	on	the	thoughts	and	feelings	of	GPs	regarding	taking	a	sexual	history	and	performing	an	examination	of	vulva/vagina	during	their	last	consultation	with	a	woman	with	vulvovaginal	complaints	and	when	confronted	with	a	vignette.	This	vignette	shows	a	woman	consulting	the	GP	the	3rd	time	in	4	months	(including	once	by	telephone)	with	“vulvar	irritation	without	discharge”.	PVD	was	not	suggested	as	a	diagnosis.	The	basis	of	the	conversation	was	the	GP's	diagnostic	process.	The	focus	groups	lasted	90	minutes	and	were	audiotaped	and	transcribed	verbatim.	One	author	(PLe)	and	a	medical	student	observed	all	groups	and	made	field	notes	of	non-verbal	communication	and	potentially	remarkable	observations.		
Data Analysis The	principal	author	(PLe)	and	a	medical	student	independently	performed	a	systematic	analysis	of	transcripts,	with	one	central	question	in	mind:	‘Which	facilitators	and	barriers	are	observed	regarding	the	diagnosis	of	vulvovaginal	complaints?’	After	analysing	two	group	interviews,	the	codes	were	discussed	with	the	supervising	committee,	and	some	small	adjustments	in	the	topic	list	were	made.	Particularly,	GPs	were	emphatically	invited	for	discussing	how	they	bring	up	sexual	issues	with	their	patients,	as	they	were	reluctant	to	discuss	this	issue.	With	this	revised	topic	list	we	conducted	the	last	two	focus	groups.	After	analysing	the	fourth	focus	group	saturation	was	reached.	A	statement	was	of	importance	when	it	was	recognised	by	others	and	was	followed	by	discussion.	Codes	referring	to	the	same	content	were	grouped	in	categories	and	subsequently	in	themes.	We	applied	all	consolidated	criteria	for	reporting	qualitative	research	(COREQ-criteria),	with	the	exception	of	the	criterion	for	returning	the	transcript	to	the	participants	for	comment.14		
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The	qualitative	research	software	package	ATLAS-ti	was	used	to	assist	with	registering,	searching	and	coding	the	data.	Quotes,	which	illustrate	the	main	results,	are	presented	(Box	1,	2,3)	and	translated	from	Dutch	to	English	by	a	bilingual	speaker.			
Results Analysis	of	the	interviews	generated	three	major	themes:	Identifying	and	discussing	sexual	complaints,	Importance	of	gender	in	professional	experience	and	Coping	with	professional	uncertainty.		
Box	1.	Identifying	and	discussing	sexual	complaints		
Reluctance	
taking	a	sexual	
history	
“...	so	in	that	case	[wondering	if	someone	might	have	a	STD]	you	can	focus	on	it	[sexual	behaviour]	and	even	then,	let’s	say,	you	would	not	take	a	thorough	sexual	history.	It’s	more	like	...	how	sure	do	you	want	to	be	whether	someone	might	have	a	chlamydia.”	(F4,	FG4,	45-55yr)		”I	think,	especially	when	it	comes	to	peers,	that	a	patient	seems	to	find	it	uncomfortable.	This	might	be	an	assumption	of	mine,	but	I	have	the	impression	that	the	discomfort	is	mutual.”	(M1,	FG2,	<	45yr)	“With	whom	you	feel	less	at	ease?”	(Moderator)	”With	women	of	my	own	age.”	(M1,	FG2,	<	45yr)	”And	in	what	way	does	it	affect	your	consultation?”	(Moderator)	“That	I	postpone	talking	about	it	[sexuality],	until	I	have	exceeded	all	my	questions	and	still	don’t	know	what	it’s	going	on.”	(M1,	FG2,	<	45yr)	
Embarrassment	 “What	do	you	want	to	recommend	to	a	GP	trainee	regarding	the	diagnosis	of	vulvovaginal	complaints”?	(Moderator)	“Do	not	hesitate	to	perform	a	vulvar	examination.”	(M1,	FG3,	45-55yr)	“This	applies	to	a	male	trainee	as	well?”	(Moderator)	“Especially	to	a	male	trainee!”	(M1,	FG3,	45-55yr)		“Somehow	I	have	the	feeling	that	it	is	none	of	my	business,	she	probably	thinks	I’m	a	curious	guy.”	(M1,	FG2,	<	45yr)		“No,	I	didn’t	ask,	and	eh	…	well,	a	bit	naïve	maybe,	but	I	thought,	eh	…	her	husband	died	5-6	years	ago,	so…	it	didn't	cross	my	mind.”	(M1,	FG3,	45-55yr)	
Convenience	in	
discussing	
sexual	issues	
“What	I	found	very	instructive	this	afternoon,	is	that	bringing	up	sexual	issues,	is	not	bad	at	all.	Actually,	women	are	very	happy	about	it	when	it	is	discussed.”	(M1,	FG2,	<	45yr)		“I	think	it’s	funny	that	you	[remark	directed	towards	a	male	GP]	say	you	have	difficulties	with	this,	the	sexual	history,	maybe	it’s	because	I’m	a	woman	that	I	think	of	it	as	usual	questions.”	(F2,	FG2,	<	45yr)	Legend:	F	and	M	stands	for	female	and	male	GP	respectively,	FG	for	focus	group,	all	followed	by	a	unique	number.		
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Identifying and discussing sexual complaints  Most	GPs	were	found	to	have	difficulties	in	inquiring	about	sexual	behaviour,	unless	it	was	related	to	the	assessment	of	the	likelihood	of	a	sexually	transmitted	disease	(STD)(Box	1).	Outside	the	context	of	STDs,	GPs	were	reluctant	to	take	a	sexual	history.	In	particular	male	GPs	mentioned	hesitance	regarding	female	patients	of	their	own	age	and	mentioned	that	this	hesitancy	to	take	a	sexual	history	and	performing	a	vulvovaginal	examination	applies	more	to	themselves	than	female	GPs.	Some	male	GPs	and	no	female	GPs	were	afraid	to	be	seen	as	overly	curious,	or	felt	embarrassed	or	noticed	a	not	well-defined	feeling	of	tension	when	inquiring	about	sexual	issues.	Some	male	GPs	feared	to	be	considered	interfering	in	patients’	private	life	or	to	be	disqualified	by	the	patient,	even	when	private	or	sexual	issues	might	be	relevant	for	the	diagnosis.		A	facilitating	factor	was	the	knowledge	that	patients	could	profit	from	being	asked	about	sexual	issues.	Some	male	GPs	were	grateful	for	the	information	provided	by	their	female	colleagues	that	women	do	expect	professional	attention	to	sexual	health	issues.			
Importance of gender in professional experience Female	GPs	mentioned	that	they	see	more	women	with	vulvovaginal	complaints	than	their	male	colleagues,	and	that	therefore	they	may	have	more	routine,	knowledge	and	skills	regarding	these	issues	(Box	2).	Also,	some	female	GPs	mentioned	that	identifying	themselves	with	the	women,	in	the	sense	that	they	more	easily	could	recognize	the	problem,	proved	to	be	a	facilitating	factor	in	the	diagnostic	process.		Finally,	a	sense	of	curiosity	and	challenge	in	searching	for	a	solution	was	expressed	by	some	female	GPs,	whereas	male	GPs	never	did	so.	The	latter	mentioned	seeing	fewer	women	with	vulvovaginal	complaints	than	their	female	colleagues.	Therefore,	male	GPs	described	that	they	were	less	experienced	and	trained	in	gynaecological	complaints,	causing	them	to	feel	insecure	about	assessing	sexuality	and	performing	a	gynaecologic	examination,	for	example,	leading	to	avoiding	or	postponing	an	examination,	thereby	maintaining	their	lack	of	experience.						
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Box	2.	Importance	of	gender	in	professional	experience	
Routine	 “When	I	started	as	a	GP,	I	was	the	only	woman	in	the	group,	so	automatically	you	will	get	some	more	experience.”	(F2,	FG1,	45-55yr)		“I	am	the	only	man	with	three	female	colleagues	and	now	the	situation	is	such	that	..	eh	..	I	manage	the	complaints	related	to	the	male	lower	urinary	tract	and	..	eh	..	the	women	insert	IUDs	and	manage	vulvovaginal	complaints“	(M1,	FG3,	45-55yr)		
Recognition	 “I	understood	her	worries,	and	..	eh	...I	experienced	the	same	as	A.	[another	female	GP]:	that	it	is	not	complicated	to	perform	a	gynaecological	examination	or	to	ask	about	it	[referring	to	sexuality].”	(F1,	FG3,	>55yr)		“When	my	attention	is	completely	focussed	on	the	patient,	the	complaint	or	the	story,	I	am	much	more	successful	in	filtering	out	the	things	that	are	necessary	to	ask	more	specific	questions.”	(F2,	FG1,	45-55yr)		
Curiosity	 “So	I	thought,	look,	a	puzzle.	This	is	something	we	have	to	solve,	so	yes,	I	want	to	know	more	details	and	make	a	plan.	It	feels	like	a	challenge.”	(F2,	FG3,	<45yr)		“I	tried	to	tickle	her	a	bit	[in	taking	responsibility	in	finding	a	solution].	I	wonder	if	she	will	succeed.”	(F3,	FG1,	45-55yr)		“What	do	you	want	to	recommend	to	a	GP	trainee	regarding	the	diagnosis	of	vulvovaginal	complaints”?	(Moderator)	“The	word	curiosity	is	coming	into	my	mind.	[..].	Curious	about	behaviour,	about	ideas,	about	meaning.	[..].”	(F1,	FG1,	45-55yr)	“How	does	curiosity	help	you,	regarding	vulvovaginal	complaints?”	(Moderator)	F1,	FG1,	45-55yr:	“To	get	a	clear	picture	of	the	problem.”			
Uncertainty	 “Because	I	see	less	[referring	to	vulvovaginal	complaints],	the	less	you	do	something,	the	less	efficient	you	become	at	it.”	(M1,	FG1,	45-55yr)		[When	performing	a	gynaecological	examination]	“In	women	of	my	own	age,	the	reluctance	[referring	to	his	own	reluctance]	is	the	highest.	[...]	When	the	complaints	vanish	on	trial	by	treating	with	miconazole,	well,	than	I	can	postpone	that	part	of	the	consultation,	that’s	the	way	it	goes,	often.”	(M1,	FG2,	<	45yr)		Legend:	F	and	M	stands	for	female	and	male	GP	respectively,	FG	for	focus	group,	all	followed	by	a	unique	number.		
Coping with professional uncertainty Confronted	with	a	vignette	of	a	patient	with	recurrent	vulvovaginal	symptoms	(consulting	the	GP	for	the	third	time	after	4	months),	for	whom	standard	therapeutic	management	was	not	successful,	GPs	generally	reacted	with	negative	emotions	like	helplessness,	discomfort,	incompetence	and	frustration	(Box	3).	GPs	compared	their	
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emotions	to	their	reactions	when	confronted	with	other	physical	complaints	that	cannot	be	explained	somatically	(MUPS,	medically	unexplained	physical	symptoms).	As	a	result	of	this	they	rarely	considered	the	problem	presented	in	the	vignette	as	a	challenge	to	explore	further.		
Box	3.	Coping	with	professional	uncertainty	
Overwhelmed	
by	negative	
emotions	
“It	makes	me	think	–	help,	what	do	I	have	to	do	next?	What	is	the	matter?	Now	and	then	I	find	that	difficult.”	(F5,	FG4,	45-55yr)		“It	is	a	troublesome	complaint	which	makes	me	think,	eh…,	what	can	I	add	to	this.	It	feels	like,	eh	…	the	knowledge	that	I	can’t	do	anything.”	(F4,	FG4,	45-55yr)		“Often	they	want	to	be	referred	to	a	gynaecologist,	and	often	you	feel	obliged	to	do	so.	Actually,	you	are	dealing	with	MUPS.”	(F2,	FG1,	45-55yr)		“You	find	yourself	with	your	back	against	the	wall	relatively	quickly,	when	you	think	you	asked	every	question	and	looked	at	everything.”	(M1,	FG2,	<45yr)	
Problem	
focused	coping	
“Is	there	any	other	way	we	need	to	confirm	this,	or	are	there	additional	STD	tests	we	need	to	do?”	(F5,	FG4,	45-55yr)		“Now	I	would	investigate	even	better.	[..].	First	of	all	I	would	like	to	exclude	the	somatic	component.”	(F2,	FG1,	45-55yr)	
Postponing	or	
avoiding	a	
referral	
“I	don’t	have	any	reason	to	refer.	I	would	not	know	to	whom	and	what	my	question	would	be.	I	think	I	can	handle	it	myself.”	(F1,	FG1,	45-55yr)		“I	would	not	know	to	whom	I	should	refer.	And	firstly,	I	want	to	clarify	..	eh	what	am	I	really	thinking	of?”	(F2,	FG1,	45-55yr)		“It	would	be	very	meaningful	to	understand	what	is	behind	that	complaint.	So	this	would	be	a	next	step	before	a	gynaecologist	is	being	involved.”	(M1,	FG2,	<45yr)	
Referred	
reluctantly	
”It	doesn’t	happen	many	times,	but	when	I	have	the	feeling	that	whatever	I	propose	hasn’t	been	taken	seriously	by	the	patient,	then	..	eh	..	then	I	do	the	same,	then	I	let	it	go	too.”	(F1,	FG3,	>55yr)	“Yes,	me	too.”	(M1,	FG3,	45-55yr)	”Yes.”	(M2,	FG3,	>55yr)	“So	you	mean,	diagnostic	uncertainty?”	(Moderator)	“Yes,	that	you	are	not	able	to	..eh	..	communicate	this	adequately	to	the	patient.”	(F1,	FG3,	>55yr)	“This	feeling	then	leads	to	a	referral?”	(Moderator)	”Yes,	this	can	be	a	reason	sometimes,	yes,	definitely.	(F1,	FG3,	>55yr)	Legend:	F	and	M	stands	for	female	and	male	GP	respectively,	FG	for	focus	group,	all	followed	by	a	unique	number.		 	
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There	were	three	main	strategies	in	coping	with	this	professional	uncertainty.	One	strategy	(problem-focused)	was	to	start	over	from	the	beginning	(examinations,	tests)	in	order	to	find	out	whether	anything	has	been	overlooked.	A	second	strategy	was	postponing	or	avoiding	a	referral	to	another	professional	until	the	GPs	understood	the	reason	why	this	referral	would	be	necessary.	Thirdly,	patients	were	referred	reluctantly	because	GPs	didn’t	feel	they	had	any	control	or	influence	over	the	patient.		Regarding	PVD,	GPs	experienced	a	lack	of	education	and	were	not	acquainted	with	this	diagnosis.	In	fact,	only	one	GP	spontaneously	mentioned	PVD	in	the	differential	diagnosis.	
	
Discussion 
Main findings Three	themes	appeared	to	best	define	facilitators	and	barriers	in	the	diagnostic	process	of	vulvodynia	in	general	practice.		First	of	all,	within	the	theme	Identifying	and	discussing	sexual	complaints,	an	important	barrier	was	male	gender	of	the	GP.	Although	all	GPs	were	reluctant	to	assess	sexual	complaints,	female	GPs	were	less	reluctant	to	take	a	sexual	history	and	to	perform	a	vulvovaginal	examination	than	male	GPs.	Other	barriers	were	feelings	of	embarrassment	and	uncertainty	of	the	male	GPs	about	whether	women	would	appreciate	their	professional	involvement	in	sexual	health	issues.		With	respect	to	the	second	theme,	Importance	of	gender	in	professional	experience,	female	gender	proved	to	be	an	important	facilitator.	Being	a	woman	appeared	to	facilitate	female	GPs	in	recognizing	the	burden	of	their	female	patients	and	to	improve	their	expertise	as	a	result	of	more	frequent	management	of	women	with	vulvovaginal	complaints,	and	of	feeling	a	greater	sense	of	curiosity	and	challenge	in	finding	a	solution.	Finally,	both	male	and	female	GPs	expressed	uncertainty	about	their	professional	expertise	when	confronted	with	recurrent	vulvovaginal	complaints.		Within	the	theme	Coping	with	professional	uncertainty,	lack	of	knowledge	and	feelings	of	incompetence	were	barriers	in	coping	professionally	with	vulvovaginal	symptoms	that	may	be	indicative	of	PVD,	a	condition	GPs	considered	an	example	of	MUPS.	GPs	showed	three	strategies	in	coping	with	this	professional	uncertainty:	starting	over	diagnostics	from	the	beginning,	postponing	a	referral	or	referring	with	reluctance.	No	facilitators	were	found	within	this	theme.	
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Strengths and limitations The	strength	of	this	study	is	its	reporting	of	findings	that	were	obtained	as	a	result	of	the	interaction	between	GPs,	shown	by	the	mutual	recognition	in	identifying	sexual	complaints	and	coping	with	professional	uncertainty.	Especially	the	gender	issue	was	raised	as	a	result	of	the	interaction	between	male	and	female	GPs.	Also,	to	our	knowledge,	this	study	is	the	first	one	investigating	the	diagnostic	process	of	vulvodynia	in	general	practice.	Finally,	the	participants	in	the	focus	groups	were	heterogeneous	with	respect	to	gender,	age,	years	of	experience	and	practice	type.	Nevertheless,	self-selection	bias	of	our	participants	may	be	qualified	as	a	limitation,	as	is	seen	as	well	in	the	very	low	response	ratio	of	about	4%.	As	was	shown	in	Table	1,	a	majority	of	our	participants	had	an	active	role	in	the	education	of	GPs	and	had	a	specific	interest	in	vulvovaginal	complaints.	Perhaps,	with	GPs	with	an	average	interest	in	such	complaints,	other	themes	would	have	emerged.		
	
Comparison with existing literature It	has	been	repeatedly	demonstrated	that	male	as	well	as	female	GPs	encounter	several	
barriers	in	discussing	sexual	issues.15-18	Most	barriers	mentioned	were	lack	of	training,	lack	of	time,	embarrassment	on	the	part	of	the	GP,	fear	of	opening	‘flood	gates’,	and	having	a	different	age	or	gender	than	the	patient.15,16		Training	in	communication	skills	and	GPs’	personal	attitude	were	found	to	be	fundamental	factors	for	sexual	history	taking	and	the	management	of	sexual	problems.17,18		Regarding	Importance	of	gender	in	professional	experience,	a	small	(n=50)	cross-sectional	study	using	questionnaires	found	that	more	male	than	female	GPs	had	little	confidence	in	managing	sexual	problems	in	female	patients,	and,	conversely,	regarding	male	patients,	confidence	was	lower	in	female	GPs.16	The	same	study	showed	that	years	of	practice	and	the	number	of	consultations	in	one	week	in	which	sexual	problems	were	discussed,	were	protective	factors	for	discussing	sexual	issues.16	In	another	study,	using	a	random	sample	of	512	family	physicians	and	gynaecologists,	physician	gender	concordance,	increased	years	in	practice,	increased	number	of	patients	seen	per	week,	and	perceptions	regarding	practice	experience,	were	found	to	be	significant	and	independent	predictors	of	increased	confidence	in	treating	patients	with	female	sexual	disorders.18	A	qualitative	study	among	22	GPs	showed	that	according	to	these	GPs	patients	preferred	to	see	same-sex	GPs	regarding	sexual	health,	and	some	GPs	felt	that	
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as	a	consequence	they	became	‘de-skilled’	in	dealing	with	sexual	matters	of	opposite	sex	patients.19	Finally,	a	small	(n=78)	survey	among	a	mixed	group	of	physicians,	showed	that	regarding	sexual	history	taking,	they	perceived	greatest	discomfort	when	interviewing	opposite	gender	patients	as	well	as	patients	of	very	young	and	old	ages.20	In	short,	findings	concerning	the	relevance	and	influence	of	gender,	age,	experience	and	(lack	of)	training,	are	in	line	with	our	results.	Apparently,	same	sex	matters.	Regarding	the	professional	uncertainty	GPs	encounter	during	their	consultations,	their	reactions	appear	to	correspond	to	the	coping	strategy	GPs	use	in	general	when	confronted	with	patients	with	MUPS.21,22	For	example,	the	GPs	in	our	study	preferred	to	uphold	the	doctor-patient	relationship	by	achieving	mutual	alliance	characterized	by	ritual	care	(repeating	regular	tests	or	physical	examination),	as	was	described	in	a	qualitative	study	among	Dutch	GPs.21	Another	qualitative	study	showed	that	the	GPs	used	more	emotion-focused	approaches	(aiming	to	reduce	or	manage	the	negative	emotions	caused	by	stress)	instead	of	problem-focused	strategies,	indicating	that	they	had	difficulties	in	managing	their	own	stress	when	working	with	patients	with	MUPS.22	Apparently,	the	vignette	we	used	in	our	study,	a	women	with	recurrent	vulvovaginal	complaints,	triggered	some	of	the	same	reactions	as	patients	with	MUPS.	
	
Implications and future perspective  Our	findings	have	implications	particularly	for	the	training	of	young	male	GPs	and	trainees.	Male	GP	trainees	should	be	better	supported	in	the	development	of	their	attitudes	and	skills	regarding	taking	a	sexual	history	and	performing	a	vulvovaginal	examination.	To	a	lesser	extent	this	also	accounts	for	female	GPs,	as	in	a	majority	of	the	female	GPs	in	this	study	symptoms	associated	with	PVD	were	not	known	to	them	as	well.	To	support	GPs	in	the	management	of	PVD,	guidelines	are	currently	available.23,24	Moreover,	training	of	GPs	in	coping	with	patients	with	MUPS	may	also	help	in	coping	with	patients	with	PVD.			It	is	interesting	to	know	whether	the	current	management	of	vulvovaginal	complaints	by	GPs	is	in	accordance	with	the	needs	and	expectations	of	women.	Insight	into	how	patients	with	PVD	perceive	and	evaluate	management	of	their	complaints	by	their	GP	may	help	to	improve	and	facilitate	both	the	diagnostic	as	well	as	the	referral	process	of	vulvovaginal	complaints	in	general	practice.	Also,	a	quantitative	survey	would	facilitate	knowledge	about	the	extent	to	which	our	findings	are	representative	for	all	Dutch	GPs.	
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Unfortunately,	quantitative	research	in	general	practice	is	limited,	among	other	things,	by	a	lack	of	clear	classification	of	vulvodynia,	as	different	ICPC	codes	could	be	applied.	For	future	research	in	this	field	in	general	practice,	well-defined	coding	of	vulvodynia	would	be	indispensable.	
	
Conclusion Male	gender,	a	lack	of	experience	regarding	PVD	symptoms	and	negative	emotional	responses	when	faced	with	professional	uncertainty,	proved	to	be	inhibiting	factors,	whereas	female	gender	and	the	understanding	that	patients	can	profit	from	inquiring	about	sexual	health	issues	were	found	to	be	facilitating	factors.	
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Abstract 
Background:	Provoked	Vulvodynia	(PVD)	is	the	most	common	cause	of	vulvar	pain.	General	practitioners	(GPs)	are	insufficiently	familiar	with	it,	causing	a	delay	in	many	women	receiving	correct	diagnosis	and	treatment.	This	delay	can	partly	be	explained	by	the	reluctance	of	GPs	to	explore	the	sexual	context	of	PVD	and	by	their	problems	in	the	management	of	patients	with	medically	unexplained	symptoms.	
Aim:	To	gain	insight	into	how	women	with	PVD	perceive	and	evaluate	condition	management	by	their	GP,	in	order	to	improve	and	facilitate	both	the	diagnostic	process	as	well	as	the	management	of	vulvodynia	in	general	practice.	
Methods:	We	performed	face-to-face	in-depth	interviews	with	women	diagnosed	with	PVD.	The	interviews	were	recorded,	transcribed	verbatim	and	thematically	analysed.	The	Consolidated	Criteria	for	reporting	Qualitative	Research	(COREQ-criteria)	were	applied.	
Results:	Analysis	of	the	interviews	generated	three	interrelated	themes:	Empathy,	Referral	process	and	Addressing	sexual	issues.	Empathy	of	the	GP,	involvement	in	decision-making	and	referral	were	important	factors	in	the	appreciation	of	the	consultation	for	women	with	PVD	who	were	referred	to	a	specialist.	Because	women	were	reluctant	to	start	a	discussion	about	sexuality	they	expected	a	proactive	attitude	from	their	GP.	The	communication	with	and	the	competence	of	the	GP	ultimately	proved	more	important	in	the	contact	than	the	gender	of	the	GP.		
Conclusion:	GPs	should	use	a	patient-centred	approach,	acknowledge	women’s	autonomy	and	proactively	address	sexuality	when	consulted	by	women	with	symptoms	of	PVD.		
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Introduction Provoked	vulvodynia	(PVD)	is	the	most	common	cause	of	vulvar	pain	and	is	defined	as	‘vulvar	pain	of	at	least	three	months	duration,	without	clear,	identifiable	cause,	which	may	have	potential	associated	factors’.1	These	associated	factors	are,	for	example,	fibromyalgia,	mood	and	sleep	disorders,	fatigue,	dyspareunia,	micturition	symptoms,	and	irritable	bowel	syndrome.2–6	Despite	the	vulvar	pain,	up	to	80%	of	women	with	PVD	continue	to	have	painful,	unaroused	intercourse,	leading	to	a	vicious	circle	with	an	exacerbation	of	vulvovaginal	symptoms.7,8	In	primary	care	PVD	is	likely	to	be	misdiagnosed,	partially	due	to	an	overlap	of	symptoms	between	PVD	and	vulvovaginal	candidiasis.6	Our	studies	also	indicated	that	recurrent	and	persistent	vulvovaginal	complaints	could	be	a	marker	of	PVD,	especially	if	accompanied	by	dyspareunia,	functional	syndromes,	micturition	symptoms,	and	mood	disorders.6,9	Unfortunately,	most	GPs	lack	knowledge	and	skills	to	diagnose	and	manage	PVD	when	confronted	with	vulvovaginal	complaints,	due	to	a	reluctance	to	perform	an	adequate	sexual	history	and	examination,10–12	to	lack	of	time13,14	or	lack	of	an	adequate	training15.	Physicians’	delay	in	diagnosing	PVD	has	repercussions	for	the	women	who	present	themselves	with	symptoms	of	PVD.	Many	women	who	consulted	a	physician	received	no	clear	diagnosis	(39-52%).16,17	Often,	three	or	more	physicians	had	to	be	consulted	before	the	diagnosis	PVD	was	made.16–19	On	average,	it	took	24	months	for	women	to	receive	the	diagnosis	of	PVD.20	As	a	consequence	of	failing	to	diagnose	PVD	correctly,	physicians	initiated	therapeutic	interventions	such	as	antifungal	medication,	antibiotics,	topical	corticosteroids	and	oestrogen	cream,	which	were	largely	ineffective	and	sometimes	worsened	the	condition.21	PVD	raises	two	barriers	to	GPs.	First,	GPs	might	be	hindered	by	the	sexual	context	of	PVD,	as	taking	a	sexual	history	and	performing	a	vulvovaginal	examination	showed	to	be	barriers	for	GPs	in	the	diagnostic	process	of	vulvodynia.10	Secondly,	a	qualitative	study	among	Dutch	GPs	concerning	their	management	of	vulvovaginal	complaints	found	that	GPs,	when	faced	with	professional	uncertainty	during	their	consultations	on	PVD-like	complaints,	showed	negative	emotional	responses	such	as	helplessness,	discomfort,	incompetence,	and	frustration,	analogous	to	their	reaction	concerning	patients	with	medically	unexplained	symptoms.10	As	this	may	influence	the	doctor-patient	relationship,	it	would	be	helpful	to	gain	insight	into	how	GPs’	responses	affect	women	with	PVD	in	order	to	improve	and	facilitate	the	diagnostic	process	and	management	of	
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PVD	in	general	practice,.	We	have	investigated	how	women	with	PVD	perceive	and	evaluate	the	management	of	their	complaints	by	their	GP.	Our	ultimate	aim	is	to	derive	information	from	the	experiences	and	needs	of	women	with	vulvovaginal	complaints	to	support	GPs	in	diagnosing	and	managing	vulvodynia.		
	
Methods 
Design We	conducted	a	qualitative	study	to	explore	the	experiences	and	needs	of	referred	women	with	PVD.	Given	the	personal	and	sensitive	character	of	the	subject,	we	preferred	individual	face-to-face	in-depth	interviews.22		
 
Participants  Purposive	sampling	was	used	to	recruit	women	diagnosed	with	PVD.	They	were	recruited	by	sexologists,	gynaecologists	and	pelvic	floor	therapists,	all	members	of	the	Dutch	Scientific	Society	of	Sexology	and	familiar	with	this	disorder.	The	inclusion	criteria	were:		
• Age	18	–	50	years,	Dutch	speaking	
• Diagnosis	established	by	a	sexologist,	gynaecologist	or	pelvic	floor	therapist	
• Consultation	by	a	GP	at	least	once	prior	to	the	diagnosis	
• The	first	visit	to	a	GP,	regarding	vulvovaginal	complaints,	was	less	than	2	years	ago	(to	minimize	possible	recall	bias)	Women	were	excluded	when	the	diagnosis	of	PVD	was	made	after	menopause	or	was	not	established	conclusively.	All	participants	were	unacquainted	to	the	researchers.		
 
Procedure Sexologists,	gynaecologists	and	pelvic	floor	therapists	were	requested	to	inform	their	patients	with	PVD	about	this	study,	and	to	provide	information	about	how	to	participate.	Women	were	invited	to	participate	regardless	of	the	evaluation	(positive	or	negative)	of	their	experiences	with	their	GP.	After	inclusion,	a	medical	student	(RS)	and	psychology	student	(MM),	both	female	and	experienced	in	discussing	sexuality,	interviewed	the	participants	in	a	private	setting	of	their	own	choice,	e.g.	in	their	own	home.	Prior	to	the	interview,	each	respondent	provided	written	informed	consent	and	filled	out	a	questionnaire	with	baseline	characteristics.		
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Data collection Data	collection	took	place	from	February	2017	until	February	2018.	For	the	interviews	we	used	an	interview	guide	based	on	literature	and	expertise	of	the	supervising	committee	(PLe,	PLu,	TT,	AL,	EL).	The	topics	in	the	interview	guide	focused	on	how	women	experienced	and	evaluated	the	diagnostic	process	and	management	of	their	vulvovaginal	complaints	by	their	GP.	In	particular,	it	contained	questions	about	the	influence	of	the	gender	of	the	GP	(e.g.	“Does	sex	of	the	GP	matter	to	you?”),	based	on	our	former	study,	as	this	study	showed	a	difference	in	barriers	and	facilitators	of	male	and	female	GPs	in	their	management	of	PVD.10	The	interviews	were	expected	to	last	on	average	60-90	minutes	and	were	recorded	on	tape	and	transcribed	verbatim.	After	seven	interviews,	all	authors	(except	RS	and	EL)	performed	data	analysis,	in	which	provisional	themes	were	appointed	and	ambiguities	discussed,	allowing	going	back	and	refine	themes	of	the	interview	guide,	and	addressing	new	emerging	topics.	Adjustments	were	made	in	querying	in	detail	on	the	participant’s	specific	experiences	with	their	GP’s	communication	and	physical	examination,	concerning	sexual	issues.	No	new	topics	were	suggested.	
 
Data analysis The	transcripts	of	the	interviews	were	thematically	analysed.23	Three	researchers	(RS,	MM	and	PLe	(GP,	sexologist))	coded	all	transcripts,	using	an	inductive	open	coding	strategy.	Discrepancies	in	coding	were	discussed	during	face-to-face	meetings	until	consensus	was	reached.	We	established	a	codebook	with	the	software	program	MaxQDA.	Saturation	was	reached	in	the	last	3	interviews	where	no	new	themes	were	discussed.		By	combining	codes	related	to	the	same	phenomenon,	conceptual	themes	emerged	during	discussion	with	PLe,	MM,	PLu	(GP,	experienced	qualitative	researcher),	TT	(GP,	expert	in	uro-gynaecology),	AL	(GP,	expert	in	gender	and	women’s	health)	and	EL	(psychologist,	sexologist,	expert	in	women´s	sexual	health).		The	Consolidated	Criteria	for	reporting	Qualitative	Research	(COREQ-criteria)	were	applied.24		
 
 
 
 
 
		
	 	
 |	105		
Ethical approval Ethical	approval	was	obtained	from	the	Medical	Ethics	Review	Board	of	the	Amsterdam	Medical	Centre.			
	
Table	1.	Characteristics	of	participants	Respondent	 n	Age	in	years	
• 20-25	
• 26-30	
• 31-50	
	
5	
4	
3	Medical	or	psychological	history	
• Anxiety	or	mood	disorder	
• Chronic	pain	
• Pelvic	floor	overactivity	
	
5	
3	
2	Education	
• (pre-)Vocational	education	
• Higher	professional	education	
• University	
	
3	
5	
4	Relational	status	
• No	steady	partner,	sexually	
active	in	last	year	
• Steady	partner,	sexually	active	
in	last	year	
• Steady	partner,	not	sexually	
active	in	last	year	
	
	
1	
	
9	
	
2	Time	between	first	consultation	GP	and	receiving	diagnosis	
• 2	years	
• 1	year		
• 6	months	
• 3	months	
	
	
4	
2	
1	
5	Number	of	GP	consultations	
• 1-3	
• 4-6	
• >6	
	
5	
4	
3	Current	severity	of	PVD*	
• 3-5	
• 6-8	
	
6	
6	
*	Severity	of	complaints	scores	range	from	1	(no	complaints)	to	10	(extreme	complaints).	 	
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Results 
Participants About	200	sexologists,	gynaecologists	and	pelvic	floor	therapists	were	approached	to	recruit	potential	research	participants.	Of	them,	63	were	willing	to	recruit	which	eventually	led	to	12	participants.	See	Table	1	for	a	summary	of	their	characteristics.	
 
Interviews Analysis	of	the	interviews	generated	three	interrelated	major	themes	(with	sub-themes	in	parentheses):	Empathy	(Quality	of	the	contact,	Openness);	Referral	Process	(Decision	making,	Feeling	dependent);	and	Addressing	sexual	issues	(Reluctance,	Taking	initiative,	Exploring,	Gender).		
Empathy 
Quality of the contact A	warm,	kind,	supporting	and	understanding	approach	as	off	the	first	contact	was	mentioned	as	an	aspect	of	a	good	doctor-patient	relationship,	an	important	condition	for	the	continuation	of	the	conversation.		That	very	first	contact	is	very	important.	General	practitioners	should	simply	be	able	to	put	people	at	ease.	The	first	time	I	got	there,	he	took	time	to	get	to	know	me,	so	just:	who	are	you,	what's	going	on,	so	that	was	just	a	good	start.	(Respondent	no.8,	aged	31	years	(R8,	31	yrs))	Because	even	someone	who	doesn’t	know	much	about	that	condition	but	simply	has	the	empathic	basis	or	is	almost	curious	about	what	it	means	to	you,	you	would	have	had	a	very	different	conversation.	(R12,	26	yrs)	Well,	she	was	just	very	nice	and	understanding	and	said	it	was	very	good	that	I	talked	about	it	in	that	way.	(R6,	24	yrs)	The	quality	of	the	contact	with	the	GP	was	also	influenced	by	the	feeling	of	being	taken	seriously	by	the	GP,	for	instance	when	the	GP	took	time	to	listen	to	the	concerns	and	when	the	GP	acknowledged	the	complaints.	I	think	anyway	because	he	always	takes	time.	I	never	…	I	have	this	doctor	from	childhood,	I've	been	with	him	all	my	life,	um	..	and,	he	is	never	in	a	hurry,	which	I	like.	(R2,	28	yrs)	
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Make	you	feel	like	she's	taking	you	seriously.	That	it	is	not	that	you	come	over	for	nothing.	(R1,	25	yrs)	Yes,	because,	yes,	I	also	had	other	experiences	with	general	practitioners.	That	I’m	not	taken	seriously	there,	although	it	does	have	a	considerable	impact	on	your	life,	and	that	he	did,	yes,	recognized	it.	What	I	especially	liked	is	that	he	gave	me	the	idea	of		'well	this	is	something	we	really	need	to	do	something	about.'	(R4,	24	yrs)	
Openness The	GP	being	open	about	his	or	her	own	uncertainty	about	the	diagnosis	or	management	of	the	problem	was	valued	as	worthwhile	and	contributed	to	a	feeling	of	reciprocity	or	equality.	This	openness	may	be	valued	as	just	as	important	as	a	GP	being	knowledgeable	and	competent.	She	said	to	me,	well	[name],	I	find	this	so	bad	for	you,	I	have	never	heard	of	it,	but	I'm	just	going	to	find	it	out.	That	was	just	a	very	equal	understanding	that	we	had	with	each	other	from	the	first	moment.	And	that	makes	it	different.	(R5,	27	yrs)	And	I	don’t	mind	that	he	is	vulnerable	like	‘yes,	I	haven’t	seen	that	very	often	and	it’s	a	good	thing,	that	is	how	it	went’,	or	that	he	says:	´these	are	good	things	to	hear	for	the	next	people	who	will	come´.	[..]	And	it	is	not	that	he	has	made	a	mistake,	I	do	not	see	it	in	that	way	at	all.	(R12,	26	yrs)	
	
Referral process 
Decision making Central	to	the	appreciation	of	the	relationship	with	their	GP	is	the	extent	to	which	women	felt	they	were	involved	in	the	decision-making	process.	This	included	any	kind	of	partnership	and	reciprocity	in	finding	a	diagnosis	or	a	good	treatment.	This	reciprocity	established	a	sense	of	being	taken	seriously	and	being	involved.	He	has	presented	things	and	really	involved	me	in	what	was	going	to	happen.	Figuring	out	together,	gosh,	what	does	this	mean	actually	and	what	can	be	done	with	it.	And	afterwards	I	also	like,	even	though	he	did	not	know	exactly	what	it	was,	that	he	at	least	participated.	(R8,	31	yrs)	There	was	always	the	question,	what	do	you	think	of	it,	or	what	do	you	think,	or	do	you	agree	with	it?	There	was	always	a	counter-question.	It	never	happened	that	he	said,	‘I'll	refer	you’	or	‘we're	going	to	do	that’.	(R1,	25	yrs)	
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When	the	GP	did	not	offer	an	effective	treatment	or	referral,	this	made	women	feel	that	their	complaints	were	not	being	taken	seriously,	about	which	women	felt	much	frustration.	This	led	to	feelings	of	disappointment	and	anger.		 That	man	only	said:	this	must	resolve	by	itself!	(R2,	28	yrs)	And	then	she	also	said	that	maybe	I	should	learn	to	live	with	it,	I	thought	that	was	a	bit	crazy.	And	ehm,	that	also	made	me	think	I	did	not	feel	taken	seriously.	Because	I	really	thought,	well,	hello,	I'm	20!	(R3,	22	yrs)	She	had	a	somewhat	different	approach	that	I	didn’t	like.	That	was	very	uuh,	very	solution-oriented.	What	are	you	coming	for,	I	will	see,	I	don’t	see	it,	and	well,	this	was	it.	At	a	certain	moment	I	noticed	that	the	mental	part	did	not	come	along	well	and	the	relational	part	neither.	(R8,	31	yrs)	
Feeling dependent When	the	GP	unilaterally	decided	that	a	referral	was	not	in	order,	women	felt	dependent.	In	the	case	of	the	cited	women,	this	led	to	delay	of	a	proper	treatment.		So	yes,	I	now	realize	that	a	GP,	well,	how	do	you	say	that,	it’s	quite	difficult,	she	is	a	young	woman,	but	in	terms	of	hierarchy	it	is	just	hard	to	be	mature	and	put	your	fist	on	the	table	and	that	you	say	...	,yes	you	are	dependent.	(R7,	35	yrs)	He	said,	you	have	to	live	with	it	because	it’s	your	age.	In	the	beginning	you	just	accept	it	because	…,	well,	in	our	health	center	there	are	four	doctors	and	I	have	been	to	all	four.	Yeah,	and	sometimes	I	also	asked	whether	I	could	go	to	the	gynaecologist,	but	that	was	irrelevant.	(R9,	53	yrs)	Some	women	expressed	low	self-esteem	and	self-doubt	about	the	significance	of	their	complaints,	particularly	when	the	complaints	recurred	and	no	new	avenues	for	diagnosis	or	treatment	were	being	suggested.				I	always	had	the	idea	that	it	was	me;	like	eh,	I	do	not	have	to	overdo	and	eh,	the	pain	that	will	pass	anyway.	(R1,	25	yrs)	A	little	that	I	thought,	now	I	come	back	again	with	that,	you	know,	that	I	thought,	now	I	am	really	known	as	the	girl	who	has	a	‘fungus-cunt’	every	time.	So	I	found	that	at	some	point	annoying,	or	that	I	had	to	call	again,	like	okay,	I	have	itching	again,	could	you	prescribe	something	for	me?	(R2,	28	yrs)		
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Addressing sexual issues 
Reluctance Women	did	not	always	start	a	conversation	about	sexuality,	partly	due	to	their	own	reluctance,	Because	she	has	asked	during	the	examination	of	my	belly	of	gosh	“hey,	do	you	have	pain	at	ehm	...	penetration”.	Then	I	said,	no,	no,	no,	there	is	nothing	wrong.	But	the	moment	she	sat	right	in	front	of	me	at	the	table,	I	certainly	would	not	have	said	anything	because	then	she	also	was	looking	at	me.	(R1,	25	yrs)	It	took	a	very	long	time	before	I	even	went	to	the	doctor,	because	it	is	quite	a	big	step	to	go	to	the	doctor	with	such	a	complaint.	(R3,	22	yrs)	
Taking initiative Most	women	appreciated	the	initiative	of	the	GP	in	starting	a	conversation	about	sexual	issues.	This	was	seen	as	a	basic	competence	of	the	GP	as	a	professional.	They	expected	discussing	it	as	a	normal	issue	and	expected	to	be	understood	and	supported.	Because	I	always	think	yes,	he	listens	to	all	these	kind	of	stories	all	the	time	and	um,	I	don’t	know,	I	just	really	see	him	as	a	good	doctor	and	as	a	professional,	so	I	am	…	he	is	needed	for	that.	(R2,	28	yrs)	[It	was	nice]	that	she	could	talk	about	it	so	easily	and	that	it	was	not	uncomfortable.	(R6,	24)	Yes,	I	prefer	asking	me	a	thousand	embarrassing	questions	to	establish	a	good	diagnosis	above	avoiding	it	because	it	is	uncomfortable.	Yes,	I	would	like	that,	and	put	you	at	ease	as	much	as	possible.	(R10,	28	yrs)	
Exploring Women	wished	that	GPs	had	asked	more	in	depth	questions	to	explore	the	sexual	context	further.	If	she	had	asked	more	than	once,	I	might	have	had	something	like	yes,	maybe	it	should	just	be	on	the	table.	(R1,	25	yrs)	No,	I	think	it	would	have	been	good	that	he	had	tried	to	get	out	of	it	because	he	followed	me	closely	[in	my	reserved	attitude].	He	asked	if	we	enjoyed	it	or	something	like	that,	the	question	was	also	quite	closed.	And	then	I	thought,	yes,	it	is	going	well.	But	it	is	also	logical	that	there	is	a	bit	more	behind	these	complaints.	(R12,	26	yrs)	
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Gender Many	of	the	participating	women	with	PVD	had	no	preference	for	a	male	or	female	GP	in	discussing	sexuality,	although	initially	some	doubted	about	whether	a	male	GP	would	make	them	feel	at	ease.	Whenever	there	was	a	preference	this	was	based	upon	them	being	familiar	with	the	GP,	regardless	of		gender.	The	communication	with	and	the	competence	of	the	GP	ultimately	proved	more	important	in	the	contact	than	the	gender	of	the	GP.		Yes,	I	was	just	afraid	that	he	would	not	go	into	that	as	an	older	man	and	it	was	nice	that	he	did.	(R4,	24	yrs)	At	that	man	I	first	thought	of,	yes,	it	is	a	man,	but	it	was	such	a	nice	man	and	very	patient	and	so	and	very	knowledgeable,	so	I	thought	it	was	great.	(R10,	28	yrs)	Yes,	I	like	a	woman	with	this	complaint.	There	is	also	a	man	in	this	practice	but	I	actually	asked	for	her.		(R7,	35	yrs)	I	do	not	care	if	it's	a	man	or	a	woman,	if	only	he	understands	his	job.	(R5,	27	yrs)		
Discussion  
Main findings Most	participating	women	mentioned	that	the	quality	of	the	doctor-patient	relationship,	more	so	than	the	level	of	knowledge	about	diagnosis	and	management	of	PVD	or	the	gender	of	the	GP,	is	important	for	the	appreciation	of	the	consultations	concerning	vulvovaginal	complaints.	However,	when	symptoms	recurred	or	persisted	and	the	GP	was	reluctant	to	refer	or	offer	a	new	treatment,	women	felt	dependent	or	frustrated.	Some	women	expressed	reluctance	to	bring	up	sexual	issues	themselves,	but	welcomed	the	GP	initiating	exploration	of	sexual	issues	during	the	consultation.	They	regarded	this	to	be	a	basic	competence	of	a	GP.	The	male	gender	of	the	GP	was	not	experienced	as	a	barrier	in	the	consultation	or	when	sexual	issues	were	discussed.		
	
Comparison with the literature The	need	for	acknowledgement	and	being	taken	seriously	among	the	interviewed	women	is	in	accordance	with	other	studies	in	women	with	PVD.	They	showed	that	many	women	felt	judged,	not	listened	to	and	not	believed	in	their	quest	for	diagnosis.25	Some	felt	despair	and	disappointment	when	they	were	told	there	was	no	cure,	but	felt	relief	when	they	finally	received	a	diagnosis.20	Mostly,	women	were	told	that	because	no	
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organic	cause	could	be	found	the	symptoms	were	of	psychological	origin.	This	led	to	feelings	of	shame	or	low	self-esteem	as	is	seen	in	our	study.25	Some	studies	report	very	negative	experiences	with	the	healthcare	system	resulting	from	physicians	invalidating	their	concerns,	failing	to	make	a	diagnosis	due	to	ignorance	and	recommending	treatments	the	women	perceived	as	ineffective.26–28	Although	some	women	in	our	study	report	the	same	experiences,	we	show	that	the	patient-centred	approach	and	the	quality	of	the	doctor-patient	relationship	partly	compensates	for	GPs’	lack	of	knowledge	about	the	management	of	PVD.	Furthermore,	our	findings	show,	corresponding	with	other	studies,	that	the	aim	of	a	patient-centred	approach	should	not	only	be	informing	and	exploring	complaints	in	an	empathic	way,	but	should	also	allow	patient	involvement	in	the	decision-making.29	Also,	GPs	being	aware	of	patients’	feelings	of	self-doubt	and	diminished	self-esteem	when	they	present	with	persistent	or	recurrent	complaints	seems	important,	as	this	may	prevent	women	feeling	silenced	and	isolated,	which	could	affect	their	relationships	or	cause	a	depression.27		Regarding	the	doctor-patient	relationship,	our	findings	correspond	to	studies	about	medically	unexplained	symptoms,	which	found	that	the	unexplained	nature	of	the	symptoms	and	how	these	symptoms	are	handled	by	their	physician	is	often	a	source	of	frustration	and	helplessness	for	patients.30	In	line	with	our	results,	studies	showed	that	this	frustration	was	also	felt	when	patients	did	not	receive	empathy	from	their	GP.31,32	Empathy,	as	well	as	treating	the	patient	as	an	equal	partner,	is	perceived	as	important	attributes	of	patient-GP	communication	and	its	presence	results	in	feelings	of	satisfaction,	relief	and	trust,	as	also	is	described	in	our	group	of	women.33,34	Greater	practitioner	empathy	or	communication	of	positive	messages	showed	to	have	small	patient	benefits	for	a	range	of	clinical	conditions,	especially	pain.35	Also,	a	patient-centred	approach	proved	to	be	beneficial	in	conditions	with	a	strong	psychosocial	context,	which	also	is	seen	in	PVD.36–39	Discussing	sexuality	does	not	prove	to	be	a	problem	to	the	woman	in	our	study	provided	that	the	GP	initiated	the	discussion.	This	positive	appreciation	of	a	proactive	attitude	is	also	seen	in	other	studies	in	primary	care.40–43	However,	these	studies	also	indicated	that	sexuality	was	not	often	proactively	addressed	by	the	GP	and	has	been	found	to	be	an	unmet	patient	need.40–43	At	the	same	time	most	people	tend	not	to	seek	help	for	their	sexual	problem,	even	when	they	are	distressed	by	the	problem.44	Consequently,	sexual	problems	remain	unaddressed	frequently.	Barriers	for	not	seeking	professional	help	
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were	embarrassment,	lack	of	confidence	in	a	medical	solution	to	the	problem	and	poor	self-perceived	health.11,45	For	gynaecologists	and	GPs,	embarrassment	proved	to	be	an	important	obstacle	to	initiating	a	dialogue	about	sexual	health,	especially	in	case	of	a	patient-physician	gender	discordance.10,12,40,46–48	However,	gender	discordance	showed	not	to	be	an	issue	to	most	women	regarding	discussing	sexuality,	taking	into	account	that	these	studies	were	limited	to	women	in	family	and	gynaecological	practice,	young	women	called	for	gynaecologic	screening,	and	women	with	cancer.42,43,49,50	These	results	correspond	to	our	findings.		Finally,	our	themes	correspond	well	with	other	research,	but	it	is	important	to	mention	that	the	themes	are	interrelated.	The	value	and	importance	of	the	competence	of	the	GP,	skills	for	a	patient-centred	approach,	being	aware	of	the	possibility	of	patients’	feelings	of	dependence	and	low	self-esteem,	and	the	value	of	openly	discussing	sexual	issues	should	be	seen	in	their	mutual	relationship.	As	far	as	we	know,	studies	on	this	relationship	are	not	conducted.	
	
Strengths and limitations The	study	has	several	strengths.	Firstly,	the	PVD	diagnosis	was	made	by	experts,	which	increases	the	internal	validity	as	far	as	it	concerns	the	group	that	was	referred	to	a	specialist.	Secondly,	the	fact	that	the	in	depth-interviews	were	done	individually	optimized	confidentiality	and	may	thus	have	increased	the	reliability	of	the	data.	Thirdly,	the	interviewers’	gender,	age	and	training	in	discussing	sexuality	may	have	benefited	the	quality	of	the	data.	Furthermore,	the	participants	were	heterogeneous	with	respect	to	education	level,	comorbid	conditions,	time	between	first	consultation	of	a	GP	and	receiving	diagnosis,	number	of	GP	consultations,	and	current	severity	of	PVD.	This	provided	a	variety	of	possibly	relevant	issues.	Finally,	our	research	group	consisted	of	professionals	with	a	broad	variety	of	expertise,	thus	considering	themes	from	different	perspectives.	Limitations	of	our	study	are	the	self-selection	bias	of	our	participants.	It	took	one	year	to	include	women	who	were	willing	to	participate.	The	participating	women	were	referred	by	their	GP	and	probably	were	ultimately	satisfied	about	the	way	they	had	been	treated.	Had	we	been	able	to	capture	women	interacting	with	the	GP	during	consultation,	or	had	we	been	able	to	interview	women	in	this	stage	of	the	diagnostic	process,	women’s	experiences	and	needs	may	have	generated	other	themes..	Also,	women	who	decided	
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not	to	partake	may	have	had	a	other	views	about	the	consultation	with	the	GP	than	the	women	in	the	study.	Also,	recall	bias	due	to	the	retrospective	character	of	the	interviews	may	have	limited	the	reliability	of	the	women’s	accounts.	Furthermore,	two	different	interviewers,	due	to	practical	circumstances,	conducted	the	interviews;	differences	in	approach	(and	response	of	participants)	cannot	be	excluded.	On	the	other	hand,	this	might	also	be	a	strength	as	it	may	have	provided	a	variety	of	issues	which	is	of	benefit	for	the	heterogeneity	of	the	content.	
	
Implications and future perspective Three	issues	might	need	attention.	First	of	all,	use	of	basic	consultation	skills	in	which	GPs	show	genuine	contact,	are	honest	and	empathic,	and	which	involves	shared	decision	making,	could	improve	the	consultations	on	PVD.	Women	are	understanding	of	GP’s	lack	of	basic	knowledge	about	PVD	and	problems	of	recognizing	PVD	in	women	with	vulvovaginal	complaints,	provided	that	they	open	about	this	and	are	willing	to	refer	to	a	specialist.	Having	said	this,	to	prevent	treatment	delay,	along	with	these	general	competencies,	GPs	should	be	educated	about	PVD	and	should	be	better	able	to	differentiate	between	VVC	and	PVD.51	Secondly,	in	addition	to	these	skills,	GPs	should	learn	to	proactively	initiate	a	discussion	about	sexuality	and	explore	the	topic	in	some	detail.	Male	GPs	should	not	be	concerned	about	the	gender	discordance	provided	that	they	apply	the	aforementioned	basic	consultation	skills	and	knowledge.	Finally,	research	on	PVD	in	primary	care	should	involve	needs	and	experiences	of	women	themselves,	as	they	would	provide	other	information	than	could	be	provided	by	GPs.	It	would	be	relevant	to	investigate	whether	improvement	of	communication	skills	and	knowledge	of	GPs	about	PVD	are	effective	in	diagnosis	and	management	of	PVD,	to	what	extent	the	GP	is	capable	to	treat	PVD	effectively	and	which	elements	in	the	management	of	PVD	in	primary	care	are	beneficial	to	women.			
Conclusion Empathy	of	the	GP	and	involvement	in	decision-making	and	referral	were	important	themes	in	women’s	experiences	with	the	way	GPs	manage	persistent	or	recurrent	vulvovaginal	complaints.		
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Because	women	are	reluctant	to	start	a	discussion	about	sexuality	they	expect	a	proactive	attitude	from	their	GP	in	this.	The	communication	with	and	the	competence	of	the	GP	ultimately	proved	more	important	in	the	contact	than	the	gender	of	the	GP.			
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This	thesis	aims	to	understand	the	diagnostic	process	of	provoked	vulvodynia	(PVD)	in	general	practice.	Given	the	gap	between	the	low	prevalence	of	PVD	in	general	practice	and	it’s	higher	prevalence	(including	a	need	for	help)	in	the	general	population,	and	given	the	lack	of	knowledge	about	this	biopsychosocial	pain	condition	in	a	sexual	context,	we	wanted	to	know	whether	PVD	is	visible	in	clinical	practice,	what	kind	of	barriers	and	facilitators	general	practitioners	(GPs)	and	women	with	PVD	experience,	and	how	GPs	can	be	supported	in	their	diagnostic	process.	To	investigate	this,	we	conducted	two	observational	studies	in	primary	care	databases,	a	systematic	review	of	the	literature	and	two	qualitative	studies.	In	this	chapter	the	main	findings	of	this	research	will	be	summarized	and	important	themes	discussed,	which	might	give	a	framework	in	order	to	understand	what	kind	of	elements	in	the	diagnostic	process	are	playing	an	important	role.	These	themes	are	the	management	of	medically	unexplained	symptoms,	addressing	sexual	health	in	general	practice,	and	coping	with	professional	uncertainty.	Furthermore,	we	will	describe	the	methodological	limitations	and	strengths	of	this	study	and	address	the	future	implications	of	this	study.		
Main findings Research	on	PVD	in	primary	care	is	limited	and	much	knowledge	is	based	upon	research	in	secondary	and	tertiary	care.	This	provides	a	bias	because	these	women	with	PVD	comprise	a	select	group	that	already	has	been	diagnosed	adequately,	and	that	has	found	its	way	to	treatment.	Therefore,	first	of	all,	we	wanted	to	know	whether	and	how	PVD	is	visible	in	the	clinical	practice	of	the	GP.	After	all,	the	presence	of	PVD-like	vulvovaginal	symptoms	in	the	context	of	associated	comorbidities	could	assist	GPs	to	recognize	PVD	at	an	earlier	stage.	Therefore,	in	chapter	2	we	explored	the	relationship	between	specific	vulvovaginal	symptoms,	which	could	be	suggestive	of	PVD	(e.g.	genital	pain,	painful	intercourse),	and	comorbidities	known	from	studies	in	secondary	and	tertiary	line	health	care,	such	as	pain	syndromes,	psychological	diagnoses	and	uro-genital	infections.	A	retrospective	analysis	of	data	from	a	primary	care	database	showed	that	premenopausal	women	with	symptoms	suggestive	of	PVD	more	often	were	diagnosed	with	vulvovaginal	candidiasis	(VVC)	and	irritable	bowel	syndrome	(IBS).	Women	with	symptoms	suggestive	of	PVD	were	also	more	likely	to	be	diagnosed	with	complaints	of	muscle	pain,	general	weakness,	insomnia,	depressive	disorder	and	anxiety.	We	wondered	whether	GPs	might	make	a	diagnosis	of	VVC	or	IBS	-	of	which	the	diagnosis	is	
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only	based	upon	clinical	manifestations	-	in	many	women	in	whom	a	diagnosis	of	PVD	would	be	more	appropriate.	To	test	this	hypothesis	we	focused	on	a	comorbid	factor	that	was	clearly	associated	with	PVD:	vulvovaginal	candidiasis.	In	chapter	3	we	described	an	observational	study	in	general	practices	of	the	NIVEL	Primary	Care	Database,	in	which	we	distinguished	women	with	an	uncertain	diagnosis	of	VVC	–	i.e.	with	the	occurrence	of	recurrent	episodes	and	persisting	complaints,	despite	treatment	-	from	women	with	certain	VVC	–	i.e.	when	the	patients	history	and	physical	exam	displayed	itching	and	non-smelling,	white	crumbling	discharge	in	combination	with	a	red	swollen	vulva	or	vaginal	wall.	Uncertain	VVC	was	found	to	account	for	28%	of	the	entire	group	of	women,	a	proportion	that	is	in	line	with	international	studies.	As	we	hypothesized,	factors	known	to	be	associated	with	PVD	were	more	prevalent	in	women	with	uncertain	VVC	compared	with	women	with	certain	VVC,	indicating	that	uncertain	vulvovaginal	candidiasis	could	be	a	marker	of	PVD.	We	concluded	that	GPs	should	reconsider	their	diagnostics	and	management	when	women	present	recurrent	and	persistent	vulvovaginal	complaints,	especially	if	accompanied	by	dyspareunia,	functional	syndromes,	micturition	symptoms	and	psychological	conditions.		However,	knowing	that	an	uncertain	diagnosis	of	VVC	could	be	a	marker	of	PVD	does	not	exclude	the	generally	suggested	hypothesis	that	VVC	might	cause	PVD.	In	order	to	explore	the	relationship	between	VVC	and	PVD,	we	conducted	a	systematic	review	of	the	literature,	which	is	described	in	chapter	4.	The	key	findings	show	that,	contrary	to	what	is	suggested,	there	is	no	evidence	of	a	relationship	between	actual	VVC	and	PVD.	We	found	that	all	population	studies	used	an	invalid	self-reported	diagnosis	of	VVC,	and	that	pathophysiological	in-vitro	studies	were	not	conclusive,	-	most	included	studies	were	of	low	methodological	quality.	Based	on	the	current	available	evidence,	an	unequivocal	conclusion	about	the	relationship	between	VVC	and	PVD	cannot	be	drawn.	The	hypothesis	that	an	uncertain	diagnosis	of	VVC	may	be	a	marker	of	PVD	is	therefore	still	justifiable.	Given	that	VVC	and	PVD	have	an	overlap	of	symptoms,	this	might	confront	GPs	with	uncertainty.	We	were	therefore	interested	in	which	barriers	and	facilitators	GPs	encounter	in	their	diagnostic	process	of	women	presenting	with	recurrent	vulvovaginal	complaints.	In	chapter	5	we	described	a	qualitative	focus	group	study	among	17	Dutch	GPs,	five	men	and	twelve	women.	Barriers	were:	the	reluctance	of	discussing	sexuality,	
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the	male	gender	of	the	GP,	GPs’	negative	emotional	responses	when	faced	with	professional	uncertainty,	alongside	lack	of	education	about	PVD.	Female	gender	and	understanding	that	patients	can	benefit	from	inquiring	about	sexual	health	issues	were	found	to	be	facilitating	factors.		We	were	also	interested	to	know	whether	the	current	management	of	vulvovaginal	complaints	by	GPs	is	in	accordance	with	the	needs	and	expectations	of	women	with	PVD.	Insight	into	how	women	with	PVD	perceive	and	evaluate	management	of	their	complaints	by	their	GP	may	help	to	improve	and	facilitate	both	the	diagnostic	as	well	as	the	therapeutic	management	of	vulvovaginal	complaints	in	general	practice.	In	chapter	6	we	described	the	results	of	in-depth	interviews	with	twelve	women	with	PVD,	conclusively	diagnosed	by	a	sexologist	or	gynaecologist.	The	main	findings	show	that	empathy	of	the	GP,	and	involvement	in	decision-making	and	referral	were	important	factors	in	the	appreciation	of	the	consultation	for	women	with	PVD	who	were	referred	to	a	specialist.	The	communication	with	and	the	competence	of	the	GP	ultimately	proved	more	important	in	the	contact	than	the	gender	of	the	GP.	Given	this	context,	discussing	sexuality	proved	not	to	be	a	problem	for	the	participating	women	in	case	the	GP	initiated	the	conversation,	but	in	taking	initiative	themselves,	the	women	felt	reluctance.		
Discussion of the most important themes Given	all	studies,	PVD	might	be	considered	in	general	practice	-	whether	or	not	concealed	by	undefined	vulvovaginal	complaints	and	other	comorbidities	-	as	one	option	in	the	differential	diagnosis	of	vulvovaginal	complaints.	However,	the	diagnostic	management	of	PVD	by	GPs	is	problematic	for	some	reasons.	Firstly	because	PVD,	due	to	its	heterogeneous,	chronic	and	multicausal	character,	may	be	seen	as	an	example	of	medically	unexplained	symptoms	(MUS),	as	will	be	addressed	in	the	next	section.	Secondly,	because	the	symptoms	of	PVD	among	other	things	arise	in	a	sexual	context	about	which	GPs	lack	knowledge	and	skills.	Thirdly,	managing	MUS	and	addressing	sexual	issues	provoke	a	feeling	of	uncertainty	in	GPs.	Therefore,	the	following	three	themes	are	considered	and	will	be	discussed	further:	the	management	of	medically	unexplained	symptoms	(MUS);	addressing	sexual	health	in	general	practice;	and	coping	with	professional	uncertainty.			
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The management of medically unexplained symptoms  Firstly,	the	question	of	whether	PVD	fits	in	the	illness	script	of	MUS	will	be	addressed,	as	this	might	support	the	GP	in	the	management	of	PVD.	Afterwards	some	remarks	will	be	made	about	how,	based	on	the	concept	of	MUS,	a	biopsychosocial	approach	in	general	practice	can	be	used	to	improve	the	management	of	PVD.	
	
Does PVD fit in the illness script of MUS? The	illness	script	theory	focuses	on	knowledge	organization	as	the	foundation	of	clinical	reasoning	during	patient	encounters.1,2	According	to	script	theory,	medical	knowledge	is	bundled	into	networks	of	small	scenarios	“that	allow	physicians	to	integrate	new	incoming	information	with	existing	knowledge,	recognize	patterns	and	irregularities	in	symptom	complexes,	identify	similarities	and	differences	between	disease	states,	and	make	predictions	about	how	diseases	are	likely	to	unfold.”1	GPs,	in	a	primary	care	set	ten	minutes	for	each	encounter,	use	goal-directed	knowledge	structures	to	perform	tasks	efficiently.3	For	example,	when	confronted	with	an	older	woman	with	a	pale	face	and	some	weight	loss,	a	GP	will	first	of	all	make	immediate	efforts	to	exclude	the	presence	of	cancer.	But	when	a	young	man	presents	himself	with	a	persistent	headache,	a	GP	will	start	to	listen	to	his	story	and	make	inquiries	about	his	psychosocial	context.	Until	now,	as	was	made	clear	by	our	qualitative	studies,	when	premenopausal	women	present	themselves	with	recurrent	and	persistent	VVC,	GPs	don’t	have	a	script	to	address	this	problem.4,5	As	we	showed,	and	has	to	be	clarified	further,	this	seems	to	make	GPs	uncertain	and	reluctant	to	address	sexual	issues,	leading	them	either	to	do	nothing,	to	prescribe	inadequate	crèmes	repeatedly	or	to	refer	these	women	with	reluctance	to	a	gynaecologist.4,5	As	we	showed	in	our	qualitative	study,	supported	by	many	other	international	studies,	this	was	not	what	the	women	expected,	leading	to	frustration	and	the	feeling	that	they	had	not	been	taken	seriously.5–7	Development	of	an	illness	script	for	PVD	could	support	GPs.	Could	it	therefore	be	helpful	to	conceptualize	PVD	as	MUS?	MUS	is	defined	by	the	NHG	(Dutch	College	for	General	Practice)	Guideline	MUS	as	physical	symptoms	that	have	existed	for	more	than	several	weeks	and	for	which	adequate	medical	examination	has	not	revealed	any	medical	condition	that	sufficiently	explains	the	symptoms.8	In	the	upcoming	version	of	the	ICD-11	for	Primary	Health	Care,	the	category	of	bodily	stress	syndrome	has	been	proposed,	which	emphasizes	the	effects	of	the	individual’s	physical	
		
	 	
 |	123		
response	to	stress	(e.g.	chronic	autonomic	arousal)	rather	than	the	‘unexplained’	nature	of	the	symptoms.9	The	DSM-5	uses	the	term	somatic	symptom	disorder,	which	definition	also	does	not	require	symptoms	to	be	medically	unexplained,	and	which	may	or	may	not	be	associated	with	another	medical	condition.10	The	somatic	symptom	disorder	may	be	seen	as	a	maladaptive	reaction	to	somatic	symptoms.11	Pending	changes	of	the	current	guideline,	for	the	time	being	in	this	chapter	the	definition	of	the	NHG	Guideline	MUS	will	be	used.	There	are	some	arguments	why	PVD	could	be	considered	as	MUS.	First	of	all,	many	studies	point	to	the	multifactorial	aetiology	of	PVD,	defining	PVD	as	a	chronic	pain	disorder	for	which	there	is	no	clear	somatic	cause;	the	explanatory	models	for	MUS,	which	are	used	by	GPs,	also	are	applicable	to	PVD.8,12–14	Central	to	all	these	models	is	the	fact	that	there	is	no	unilateral	cause,	but	that	predisposing,	eliciting	and	maintaining	factors	reinforce	each	other	in	a	vicious	circle.	Moreover,	as	our	qualitative	study	with	GP	focus	groups	shows	and	which	has	to	be	confirmed	by	quantative	research,	GPs	react	on	recurrent	and	persistent	vulvovaginal	complaints	like	GPs	do	when	faced	with	MUS.4,15,16	Finally,	both	women	with	PVD	and	patients	with	MUS	value	a	patient-centered	approach	in	their	consultation	with	a	GP	and	show	the	same	emotional	barrier	to	the	GP	regarding	the	uncertainty	surrounding	the	problem,	leading	to	feelings	of	being	uncared	for	or	not	being	taken	seriously.8,17–23.	This	is	supported	by	our	qualitative	study	among	women	with	PVD	and	which	has	to	be	confirmed	by	quantative	research.		As	a	result	of	considering	PVD	as	MUS,	it	should	be	clear	not	to	consider	PVD	as	an	established	disease.	As	indicated	in	the	Discussion	and	in	accordance	with	its	definition,	PVD	should	be	considered	as	a	syndrome,	which	has	no	proven	pathological	or	pathophysiological	aetiology.	This	means	that	even	when	a	GP	is	not	able	to	diagnose	PVD	conclusively,	be	it	provoked	or	unprovoked,	it	can	be	diagnosed	and	managed	by	the	GP	as	MUS	as	long	as	somatic	pathology	has	been	adequately	ruled	out.	This	is	in	accordance	with	the	definition	of	MUS	as	is	stated	in	the	Dutch	Guideline	MUS.	Any	change	in	symptoms	could	be	a	reason	to	revise	the	working	hypothesis.8	The	second	consequence	of	PVD	considering	as	MUS	is	the	need	to	apply	a	biopsychosocial	approach	whenever	women	present	themselves	with	recurrent	and	persistent	vulvovaginal	complaints.		
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The biopsychosocial approach About	twenty	years	before	Engel	published	his	influential	1977	article,	advocating	the	need	for	a	new	(biopsychosocial)	medical	model,	Dutch	general	practitioners	stated	their	biopsychosocial	model	as	a	base	for	Dutch	family	medicine.24,25	The	NHG	(Dutch	College	for	General	Practice)	was	founded	in	1956	and	defined	general	practice	as	"continuous,	personal	and	integral	care	to	the	patient	and	his	family",	and	this	has	not	changed	since	then.25	Even	though	in	1957,	GPs	observed	that	“[..]	apparently	GPs	are	not	able	to	find	a	clear	relationship	between	the	somatic	complaints	on	the	one	hand	and	the	psychological	and	social	problems	on	the	other	hand.	This	inability	can	be	a	result	of	our	training,	during	which	we	[..]	mainly	are	focused	on	diseases	and	not	on	the	ill.	It	is	also	possible,	partly,	that	we	have	no	desire	to	get	into	the	problems	of	our	patients.	Often	we	do	think	we	have	no	time	for	these	patients.”	26	There	is	nothing	new	in	this.	At	that	time	already	psychosomatic	history	taking	was	advocated,	after	which	training	in	the	communication	between	GP	and	patient	further	developed,	resulting	in,	since	15	years,	SCEBS	as	a	useful	model	in	the	training	of	the	general	practitioner.27–29	The	acronym	SCEBS	stands	for	the	somatic,	cognitive,	emotional,	behavioural	and	social	dimensions	of	the	complaint	according	to	the	biopsychosocial	model.	The	biopsychosocial	model	emphasises	the	importance	of	the	context	of	the	patient.	The	model	assumes	that	(perceived)	health	is	associated	with	biological	but	also	psychosocial	dimensions	of	human	existence,	and	that	people	are	constantly	interacting	with	their	environment.	Applying	the	SCEBS	model	can	assist	the	GP	in	determining	whether	all	symptom	dimensions	have	been	explored.	This	is	important	for	every	complaint	but	especially	when	someone	presents	with	MUS.8	In	the	training	of	GPs,	and	sometimes	of	medical	students,	the	SCEBS	model	is	incorporated	in	their	curriculum.		A	syndrome	like	PVD	fits	well	into	the	biopsychosocial	model.	As	considered	in	the	Introduction,	PVD	comprises	of	a	complexity	of	physical	and	emotional	complaints,	elicited	and	maintained	by	its	biopsychosocial	context.	However,	until	now,	as	we	showed	in	our	studies,	Dutch	GPs	seem	unaware	of	PVD	as	a	biopsychosocial	syndrome	as	they	persistently	try	to	find	a	somatic	solution	for	‘what	has	to	be	a	vulvar	disease’,	also	known,	due	to	its	recurrent	and	persistent	character,	as	a	crux	medicorum,	a	term	from	the	time	before	the	biopsychosocial	model	was	developed.4,30	Confronted	with	PVD	GPs	are	looking	at	the	disease,	not	at	the	illness.	As	we	have	shown,	a	part	of	the	28%	of	the	patients	diagnosed	with	VVC	could	probably	better	be	diagnosed	with	PVD,	but	GPs	
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encounter	various	barriers	to	do	this.4,30	Conceptualizing	PVD	as	MUS	might	be	supportive	to	GPs,	as	it	provides	a	frame,	an	illness	script	for	which	they	can	use	the	SCEBS	model.	The	Guideline	Sexual	complaints	of	the	Dutch	College	of	General	Practitioners	(NHG)	will	provide	the	GP	with	sufficient	instructions	to	deal	with	PVD,	but	that	does	not	exclude	that	the	NHG	Guideline	MUS	could	be	just	as	important.8,31	This	topic	is	further	addressed	in	the	section	Implications	for	practice	and	education.	The	only	difference	with	other	MUS	is	that	PVD	also	interferes	with	sexual	functioning,	and	perhaps	this	makes	the	GP	feel	uncomfortable?	Is	the	reluctance	to	not	addressing	sexual	issues,	as	shown	in	some	of	our	studies,	only	applicable	to	PVD	or	is	this	a	general	phenomenon	which	can	be	confirmed	by	quantative	research?	Why	might	this	be	problematic	and	what	can	be	learned	from	the	needs	of	women	regarding	addressing	their	sexual	health?		
Addressing sexual health in general practice In	this	section	I	will	make	clear	how	sexual	health	is	addressed	in	general	practice,	and	provide	some	arguments	of	why	improvements	are	necessary.	Thereafter,	I	will	focus	on	the	barriers	GPs	experience	in	talking	about	sex	and	the	unmet	needs	of	their	patients.			
	
Is underreporting of sexual complaints in general practice problematic? Arguments for GPs to 
talk about sex. In	our	observational	study	in	Dutch	general	practices	of	the	NIVEL	Primary	Care	Database,	the	absolute	percentage	of	women	with	reduced	sexual	desire	was	0.1	for	women	with	vulvovaginal	candidiasis,	which	is,	compared	to	national	studies,	unlikely	low.30	Also,	in	our	retrospective	analysis	of	data	from	a	primary	care	database	we	found	an	unlikely	low	number	(1.3%)	of	women	with	sexual	abuse	in	their	history	compared	with	national	research.32	This	great	gap	between	prevalence	of	sexual	problems	in	the	Dutch	population	(11%	of	men	and	15%	of	women	between	18-80	years)	and	in	general	practice	was	found	in	several	studies	about	sexuality	in	the	last	decades	and	cannot	be	explained	otherwise	than	by	underreporting.33–36		One	might	contest	that	this	is	a	normal	phenomenon	that	counts	for	all	physical	complaints.	Approximately	90%	of	the	general	population	report	that	they	have	experienced	at	least	one	physical	symptom	in	the	past	two	weeks.8	Most	cases	are	not	seen	by	a	GP	because	whether	or	not	people	visit	their	doctor	for	physical	symptoms	
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appears	to	be	more	strongly	related	to	the	personal	significance	of	the	symptom,	than	to	the	severity	of	their	symptoms.8	This	is	also	seen	in	a	Dutch	group	of	men	and	women	with	sexual	problems	with	distress,	of	which	only	15%	had	need	for	treatment.37		Yet,	regarding	sexual	complaints,	there	are	four	arguments	why	this	gap	between	prevalence	in	the	population	and	in	general	practice	might	be	problematic.	First	of	all,	of	those	15%	who	had	a	need	for	treatment,	only	43%	did	really	find	help.37	This	unmet	requirement	for	sexual	health	care	is	found	in	a	variety	of	studies,	for	example	concerning	care	after	cancer,	poorer	mental	health	of	LGBTs,	gynaecological	and	urological	care,	QOL	in	aging	people	with	or	without	chronic	illness	and	sexual	health	in	adolescents.38–44	Secondly,	and	this	is	related	to	the	former	point,	the	idea	that	the	patient	will	present	the	complaints	spontaneously	if	the	sexual	complaint	is	serious	enough	is	not	supported	by	evidence.	Most	patients	do	not	initiate	the	discussion	about	sexuality	themselves,	for	which	shame	is	the	most	important	reason.	It	was	shown	that	the	moment	a	professional	takes	the	initiative	to	inquire	about	sexuality,	the	prevalence	of	sexual	dysfunctions	(with	distress)	increased	and	unfulfilled	needs	were	met.45	Thirdly,	a	correct	diagnosis	and	management	of	a	number	of	complaints	need	a	sexual	context	before	a	well	formulated	request	for	help	can	be	expressed,	as	various	examples	regarding	sexual	health	issues	in	general	practice	show.46-49	This	also	applies	to	asking	about	sexual	abuse	in	patients	with	severe	MUS	and	with	unexplained	gynaecological	complaints,	because	patients	who	have	been	sexually	abused	in	childhood	are,	compared	to	non-abused	people,	at	higher	risk	of	MUS,	and	because	effective	interventions	are	only	possible	after	having	addressed	this	subject.50-52	Finally,	most	sexual	dysfunctions	are	multicausal	and	are	maintained	by	ineffective	coping	strategies	in	a	vicious	cycle.	The	first	step	in	stopping	this	cycle	is	someone	who	is	asking	about	sexual	complaints	and	who	can	give	advice	about	how	to	deal	with	the	problem.	Not	asking	about	sex	will	lead	to	delay	for	doctors	and	patients.	This	is	also	the	case	for	women	with	PVD,	where	the	delay	to	its	diagnosis	adversely	affected	women	because	of	worsening	of	their	symptoms.6,23,33,53		In	conclusion,	underreporting	of	sexual	complaints	cannot	entirely	be	compared	to	underreporting	of	other	complaints,	as	sexuality	is	still	a	taboo	and	has	to	be	approached	by	a	GP	in	a	proactive	manner	in	order	to	establish	a	correct	diagnosis,	to	formulate	a	clear	request	for	help	and	to	intervene	in	a	personalized	way.	Successful	integration	of	sexual	health	care	into	general	practice,	for	example	when	women	present	
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themselves	with	vulvovaginal	complaints,	can	decrease	morbidity	like	PVD	and	enhance	well-being	in	the	patient.46,54			
Talking about sex Talking	about	sex	between	the	GP	and	women	with	PVD	shows	to	be	an	important	topic	in	the	two	qualitative	studies	we	carried	out.4,5	The	participating	GPs	experienced	reluctance	in	bringing	this	subject	forward.	In	particular	male	GPs,	more	than	female	GPs,	mentioned	reluctance	in	taking	a	sexual	history	in	female	patients	of	their	own	age	and	performing	a	vulvovaginal	examination.	Male	GPs	were	also	afraid	to	be	perceived	as	overly	curious,	felt	embarrassed	or	noticed	a	not	well-articulated	feeling	of	tension	when	inquiring	about	sexual	issues.	GPs	feared	to	be	considered	interfering	in	patients’	private	life	or	to	be	disqualified	by	the	patient,	even	when	private	or	sexual	issues	might	be	relevant	for	the	diagnosis.4	A	facilitating	factor	was	the	knowledge	that	patients	could	benefit	from	being	asked	about	sexual	issues	and	this	was	confirmed	by	our	qualitative	study	among	women	with	PVD.5	The	reasons	why	GPs	don't	talk	about	sex	have	been	known	for	some	time.	The	most	important	themes	are	fear	about	"opening	up	a	can	of	worms",	lack	of	time,	resources	and	training,	concern	about	knowledge	and	abilities,	worry	about	causing	offense,	personal	discomfort,	and	a	lack	of	awareness	about	sexual	issues.55–58	In	addition,	GPs	sometimes	experienced	personal	discomfort	in	discussing	sexual	issues	with	patients	of	the	opposite	sex,	with	black	and	ethnic	minority	groups,	older	and	non-heterosexual	service	users,	and	people	with	intellectual	disabilities.55–58	It	is	not	only	GPs	who	feel	reluctance	in	discussing	sexual	issues.	Doctors	and	nurses	who	have	limited	knowledge	about	sexual	complications	and	those	who	feel	uncomfortable	discussing	sexual	issues	are	all	less	likely	to	discuss	these	matters	with	patients,	using	embarrassment	patients	may	experience	as	the	main	excuse.59	Moreover,	GPs	show	similar	reactions	when	they	are	confronted	with	anal	complaints.60	Apparently,	taboo	subjects	in	general	cause	discomfort	and	reluctance	among	physicians	and	this	is	not	limited	to	sexuality	and	general	practice.			Contrary	to	the	findings	among	GPs,	talking	about	sexuality	was	not	experienced	as	a	barrier	by	the	women	with	PVD	in	our	study,	neither	was	the	gender	of	the	GP	they	talked	with	about	sexuality,	provided	that	the	GP	showed	patient-centred	care:	genuine	involvement,	empathy	and	making	shared	decisions.	Participants	expected	the	GP	to	
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initiate	talking	about	sexuality	regarding	their	complaints.	The	women	in	our	study	understood	that	it	was	needed	to	address	sexuality	even	when	their	partner	was	invited	to	the	GP,	which	was	seldom	done.	This	relatively	positive	and	cooperative	attitude	of	women	towards	sexual	history	taking	was	consistently	shown	in	many	other	studies,	in	varying	situations	such	as	for	example	sexual	assault,	chronic	disease,	cancer,	STI	and	general	medical	problems,	and	in	both	primary	care	and	outpatient	departments.61–72	Unfortunately,	most	studies	around	this	topic	had	a	qualitative	design	and	were	not	conducted	in	representative	samples.	For	the	time	being,	there	are	no	studies	that	allow	for	an	opposite	conclusion.	These	contrasting	findings	between	the	apparently	relatively	open	attitude	of	the	patients	and	the	reluctance	of	GPs	are	challenging.	What	is	the	meaning	of	these	findings?	Are	GPs	hiding	behind	an	excuse	when	they	explain	their	reluctance	by	directing	blame	to	patients?	Could	it	be	an	expression	of	a	specific	or	a	general	uncertainty?			
Coping with professional uncertainty First	of	all	I	will	describe	how	uncertainty	experienced	by	the	GP	during	the	diagnostic	process	is	shaped	by	the	consultation	itself.	The	context	of	the	doctor-patient	relationship	regarding	the	management	of	diagnostic	uncertainty	may	be	more	important	than	the	fear	of	negative	medical	outcomes	or	the	use	of	guidelines	in	medical	reasoning.	Secondly,	I	will	describe	the	importance	of	a	patient-centred	approach	for	the	management	of	uncertainty.	Thirdly,	it	will	be	discussed	whether	expressing	professional	uncertainty	to	patients	would	be	beneficial	to	them.	Afterwards,	uncertainty	of	the	GP	will	be	discussed	in	the	light	of	competencies	and	finally,	professional	uncertainty	and	false	safety	behaviour	will	be	considered.		
Uncertainty experienced by the GP during the diagnostic process Since	there	is	usually	no	clear	diagnosis	from	the	start	of	patient’s	presentation	and	undifferentiated	problems	are	common	in	general	practice,	one	can	say	that	uncertainty	is	inherent	in	general	practice.73	Worries	about	medical	or	legal	consequences	have	often	been	suggested	as	one	of	the	reasons	for	this	uncertainty,	but	these	reasons	were	not	mentioned	by	the	GPs	in	our	qualitative	study	regarding	PVD.	As	demonstrated,	lack	of	knowledge,	feelings	of	incompetence	towards	MUS-like	vulvovaginal	symptoms	that	
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occur	in	a	context	of	sexual	activity,	and	examination	of	the	vulva	were	barriers	for	the	participating	GPs	in	coping	professionally	with	vulvovaginal	symptoms	that	may	be	indicative	of	PVD.30	The	GPs	in	our	study	showed	three	strategies	in	coping	with	this	professional	uncertainty,	all	doctor-centred:	redoing	the	diagnostic	process	from	the	beginning	(‘there	must	be	a	medical	reason’),	postponing	a	referral	(’I	think	I	can	handle	it	myself’)	or	referring	with	reluctance	(‘the	patient	doesn’t	take	me	seriously’).30	A	qualitative	study	about	how	GPs	manage	patients	with	MUS	in	daily	practice	demonstrated	that	independent	of	which	strategy	was	chosen	(the	types	of	consultations	that	were	found	were	for	example	‘searching	for	a	disease’	or	‘going	by	the	routine’),	this	management	was	influenced	by	the	GP,	the	patient	and	contextual	factors.	The	authors	of	this	study	concluded	that	the	diagnostic	process	is	mainly	shaped	by	the	consultation	itself.74	For	example,	whether	a	GP	will	be	sensitive	to	psychosocial	clues	depends	partly	on	GP’s	mood	and	work	pressure,	on	GP’s	feelings	of	sympathy	for	the	patient,	or	the	time	a	consultation	needs.74	And	whether	a	GP	will	choose	a	more	biomedical	approach	depends	partly	on	how	firm	the	patient	presents	his/her	needs,	on	the	length	of	the	consultation,	and	on	the	possibility	to	reassure	the	patient	or	to	find	an	explanation	for	the	problem	together	with	the	patient.74			
A patient-centred approach and the management of uncertainty A	patient-centred	approach	including	shared	decision	making	is	vital	for	the	management	of	professional	uncertainty.73,75,76	This	mechanism	was	also	demonstrated	in	our	qualitative	study	among	women	with	PVD	who	valued	GPs	disclosing	of	uncertainty	positively,	provided	that	the	woman	felt	that	the	GP	also	showed	empathy	and	took	her	seriously.5	Moreover,	it	was	shown	in	an	implementation	study	of	shared	decision	making	that	primary	care	physicians	who	cope	well	with	their	professional	uncertainty	may	be	more	likely	to	support	shared	decision	making.77	A	qualitative	study	among	supervisors	and	registrars	in	general	practice	demonstrated	that	when	GPs	lack	a	framework	for	managing	patients	with	MUS,	this	might	lead	to	negative	feelings	such	as	helplessness,	frustration	and	shame	towards	patients,	which	feelings	were	experienced	as	uncomfortable	and	confronting.78	GPs’	stress	reactions	to	experienced	uncertainty	were	shown	to	be	associated	with	having	a	biomedical	attitude,	whereas	low	stress	to	experienced	uncertainty	was	associated	with	having	a	biopsychosocial	attitude.79	These	
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findings	demonstrate	that	GPs	who	assume	a	biopsychosocial	approach	may	feel	more	comfortable	during	consultations.			
Expression of professional uncertainty GPs	verbal	expressions	of	professional	uncertainty	in	a	consultation,	be	it	diagnostic	uncertainty	(“I'm	not	sure	what	might	cause	your	complaints”)	or	therapeutic	uncertainty	(“I’m	not	sure	whether	this	is	the	right	treatment,	but	please	come	back	when	it	doesn’t	work.”),	might	be	seen	as	a	way	to	cope	with	these	hesitations,	because	clear	communication	of	uncertainty	may	prevent	unrealistic	patient	expectations	(“The	doctor	knows	best”).	However,	expression	of	uncertainty	to	patients	was	not	necessarily	beneficial,	as	the	impact	of	expressions	of	uncertainty	upon	patients’	confidence	showed	not	to	be	consistent.80	A	study	that	investigated	the	impact	on	patients	of	fourteen	scenario’s	that	exemplified	verbal	or	behavioural	expressions	of	GP	uncertainty	showed,	however,	that	verbal	expressions	(such	as	‘I	don’t	know’,	or	‘Let’s	see	what	happens’)	resulted	in	patients	trusting	GPs	less,	whereas	behavioural	expressions	of	uncertainty	(such	as	asking	the	advice	of	a	medical	specialist,	referring	the	patient	to	a	hospital,	or	using	a	book	or	computer	during	the	consultation),	resulted	in	patients	trusting	GPs	more.80	Not	only	was	there	a	difference	in	trustworthiness	between	verbal	and	behavioural	expressions	of	uncertainty,	the	effects	of	such	expressions	of	uncertainty	on	patients	also	seemed	to	depend	on	gender	of	the	GP.	In	one	study	it	was	found	that	expressed	uncertainty	was	negatively	related	to	patient	satisfaction	only	when	the	physician	was	a	woman	and	the	patient	was	a	man.81			
Diagnostic uncertainty and lack of competencies The	use	of	guidelines	may	not	contribute	to	understanding	the	doctors’	strategies	of	managing	diagnostic	uncertainty,	as	was	demonstrated	in	a	systematic	review	and	another	study	about	how	to	deal	with	diagnostic	uncertainty.76,82	Qualitative	research	on	how	to	understand	this	finding,	is	not	known	to	us.	Nevertheless,	diagnostic	uncertainty	is	primarily	a	function	of	knowledge	acquisition,	processing	and	recall.76	Besides	lack	of	knowledge,	uncertainty	also	can	be	determined	by	lack	of	skills.	In	a	qualitative	study	among	Dutch	GPs	about	methods	in	which	they	explain	MUS	to	patients,	GPs	often	feel	incapable	to	explain	the	symptoms	clearly.83	When	patients	keep	presenting	with	MUS	GPs	are	facing	difficulties	in	trying	to	balance	between	maintaining	a	good	doctor-
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patient	relationship	and	the	prevention	of	unintended	consequences	of	unnecessary	interventions.83	Managing	MUS	is	also	a	common	problem	for	GP	trainees,	resulting	in	a	disproportionate	amount	of	uncertainty.84	In	our	focus	group	study,	we	showed	that,	especially	male	GPs,	experienced	professional	uncertainty	due	to	lack	of	knowledge,	feelings	of	incompetence	towards	MUS-like	vulvovaginal	symptoms	that	occur	in	a	context	of	sexual	activity,	and	examination	of	the	vulva.30	We	do	not	know	to	what	extent	this	applies	to	GPs.		
Professional uncertainty and false safety behaviour  Sometimes	uncertainty	can	be	dealt	with	by	false	safety	behaviour.	Regarding	recurrent	vulvovaginal	PVD-like	symptoms,	a	GP	and	the	woman	might	be	satisfied	on	the	short-term	by	a	‘conspiracy	of	somatisation’.	This	means	that	both	GPs	and	women	seem	to	hide	behind	a	false	certainty	of	a	somatic	disorder,	so	as	to	be	able	to	avoid,	for	example,	discussion	of	the	sexual	or	relational	context	of	a	particular	problem.	Possibly,	GPs’	lack	of	competence	to	diagnose	and	treat	PVD	and	their	reluctance	to	discuss	sexual	issues,	maintains	the	negative	beliefs	and	experiences	of	women	regarding	the	benefit	of	seeking	help.	Given	the	social	context	of	the	coital	imperative	and	the	presumed	quick	fix	medical	solution	in	which	women	seek	to	be	‘normal’	and	to	be	taken	seriously,	most	women	with	PVD	searching	for	legitimacy	of	their	problem	ultimately	experience	frustration,	failure	and	shame.18,19,85–88	GPs	and	women	with	PVD	might	be	entangled	in	a	mind-body	struggle	in	which	doctors’	sincere	but	ineffective	somatic	efforts	maintain	women’s	avoidance	of	facing	her	complaints	as	a	sexual	and	a	chronic	pain	problem,	which	asks	for	another	diagnostic	and	therapeutic	perspective	rather	than	just	a	medical	one.	As	this	perspective	may	elicit	some	uncertainty	for	both	GP	and	a	woman,	they	erroneously	turn	to	a	merely	somatic	approach.	
	
Strengths and limitations To	our	knowledge,	this	is	the	first	study	in	Dutch	general	practice	that	investigated	the	diagnostic	process	of	PVD.	We	used	studies	with	both	quantitative	and	qualitative	designs	(observational,	qualitative,	and	systematic	review).		The	datasets	used	in	our	two	observational	studies	included	a	large	number	of	patients	and	their	episodes,	and	comprised	of	a	GP	population	representative	of	the	general	Dutch	population	with	less	selection	of	patients	than	in	specialized	populations.	The	
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participating	GPs	of	these	two	data	systems	were	motivated	to	perform	adequate	ICPC	coding	according	to	the	International	Classification	of	Primary	Care	and	the	reliability	of	their	registration	and	coding	preciseness	is	estimated	to	be	higher	than	usual	in	primary	care.89	In	our	observational	study	about	the	relationship	between	specific	vulvovaginal	symptoms,	which	could	be	suggestive	of	PVD	and	related	diseases,	all	effect	sizes	but	one,	were	large	(OR	≥	3.48)	and	therefore	meaningful.		At	the	same	time	there	are	important	limitations,	firstly	in	particular	the	doubts	on	validity	of	the	diagnosis	PVD	in	general	practice.	In	the	datasets	of	our	two	observational	studies,	due	to	the	lack	of	an	ICPC	code	for	PVD,	only	indirect	measures	of	PVD	were	available	of	complaints	or	disorders	known	to	be	related	to	PVD.	They	lack	specificity	as	some	of	these	nonspecific	complaints	may	also	occur	in	case	of	lichen	sclerosus	or	eczema	for	example,	therefore	possibly	overestimating	the	hypothesized	relation	between	recurrent	and	persistent	vulvovaginal	complaints	and	PVD.	On	the	other	hand,	the	existence	of	PVD	may	also	be	underestimated	as	our	data	showed	a	very	low	number	of	women	with	sexual	complaints,	which	may	indicate	that	GPs	possibly	didn’t	take	an	adequate	or	consistent	sexual	history.	Moreover,	due	to	the	obsolete	view	that	PVD	would	be	an	infection,	it	is	possible	that	PVD	erroneously	was	registered	by	GPs	under	the	ICPC	code	“vaginitis/vulvitis	(NOS)”,	which	in	the	Comorbidity	study	(see	Chapter	3)	indeed	was	found	to	be	significantly	more	prevalent	in	the	group	of	uncertain	VVC.	As	a	result,	some	women	with	PVD	may	not	have	been	included.		Secondly,	in	general,	although	the	reliability	of	the	registration	and	coding	preciseness	of	the	GPs	participating	in	the	used	databases	is	estimated	to	be	higher	than	usual	by	GPs	in	daily	practice,	this	reliability	is	always	limited	due	to	the	uncertainty	of	the	diagnostic	process	itself.	For	example,	sometimes	complaints	are	registered	as	a	complaint,	sometimes	as	a	disease,	or	sometimes	are	thought	to	be	part	of	a	comorbid	condition	while	it	may	be	an	indication	of	a	new	condition.		Thirdly,	the	validity	of	some	comorbidities	is	at	issue,	as	they	also	have	been	registered	erroneously.	Comorbidities	like	fibromyalgia,	chronic	fatigue	syndrome	and	physical	and	sexual	abuse	are	in	fact	classified	by	ICPC	sub	codes,	but	since	only	general	ICPC	codes	are	accessible	for	research	and	sub	codes	are	not,	the	extent	of	the	group	of	women	with	these	comorbidities	is	not	clear.	Using	their	sub	codes	may	have	led	to	stronger	associations	between	these	comorbidities	and	symptoms	suggestive	of	PVD.	On	the	other	hand,	the	relation	of	recurrent	VVC	(RVVC),	as	a	subtype	of	uncertain	VVC,	
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with	PVD,	may	be	overestimated	because	RVVC	can	in	fact	be	caused	by	a	candida-infection,	especially	in	case	of	comorbidity	such	as	diabetes	mellitus,	reduced	immunity	status	and	use	of	immunity	decreasing	drugs,	for	example	anti-rheumatic	and	chemotherapeutic	drugs,	corticosteroids	and	antibiotics.	No	correction	for	this	bias	was	being	made.	Nevertheless,	it	should	be	emphasized	that	one-third	to	one-half	of	RVVC	cases	have	no	clear	cause.	Furthermore,	the	low	number	of	episodes	per	year	for	the	various	comorbidities	may	have	resulted	in	inaccurate	outcomes	with	broad	CIs.	For	example,	our	data	show	a	very	low	number	of	women	with	sexual	complaints,	underestimating	their	well-known	relation	to	PVD,	which	is	found	in	the	literature.	Fourthly,	our	two	qualitative	studies	are	by	nature	not	generalizable	to	the	wider	population	of	neither	women	with	PVD	nor	Dutch	GPs.	We	did	not	conduct	a	quantitative	study	on	the	extent	to	which	the	themes	found	are	present	in	the	population.	Therefore	findings	of	our	qualitative	studies	must	be	judged	on	their	own	merits,	i.e.	their	internal	validity.		The	study	among	GPs	showed	a	low	response	ratio	and	the	majority	of	the	participants	had	an	active	role	in	the	education	of	GPs,	and	had	a	specific	interest	in	vulvovaginal	complaints.	Recruiting	women	with	PVD	for	interviews	lasted	more	than	a	year	and	it	is	not	known	whether	and	how	responders	and	non-responders	differ.	Possibly,	the	sexual	context	of	our	subject	raised	barriers	for	both	GPs	and	women.	This	may	have	resulted	in	self-selection	on	the	part	of	both	GP-	and	patient-participants.	The	motivated	GPs	and	women	studied,	might	have	generated	other	themes	playing	a	role	in	the	diagnostic	process	than	the	non-responders.	However,	GPs	in	the	focus	groups	were	heterogeneous	with	respect	to	gender,	age,	years	of	experience	and	practice	type	and	the	interviewed	women	with	PVD	were	heterogeneous	with	respect	to	education	level,	comorbid	conditions,	number	of	GP	consultations,	and	current	severity	of	PVD.	Finally,	given	the	exploratory	character	of	this	thesis,	hardly	any	other	studies	are	performed	on	the	diagnostic	process	of	PVD	in	primary	care,	which	could	have	given	our	conclusions	more	robustness.	Comparisons	were	mostly	made	with	studies	on	MUS,	which	admittedly	gave	interesting	viewpoints,	but	which	were	not	very	specific	with	regard	to	the	sexual	context	of	the	problem.			
	
	
	134	|		
Future perspectives 
Implications for practice Given	the	main	results	of	our	studies,	the	most	important	suggestion	for	a	GP	when	confronted	with	recurrent	and	persistent	vulvovaginal	complaints	might	be:	dare	to	ask.	This	refers	to	involving	PVD	in	the	differential	diagnosis	but	also	to	an	awareness	of	a	‘conspiracy	of	somatisation’	as	well	as	to	explore	the	biopsychosocial	dimensions	of	the	complaint	including	sexual	issues.	The	only	action	a	GP	has	to	add	to	one’s	basic	competencies,	is	involving	sexual	and	relational	issues	into	the	conversation,	which	is	supported	by	the	knowledge	that	in	general	women	with	PVD	will	give	permission	for	this,	provided	that	the	GP	initiates	the	discussion	and	shows	patient-centered	care.	The	GP	can	utilize	both	the	NHG	Guideline	Sexual	complaints	and	the	NHG	Guideline	on	MUS	for	background	information,	because	PVD	might	be	seen	as	a	MUS.	The	main	recommendations,	in	line	with	these	guidelines	and	supported	by	our	studies,	are	summarized	in	Box	1.	Because	this	thesis	is	about	the	diagnostic	process,	further	information	regarding	treatment	of	PVD	is	not	given,	this	can	be	found	in	the	NHG	Guideline	Sexual	complaints.	As	to	the	biopsychosocial	aspects	of	PVD,	the	GP	should	cope	with	this	on	two	levels.	First	of	all,	the	GP	should	apply	general	competencies	just	like	one	would	if	one	was	confronted	with	MUS,	using	SCEBS	and	a	patient-centred	approach	including	shared	decision-making.	Secondly,	the	GP	should	cooperate	with	professionals	from	other	disciplines,	e.g.	a	nurse	practitioner	on	mental	health,	a	consultant	on	sexual	health,	a	pelvic	floor	therapist,	a	sexologist	or	a	gynaecologist,	provided	they	have	sexological	competencies.	It	is	important	to	be	clear	to	the	patient	which	professional	will	be	in	charge	after	the	referral	and	what	the	purpose	is	of	the	referral.	A	GP	should	have	a	network,	which	can	support	in	sexological	issues.	As	to	the	management	of	vulvovaginal	complaints,	and	given	that	persistent	and	recurrent	VCC-like	symptoms	may	be	indicative	of	PVD,	reiteration	of	antifungal	prescriptions	by	GPs	without	a	correct	diagnosis,	will	lead	to	mistreatment.	Physicians	and	their	assistants	should	be	aware	of	this	during	telephone	triage	and	consultations,	and	have	to	adapt	their	management	of	vulvovaginal	complaints	accordingly.			
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Box	1.	Practical	recommendations	when	women	present	recurrent	and	persistent	vulvovaginal	complaints		
• Reconsider	diagnostics	and	management,	especially	if	accompanied	by	dyspareunia,	functional	syndromes,	micturition	symptoms	and	psychological	conditions	
• Spread	the	diagnostic	process	over	several	consultations,	ask	her	whether	this	suits	her	
• Use	SCEBS	to	explore	the	complaints	and	request	permission	of	the	woman	to	take	a	sexual	history	and	explain	to	the	woman	why	that	is	necessary;	using	SCEBS	in	patients	with	PVD	automatically	implies	that	the	GP	explores	sexual	issues	
• Perform	a	vulvar	examination	to	exclude	somatic	pathology	and	examen	the	pelvic	floor	
• Summarise	the	findings	and	involve	expectations	or	anxieties	that	have	previously	been	expressed	by	the	woman,	e.g.:	“The	examination	of	the	vulva	only	showed	some	tense	muscles	of	the	pelvic	floor	but	there	are	no	skin	diseases	or	infections.	The	complaints	you	told	me	are	in	line	with	these	findings.	I	can	imagine	that	your	vulva	will	feel	painful	during	intercourse.”		
• Come	to	a	shared	definition	or	description	of	the	problem,	and	avoid	explanations	which	emphasize	solely	a	somatic	or	psychological	cause,	e.g.:	“All	the	findings	point	to	what	is	called	PVD,	but	you	also	may	call	it	pain	of	the	vulva,	provoked	by	different	stimuli.	It	is	not	a	disease	but	a	condition,	which	can	give	much	burden.	Unfortunately,	the	eliciting	cause	is	not	always	known.	But	we	know	how	this	pain	is	maintained	and	your	story	is	very	much	in	line	with	this.	[For	an	explanation	of	the	vicious	circle,	the	GP	can	use	the	NHG	Guideline	Sexual	complaints].	Finally,	you	came	into	this	vicious	circle,	do	you	recognize	this?”		
• Take	the	concerns	seriously	and	offer	proposals	on	how	to	cope	with	unresolved	questions,	e.g.	by	referring	to	a	sexologist	or	gynaecologist,	or	offering	a	next	consultation.	Be	clear	to	the	woman	what	she	might	expect	(e.g.	excluding	a	disease	or	offering	a	treatment	for	her	problem),	e.g.:	“Well,	I	have	some	thoughts	about	what	is	going	on	here	but	I’m	not	sure.	To	offer	you	the	best	I	want	to	propose	that	I	call	a	sexologist,	that’s	a	health	care	professional	I	know	well.	Do	you	agree	to	come	back	next	week,	then	I	can	give	you	some	advice	on	how	to	go	on?”	
• State	that	the	prognosis	is	good	provided	that	time	will	be	taken	and	professional	help	is	sought	(or	advices	will	be	followed),	e.g.:	“Unfortunately,	mostly	this	complaint	will	not	go	away	by	itself.	But	with	good	support	it	is	certain	possible	after	a	while	to	get	rid	of	this	symptom	and	to	also	enjoy	your	sexual	life	again.	Do	you	want	further	help	in	this?”			
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The	Guideline	Vaginal	Discharge	advises	to	reconsider	the	diagnosis	of	VVC	in	case	of	recurrent	VVC.	Possibly,	it	would	be	wiser	in	the	first	place	to	reconsider	the	Guideline’s	advice	to	start	the	treatment	of	VVC	without	additional	examinations.	This	would	be	of	benefit	for	women	with	PVD	who	are	over-treated	with	antifungal	medication.		Finally,	even	in	case	of	an	acute	and	established	VVC,	the	condition	might	induce	immunological	reactions	of	the	vulva	and	vagina.	Therefore,	women	should	be	informed	by	their	physician	that	1.	Intercourse	during	(or	shortly	after)	the	treatment	of	VVC	might	worsen	the	vulnerability	of	the	vulvar	skin,	2.	Intercourse	should	be	practised	only	when	sufficiently	sexually	aroused,	and	3.	Intercourse	should	preferably	be	postponed	until	all	symptoms	have	subsided.	Although	these	recommendations	seem	very	self-evident,	repeating	these	might	be	supportive,	as	especially	in	a	sexual	context	people	do	not	always	make	rational	choices.		
Implications for education In	order	to	improve	the	care	for	women	with	PVD,	assuming	that	the	GP	is	aware	of	the	knowledge	about	PVD	as	provided	in	the	NHG	Guideline	Sexual	complaints,	attitude	and	skills	of	GPs	regarding	taking	a	sexual	history	and	performing	a	vulvovaginal	examination	should	be	addressed,	as	well	as	GPs’	management	of	MUS.	Therefore	training	will	be	necessary.	Training	in	communication	skills	and	GPs’	personal	attitude	were	found	to	be	fundamental	factors	for	sexual	history	taking	and	the	management	of	sexual	problems.58,90–94	Unfortunately,	training	in	sexual	history	taking	and	the	management	of	sexual	problems	is	nationwide	not	structurally	included	in	the	curriculum	of	GPs	but	is	dependent	of	the	efforts	of	individuals.	There	is	room	for	much	improvement,	not	only	concerning	PVD,	but	also	concerning	the	issue	of	sexual	health	in	a	broad	sense.	Also,	learning	to	talk	about	sexual	issues	should	not	merely	be	approached	as	a	separate	subject,	but	being	integrated	in	training	of	communication	skills	and	in	reflection	during	supervision	on	one’s	own	attitude	towards	taboos	in	general	or	towards	one’s	own	professional	role.		Training	doctors	to	deal	with	unexplained	symptoms	should	concentrate	on	careful	evaluation	of	the	symptoms	including	co-creating	explanations	by	patient	and	GP95,	exclusion	of	relevant	differential	diagnosis,	shared	decision	making	and	establishing	and	maintaining	a	trustful	relationship	with	the	patient.73	This	is	in	accordance	with	the	needs	of	patients.16	
		
	 	
 |	137		
Strikingly,	many	researchers	in	this	field	recommend	improved	management	of	patients	with	MUS	by	transferring	experience-based,	reality-adjusted	knowledge	from	senior	GPs	or	supervisors	to	juniors.78,96	Currently,	generic	communication	skills	training	of	GPs	in	the	Netherlands	does	not	seem	to	support	trainees	sufficiently	to	handle	effectively	the	challenges	they	encounter	during	consultations.	There	is	a	need	to	provide	trainees	with	communication	strategies	adapted	to	handle	specific	challenging	situations.97	Also,	communication	repertoires	showed	to	be	highly	idiosyncratic,	emphasizing	the	need	of	a	facilitating	clinical	supervisor.98	These	findings	support	the	current	policy	of	the	special	interest	group	Sexual	Health	of	the	NHG	to	prioritize	the	training	of	the	GP	trainers	above	the	trainees,	which	unfortunately,	is	not	implemented	in	every	academic	centre.	Finally,	in	the	long-term,	some	advocate	a	full	reframing	of	the	problem	of	MUS,	implying	broad	changes	in	basic	medical	knowledge	and	education,	working	towards	new	models	of	disease	that	integrate	knowledge	from	all	relevant	disciplines.96	Regarding	sexuality,	the	latter	is	always	necessary.		
Implications for research In	general,	sexuality	is	strongly	subject	to	values	and	norms,	as	it	is	regarded	by	many	a	very	personal	and	delicate	issue.	Therefore,	scientific	evidence	is	needed	to	dispel	prevailing	myths	and	misconceptions	about	which	behaviour	should	be	seen	as	normal	or	preferable.	Also,	evidence	can	help	to	prevent	unnecessary	medicalization,	as	increasingly	sexual	adjustments	within	a	relationship	or	variation	of	sexual	behaviour	are	being	pathologized	and	subjected	to	pharmacological	and	surgical	treatments.		As	we	argued	before,	sexological	research	is	mainly	conducted	in	specialised	centres	in	well-defined	groups,	which	limits	the	statements	about	generalizability	in	primary	care.	Therefore,	scientific	research	in	general	practice	on	sexual	health	is	highly	necessary.	Briefly,	and	not	exhaustive,	such	an	agenda	regarding	PVD	might	comprise	the	following	research:	
• Replication	of	our	studies	on	PVD	in	general	practice,	expanded	with	quantitative	and	representative	data	based	upon	our	qualitative	findings		
• Prospective	studies	among	a	cohort	of	women	with	vulvovaginal	complaints,	collecting	data	for	relapse	and/or	remission,	spontaneously	or	after	treatment,	whether	or	not	influenced	by	comorbid	factors,	especially	vulvovaginal	candida	
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• A	usual	care	controlled	study	on	the	efficacy	of	interventions,	for	example	like	psycho-education	or	referral	to	a	pelvic	floor	therapist,	made	by	the	general	practitioner	in	women	with	PVD		
• Observational	and	qualitative	research	on	how	women	with	persistent	vulvovaginal	complaints	seek	help	and	how	they	present	themselves	to	GPs	
• Qualitative	research	on	the	barriers	and	facilitators	in	the	implementation	of	the	recommendations	on	PVD	as	provided	by	the	NHG	Guideline	Sexual	Complaints.	In	2018	the	Dutch	College	of	General	Practitioners	established	a	National	Research	Agenda	for	General	Practice,	in	which	787	knowledge	gaps	and	research	questions	were	documented	and	prioritized	according	to	researchers,	clinicians	and	stakeholders.99	Unfortunately,	sexual	complaints	showed	not	to	be	a	prioritized	topic	and	therefore	it	is	not	to	be	expected	on	the	short-term	that	academic	centres	of	general	practice	will	conduct	research	on	sexual	health	in	a	structured	way.99	This	might	result	in	a	‘catch	22’:	if	you	do	not	investigate	it,	it	does	not	exist.	If	it	does	not	exist,	you	do	not	see	it.	If	you	do	not	see	it,	you	do	not	investigate	it,	etcetera.	One	can	only	speculate	why	a	subject	like	sexuality,	that	is	so	omnipresent	in	society,	is	important	for	the	wellbeing	of	people,	and	is	considered	by	people	with	a	chronic	illness	to	be	the	most	affected	subject100,	is	not	being	investigated	more	often	in	primary	care.	This	question	in	itself	is	worth	a	scientific	study.	Finally,	as	the	base	of	research	is	adequate	documentation	and	uniform	classification	in	order	to	standardize	observations,	ICPC	codes	regarding	sexuality	should	be	revised	and	added.	As	was	mentioned,	PVD	is	not	classified	as	such	and	other	codes	about	sexual	complaints	are	not	well	defined	and	randomly	assigned	to	either	somatic	or	psychic	chapters.	This	will	not	motivate	GPs	to	code	these	encounters	and	will	give	inadequate	and	incomplete	data.	PVD	being	a	condition	with	a	changing	working	definition	in	the	course	of	time	and	without	being	a	disease	entity	with	a	stated	aetiology	and	pathology,	is	not	an	argument	not	to	involve	it	into	the	ICPC	classification.	The	theoretical	framework	used	to	assign	inclusion	criteria	in	this	classification	system	is	based	on	the	presence	of	four	general	categories	of	diagnosis	in	primary	care:	aetiological	and	pathological	disease	entities,	pathophysiological	conditions,	nosological	diagnoses	(syndromes),	and	symptom	diagnoses.101	PVD	might	be	classified	as	a	syndrome,	which	is	based	on	the	following	characteristics:	“the	diagnosis	depends	on	a	symptom	complex	based	on	consensus	between	physicians,	without	a	proven	pathological	or	
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pathophysiological	base	or	aetiology;	inclusion	criteria	include	only	symptoms	and	complaints.”101	PVD’s	working	definition	is	for	example	comparable	with	that	of	the	Irritable	Bowel	Syndrome	with	its	Rome	Criteria	which	also	altered	in	the	course	of	time.102	Large	cohort	studies	in	cooperation	with	gynaecologists,	dermatologists	and	sexologists	will	be	needed	to	validate	its	definition	as	this	might	align	different	policies.		
Conclusion PVD	can	be	considered	in	general	practice	as	one	of	the	possible	explanations	of	recurrent	or	persistent	vulvovaginal	pain	where	the	causal	role	of	vulvovaginal	candidiasis	remains	highly	controversial.	Moreover,	PVD	can	be	considered	as	a	condition	like	MUS,	which	faces	GPs	with	some	difficulties	because	this	requires	a	biopsychosocial	approach	embedded	in	a	sexual	context,	which	proves	to	be	a	barrier	to	GPs.	Although	some	GPs	and	women	might	initially	hold	on	to	the	discourse	of	‘conspiracy	of	somatisation’,	which	might	falsely	seem	beneficial	on	the	short	term	for	both	of	them,	women	finally	will	benefit	from	GPs	who	dare	to	explore	the	biopsychosocial	dimensions	of	the	complaint	including	sexual	and	relational	aspects.	GPs	will	be	supported	by	the	knowledge	that	women	with	PVD	expect	GPs	to	initiate	discussing	about	sexuality,	given	that	the	GPs	will	show	empathy	and	take	her	seriously.	Ultimately,	provided	that	basic	knowledge	about	PVD	is	present,	as	is	provided	in	the	NHG	Guideline	Sexual	complaints,	it	will	be	the	quality	of	the	doctor-patient	relationship,	in	which	there	is	patient	involvement	in	decision-making	and	referral	and	in	which	the	complaints	of	the	women	with	PVD	are	met	with	empathy	that	will	be	of	decisive	significance	to	meet	her	needs.				
References 1.		 Lubarsky	S,	Dory	V,	Audétat	M-C,	Custers	E,	Charlin	B.	Using	script	theory	to	cultivate	illness	script	formation	and	clinical	reasoning	in	health	professions	education.	Can	Med	Educ	J.	2015;6:e61-70.		2.		 Bissessur	SW,	Geijteman	ECT,	Al-Dulaimy	M,	Teunissen	PW,	Richir	MC,	Arnold	AER,	et	al.	Therapeutic	reasoning:	From	hiatus	to	hypothetical	model.	J	Eval	Clin	Pract.	2009;15:985–9.		3.		 Charlin	B,	Boshuizen	HPA,	Custers	EJ,	Feltovich	PJ.	Scripts	and	clinical	reasoning.	Med	Educ.	2007;41:1178–84.		4.		 Leusink	P,	Teunissen	D,	Lucassen	PL,	Laan	ET,	Lagro-Janssen	AL.	Facilitators	and	barriers	in	the	diagnostic	process	of	vulvovaginal	complaints	(vulvodynia)	in	general	practice:	a	qualitative	study.	Eur	J	Gen	Pract.	2018;24:92–8.		
	140	|		
5.		 Leusink	P,	Steinmann	R,	Makker	M,	Lucassen	P,	Teunissen	TA.,	Lagro-Janssen	AL.,	et	al.	Women’s	appraisal	of	the	management	of	vulvodynia	by	their	general	practitioner:	a	qualitative	study.	2018;	submitted.	6.		 Buchan	A,	Munday	P,	Ravenhill	G,	Wiggs	A,	Brooks	F.	A	qualitative	study	of	women	with	vulvodynia:	I.	The	journey	into	treatment.	J	Reprod	Med.	2007;52:15–8.		7.		 Sadownik	LA.	Clinical	profile	of	vulvodynia	patients.	A	prospective	study	of	300	patients.	J	Reprod	Med.	2000;45:679–84.		8.		 Hartman	OT,	van	den	Berg	BD,	der	Horst	VH,	Olde	Hartman	T,	Blankenstein	N,	Molenaar	B,	et	al.	NHG	Guideline	on	Medically	Unexplained	Symptoms	(MUS).	Huisarts	Wet.	2013;56:222–30.		9.		 Goldberg	DP,	Lam	T-P,	Minhas	F,	Razzaque	B,	Robles	R,	Bobes	J,	et	al.	Primary	care	physicians’	use	of	the	proposed	classification	of	common	mental	disorders	for	ICD-11.	Fam	Pract.	2017;34:574–80.		10.		 American	Psychiatric	Association.	Diagnostic	and	Statistical	Manual	of	Mental	Disorders	(5th	edn)	(DSM-5).	APA;	2013.		11.		 Van	Der	Feltz-Cornelis	CM,	Van	Houdenhove	B.	DSM-5:	Van	somatoforme	stoornissen	naar	“somatic	symptom	and	related	disorders.”	Tijdschr	Psychiatr.	2014;56:182–6.		12.		 Basson	R.	The	recurrent	pain	and	sexual	sequelae	of	provoked	vestibulodynia:	a	perpetuating	cycle.	J	Sex	Med.	2012;9:2077–92.		13.		 De	Andres	J,	Sanchis-Lopez	N,	Asensio-Samper	JM,	Fabregat-Cid	G,	Villanueva-Perez	VL,	Monsalve	Dolz	V,	et	al.	Vulvodynia-An	Evidence-Based	Literature	Review	and	Proposed	Treatment	Algorithm.	Pain	Pract.	2015;		14.		 Leusink	P,	Van	de	Pasch	S,	Teunissen	D,	Laan	ET,	Lagro-Janssen	AL.	The	relationship	between	vulvovaginal	candidiasis	and	provoked	vulvodynia:	a	systematic	review.	J	Sex	Med.	2018;	doi:	10.1016/j.jsxm.2018.07.011	15.		 Olde	Hartman	TC,	Woutersen-Koch	H,	Van	Der	Horst	HE.	Medically	unexplained	symptoms:	Evidence,	guidelines,	and	beyond.	Br	J	Gen	Pract.	2013;63:625–6.		16.		 Houwen	J,	Lucassen	PL,	Stappers	HW,	Assendelft	WJ,	van	Dulmen	S,	Hartman	TCO.	Improving	GP	communication	in	consultations	on	medically	unexplained	symptoms:	a	qualitative	interview	study	with	patients	in	primary	care.	Br	J	Gen	Pract.	2017;bjgp17X692537.		17.		 Houwen	J,	Lucassen	PLBJ,	Stappers	HW,	Assendelft	PJJ,	van	Dulmen	S,	olde	Hartman	TC.	Medically	unexplained	symptoms:	The	person,	the	symptoms	and	the	dialogue.	Fam	Pract.	2017;34:245–51.		18.		 Bond	K,	Mpofu	E,	Weerakoon	P,	Shuttleworth	R.	Treatment	seeking	for	vulvodynia	and	vaginismus:	A	systematic	review.	New	Voices	Psychol	8(2).	2012;8:53–70.		19.		 Braksmajer	A.	Struggles	for	medical	legitimacy	among	women	experiencing	sexual	pain:	A	qualitative	study.	Women	Health.	Taylor	&	Francis;	2018;58:419–33.		20.		 Sheppard	C,	Hallam-Jones	R,	Wylie	K.	Why	have	you	both	come?	Emotional,	relationship,	sexual	and	social	issues	raised	by	heterosexual	couples	seeking	sexual	therapy	(in	women	referred	to	a	sexual	difficulties	clinic	with	a	history	of	vulval	pain).	Sex	Relatsh	Ther.	2008;23:217–226.	21.		 Bond	K,	Mpofu	E,	Millington	M.	Treating	women	with	genito-pelvic	pain	disorder:	influences	of	patient	agendas	on	pain-seeking.	J	Fam	Med.	2015;2:1–8.		22.		 Salmon	P,	Ring	A,	Humphris	GM,	Davies	JC,	Dowrick	CF.	Primary	care	consultations	about	medically	unexplained	symptoms:	How	do	patients	indicate	what	they	want?	J	Gen	Intern	Med.	2009;24:450–6.		23.		 Shallcross	R,	Dickson	JM,	Nunns	D,	Mackenzie	C,	Kiemle	G.	Women’s	Subjective	Experiences	of	Living	with	Vulvodynia:	A	Systematic	Review	and	Meta-Ethnography.	Arch	Sex	Behav.	2018;47:577–95.		24.		 Engel	G.	The	Need	for	a	New	Medical	Model:	A	Challenge	for	Biomedicine.	Science	(80-	).	1977;196:129–36.		25.		 Werf	G	Van	Der,	Zaat	J.	De	geboorte	van	een	ideologie :	Woudschoten	en	de	huisartsgeneeskunde.	Huisarts	Wet.	2001;428–35.		
		
	 	
 |	141		
26.		 Takens	H.	Verslag	van	de	studiegroep	psychosomatiek	te	Groningen.	Huisarts	Wet.	1958;8:176–8.		27.		 van	Wirdum	P.	De	anamnese	bij	het	psychosomatisch	onderzoek.	Huisarts	Wet.	1958;8:171–6.		28.		 Verhaak	IPFM.	Hoe	speciaal	is	de	communicatie	van	de	huisarts ?	Huisarts	Wet.	1991;34:320–4.		29.		 Brandsma	F.	Cognitieve	gedragstherapie.	Win-winsituatie	voor	huisarts	en	patiënt.	Huisarts	Wet.	2003;46:284–5.		30.		 Leusink	P,	van	Moorsel	D,	Bor	H,	Donker	GA,	Lucassen	P,	Teunissen	D,	et	al.	Is	uncertain	vulvovaginal	candidiasis	a	marker	of	vulvodynia?	A	study	in	a	Dutch	general	practice	research	database.	BJGP	Open.	2017;bjgpopen17X100905.		31.		 NHG-Werkgroep	Seksuele	klachten.	NHG-Standaard	Seksuele	klachten	(eerste	herziening).	Huisarts	Wet.	2015;58:586–97.		32.		 Leusink	P,	Kaptheijns	A,	Laan	E,	van	Boven	K,	Lagro-Janssen	A.	Comorbidities	Among	Women	With	Vulvovaginal	Complaints	in	Family	Practice.	J	Sex	Med.	2016;13:220–5.		33.		 Harlow	BL,	Stewart	EG.	A	population-based	assessment	of	chronic	unexplained	vulvar	pain:	have	we	underestimated	the	prevalence	of	vulvodynia?	J	Am	Med	Womens	Assoc.	2003;58:82–8.		34.		 Graaf	de	H,	Kruijer	H,	Acker	van	J,	Meijer	S.	Seks	onder	je	25:	seksuele	gezondheid	van	jongeren	in	Nederland	anno	2012.	Utrecht;	2012.		35.		 Graaf	de	H,	Wijsen	C.	Seksuele	gezondheid	in	Nederland	2017.	Delft;	2018.		36.		 Kedde	H,	Donker	G,	Leusink	P,	Kruijer	H.	The	Incidence	of	Sexual	Dysfunction	in	Patients	Attending	Dutch	General	Practitioners.	International	Journal	of	Sexual	Health.	2011;269–77.		37.		 Picavet	C,	Tonnon	S,	Franssens	D,	Wijsen	C.	Hulpzoekgedrag	en	route	naar	zorg	bij	seksuele	problemen.	Tijdschr	voor	Seksuol.	2012;36:3–11.		38.		 Beesley	VL,	Alemayehu	C,	Webb	PM.	A	systematic	literature	review	of	the	prevalence	of	and	risk	factors	for	supportive	care	needs	among	women	with	gynaecological	cancer	and	their	caregivers.	Support	Care	Cancer.	Supportive	Care	in	Cancer;	2017;701–10.		39.		 Pennay	A,	Mcnair	R,	Hughes	TL,	Leonard	W,	Brown	R,	Lubman	DI.	Improving	alcohol	and	mental	health	treatment	for	lesbian,	bisexual	and	queer	women:	Identity	matters.	Aust	N	Z	J	Public	Health.	2017;35–42.		40.		 Simon	JA,	Lukas	VA.	Distressing	sexual	function	at	midlife:	Unmet	needs,	practical	diagnoses,	and	available	treatments.	Obstet	Gynecol.	2017;130:889–905.		41.		 Steele	LS,	Daley	A,	Curling	D,	Gibson	MF,	Green	DC,	Williams	CC,	et	al.	LGBT	Identity,	Untreated	Depression,	and	Unmet	Need	for	Mental	Health	Services	by	Sexual	Minority	Women	and	Trans-Identified	People.	J	Women’s	Heal.	2017;26:116–27.		42.		 Tanton	C,	Jones	KG,	Macdowall	W,	Clifton	S,	Mitchell	KR,	Datta	J,	et	al.	Patterns	and	trends	in	sources	of	information	about	sex	among	young	people	in	Britain:	Evidence	from	three	National	Surveys	of	Sexual	Attitudes	and	Lifestyles.	BMJ	Open.	2015;5:1–10.		43.		 Nusbaum	M,	Gamble	G,	Skinner	B,	Heiman	J.	The	high	prevalence	of	sexual	concerns	among	women	seeking	routine	gynecological	care.	J	Fam	Pract.	49:229–32.		44.		 Lee	DM,	Nazroo	J,	O’Connor	DB,	Blake	M,	Pendleton	N.	Sexual	Health	and	Well-being	Among	Older	Men	and	Women	in	England:	Findings	from	the	English	Longitudinal	Study	of	Ageing.	Arch	Sex	Behav.	2016;45:133–44.		45.		 Bachmann	GA,	Leiblum	SR	GJ.	Brief	sexual	inquiry	in	gynecologic	practice.	Obstet	Gynecol.	1989;73:425–7.		46.		 Leusink	P.	Seks,	dat	spreekt	vanzelf?	Huisarts	Wet.	2015;58:582–5.		47.		 Bergen	J	Van.	Als	je	niet	over	seks	práát,	is	een	goede	behandeling	en	counseling	niet	mogelijk.	Huisarts	Wet.	2015;58:608–9.		48.		 Van	Bergen	JEAM,	Dekker	JH,	Boeke	AJP,	Kronenberg	EHA,	Van	der	Spruit	R,	Burgers	JS,	Bouma	M	VE.	NHG-Standaard	Het	soa-consult.	Huisarts	Wet.	2013;56:450–63.		49.		 Giesen	A,	Lagro-Janssen	T,	Dielissen	P.	Niet	gekomen	voor	het	uitstrijkje?	In	gesprek	over	seks.	Huisarts	Wet.	2014;57:490–3.		
	142	|		
50.		 Nelson	S,	Baldwin	N,	Taylor	J.	Mental	health	problems	and	medically	unexplained	physical	symptoms	in	adult	survivors	of	childhood	sexual	abuse:	An	integrative	literature	review.	J	Psychiatr	Ment	Health	Nurs.	2012;19:211–20.		51.		 Bonvanie	IJ,	van	Gils	A,	Janssens	KAM,	Rosmalen	JGM.	Sexual	abuse	predicts	functional	somatic	symptoms:	An	adolescent	population	study.	Child	Abus	Negl.	2015;46:1–7.		52.		 Golding	JM.	Sexual	assault	history	and	women’s	reproductive	and	sexual	health.	Psychol	Women	Q.	1996;20:101–21.		53.		 Harlow	BL,	Kunitz	CG,	Nguyen	RHN,	Rydell	SA,	Turner	RM,	MacLehose	RF.	Prevalence	of	symptoms	consistent	with	a	diagnosis	of	vulvodynia:	population-based	estimates	from	2	geographic	regions.	Am	J	Obstet	Gynecol.	2014;210:40.e1-40.e8.		54.		 Nusbaum	MRH,	Hamilton	CD.	The	proactive	sexual	health	history.	Am	Fam	Physician.	2002;66:1705–12.		55.		 Dyer	K,	das	Nair	R.	Why	don’t	healthcare	professionals	talk	about	sex?	A	systematic	review	of	recent	qualitative	studies	conducted	in	the	United	Kingdom.	J	Sex	Med.	2013;10:2658–70.		56.		 Alarcão	V,	Ribeiro	S,	Miranda	FL,	Carreira	M,	Dias	T,	Garcia	e	Costa	J,	et	al.	General	practitioners’	knowledge,	attitudes,	beliefs,	and	practices	in	the	management	of	sexual	dysfunction-results	of	the	Portuguese	SEXOS	study.	J	Sex	Med.	2012;9:2508–15.		57.		 Ribeiro	S,	Alarcão	V,	Simões	R,	Miranda	FL,	Carreira	M,	Galvão-Teles	A.	General	Practitioners’	Procedures	for	Sexual	History	Taking	and	Treating	Sexual	Dysfunction	in	Primary	Care.	J	Sex	Med.	2014;11:386–93.		58.		 Tsimtsiou	Z,	Hatzimouratidis	K,	Nakopoulou	E,	Kyrana	E,	Salpigidis	G,	Hatzichristou	D.	Predictors	of	physicians’	involvement	in	addressing	sexual	health	issues.	J	Sex	Med.	2006;3:583–8.		59.		 Eeltink	CM,	Witte	BI,	Stringer	J,	Liptrott	S,	Babic	A,	Greenfield	DM,	et	al.	Health-care	professionals’	perspective	on	discussing	sexual	issues	in	adult	patients	after	haematopoietic	cell	transplantation.	Bone	Marrow	Transplant.	2017;1–11.		60.		 Tournu	G,	Abramowitz	L,	Couffignal	C,	Juguet	F,	Sénéjoux	A,	Berger	S,	et	al.	Prevalence	of	anal	symptoms	in	general	practice:	a	prospective	study.	BMC	Fam	Pract.	2017;18:78.		61.		 Kim	SH,	Lee	YM,	Park	JT.	Patients’	perspectives	on	sexual	history	taking	in	Korea.	Patient	Educ	Couns.	2008;70:370–5.		62.		 Wendt	EK,	Lidell	EAS,	Westerståhl	AKE,	Marklund	BRG,	Hildingh	CI.	Young	women’s	perceptions	of	being	asked	questions	about	sexuality	and	sexual	abuse:	A	content	analysis.	Midwifery.	2011;27:250–6.		63.		 Berry	K,	Rutledge	C.	Factors	That	Influence	Women	to	Disclose	Sexual	Assault	History	to	Health	Care	Providers.	J	Obstet	Gynecol	neonatal	Nurs.	2016;45:553–64.		64.		 Meystre-Agustoni	G,	Jeannin	A,	de	Heller	K,	Pécoud	A,	Bodenmann	P,	Dubois-Arber	F.	Talking	about	sexuality	with	the	physician:	are	patients	receiving	what	they	wish?	Swiss	Med	Wkly.	2011;141:w13178.		65.		 Fairchild	PS,	Haefner	JK,	Berger	MB.	Talk	About	Sex:	Sexual	History-Taking	Preferences	Among	Urogynecology	Patients	and	General	Gynecology	Controls.	Female	Pelvic	Med	Reconstr	Surg.	2016;22:297–302.		66.		 Bjarnadottir	RI,	Bockting	W,	Dowding	DW.	Patient	perspectives	on	answering	questions	about	sexual	orientation	and	gender	identity:	an	integrative	review.	J	Clin	Nurs.	2017;26:1814–33.		67.		 Verhoeven	V,	Colliers	A,	Verster	A,	Avonts	D,	Peremans	L,	Van	Royen	P.	Collecting	data	for	sexually	transmitted	infections	(STI)	surveillance:	What	do	patients	prefer	in	Flanders?	BMC	Health	Serv	Res.	2007;7:1–4.		68.		 Barber	B,	Hellard	M,	Jenkinson	R,	Spelman	T,	Stoove	M.	Sexual	history	taking	and	sexually	transmissible	infection	screening	practices	among	men	who	have	sex	with	men:	a	survey	of	Victorian	general	practitioners.	Sex	Health.	2011;8:349–54.		69.		 Canzona	MR,	Garcia	D,	Fisher	CL,	Raleigh	M,	Kalish	V,	Ledford	CJW.	Communication	about	sexual	health	with	breast	cancer	survivors:	Variation	among	patient	and	provider	perspectives.	Patient	Educ	Couns.	2016;99:1814–20.		
		
	 	
 |	143		
70.		 Flynn	KE,	Reese	JB,	Jeffery	DD,	Amy	P,	Lin	L,	Shelby	RA,	et	al.	Patient	experiences	with	communication	about	sex	during	and	after	treatment	for	cancer.	Psychooncology.	2012;21:594–601.		71.		 Traa	MJ,	De	Vries	J,	Roukema	JA,	Rutten	HJT,	Den	Oudsten	BL.	The	sexual	health	care	needs	after	colorectal	cancer:	the	view	of	patients,	partners,	and	health	care	professionals.	Support	Care	Cancer.	2014;22:763–72.		72.		 Harrison	JD,	Young	JM,	Price	MA,	Butow	PN,	Solomon	MJ.	What	are	the	unmet	supportive	care	needs	of	people	with	cancer?	A	systematic	review.	Support	Care	Cancer.	2009;17:1117–28.		73.		 O’Riordan,	M,	Dahinden	A,	Aktürk	Z,	Ortiz	J,	Dağdeviren	N,	Elwyn	G,	et	al.	Discussion	paper	Dealing	with	uncertainty	in	general	practice :	an	essential	skill	for	the	general	practitioner.	Qual	Prim	Care.	2011;19:175–81.		74.		 Hansen	HS,	Rosendal	M,	Fink	P,	Risør	MB.	The	General	Practitioner’s	Consultation	Approaches	to	Medically	Unexplained	Symptoms:	A	Qualitative	Study.	ISRN	Fam	Med.	2013;2013:541604.		75.		 Lian	OS,	Robson	C.	“It´s	incredible	how	much	I´ve	had	to	fight.”	Negotiating	medical	uncertainty	in	clinical	encounters.	Int	J	Qual	Stud	Health	Well-being.	2017;12:1392219.		76.		 Alam	R,	Cheraghi-Sohi	S,	Panagioti	M,	Esmail	A,	Campbell	S,	Panagopoulou	E.	Managing	diagnostic	uncertainty	in	primary	care:	A	systematic	critical	review.	BMC	Fam	Pract.	2017;18:1–13.		77.		 Politi	MC,	Légaré	F.	Physicians’	reactions	to	uncertainty	in	the	context	of	shared	decision	making.	Patient	Educ	Couns.	2010;80:155–7.		78.		 Stone	L.	Managing	the	consultation	with	patients	with	medically	unexplained	symptoms:	a	grounded	theory	study	of	supervisors	and	registrars	in	general	practice.	BMC	Fam	Pract.	2014;15:192.		79.		 Evans	L,	Trotter	DRM.	Epistemology	and	uncertainty	in	primary	care:	An	exploratory	study.	Fam	Med.	2009;41:319–26.		80.		 Ogden	J,	Fuks	K,	Gardner	M,	Johnson	S,	McLean	M,	Martin	P,	et	al.	Doctors	expressions	of	uncertainty	and	patient	confidence.	Patient	Educ	Couns.	2002;48:171–6.		81.		 Cousin	G,	Schmid	Mast	M,	Jaunin-Stalder	N.	When	physician-expressed	uncertainty	leads	to	patient	dissatisfaction:	A	gender	study.	Med	Educ.	2013;47:923–31.		82.		 Schneider	A,	Löwe	B,	Barie	S,	Joos	S,	Engeser	P,	Szecsenyi	J.	How	do	primary	care	doctors	deal	with	uncertainty	in	making	diagnostic	decisions?:	The	development	of	the	“Dealing	with	Uncertainty	Questionnaire”	(DUQ).	J	Eval	Clin	Pract.	2010;16:431–7.		83.		 Olde	Hartman	TC,	Hassink-Franke	LJ,	Lucassen	PL,	Van	Spaendonck	KP,	Van	Weel	C.	Explanation	and	relations.	How	do	general	practitioners	deal	with	patients	with	persistent	medically	unexplained	symptoms:	A	focus	group	study.	BMC	Fam	Pract.	2009;10:1–9.		84.		 Howman	M,	Walters	K,	Rosenthal	J,	Ajjawi	R,	Buszewicz	M.	“You	kind	of	want	to	fix	it	don’t	you?”	Exploring	general	practice	trainees’	experiences	of	managing	patients	with	medically	unexplained	symptoms.	BMC	Med	Educ.	2016;16:1–10.		85.		 Marriott	C,	Thompson	AR.	Managing	threats	to	femininity:	Personal	and	interpersonal	experience	of	living	with	vulval	pain.	Psychol	Health.	2008;23:243–58.		86.		 Farrell	J,	Cacchioni	T.	The	Medicalization	of	Women’s	Sexual	Pain.	J	Sex	Res.	2012;49:328–36.		87.		 Tiefer	L.	Medicalizations	and	Demedicalizations	of	Sexuality	Therapies.	J	Sex	Res.	2012;49:311–8.		88.		 Labuski	C.	It	Hurts	Down	There.	The	Bodily	Imaginaries	of	Female	Genital	Pain.	New	York:	State	University	of	New	York	Press;	2015.		89.		 Okkes	I,	van	Boven	K,	Lamberts	H.	Episodes	of	care	in	Dutch	Family	Practice	(EFP).	Epidemiological	data	based	on	the	routine	use	of	the	International	Classification	of	Primary	Care	(ICPC)	in	the	Transition	Project	of	the	Academic	Medical	Center/University	of	Amsterdam	(1985-2003).	In:	Okkes	IM,	Oskam	SK,	Lamberts	H,	eds	ICPC	in	the	Amsterdam	Transition	Project	[CD-Rom].	Amsterdam:	Academic	Medical	Center/	
	144	|		
University	of	Amsterdam,	Department	of	Family	Medicine.	2005.		90.		 Abdolrasulnia	M,	Shewchuk	RM,	Roepke	N,	Granstaff	US,	Dean	J,	Foster	JA,	et	al.	Management	of	Female	Sexual	Problems:	Perceived	Barriers,	Practice	Patterns,	and	Confidence	among	Primary	Care	Physicians	and	Gynecologists.	J	Sex	Med.	2010;7:2499–508.		91.		 Coverdale	JH,	Balon	R,	Roberts	LW.	Teaching	sexual	history-taking:	A	systematic	review	of	educational	programs.	Acad	Med.	2011;86:1590–5.		92.		 Dubois	JM,	Walsh	HA,	Chibnall	JT,	Anderson	EE,	Eggers	MR,	Fowose	M,	et	al.	Sexual	violation	of	patients	by	physicians:	A	mixed-methods,	exploratory	analysis	of	101	cases.	Sex	Abus.	2017;June	19:1–21.		93.		 Rosen	R,	Kountz	D,	Post-Zwicker	T,	Leiblum	S,	Wiegel	M.	Sexual	communication	skills	in	residency	training:	the	Robert	Wood	Johnson	model.	J	Sex	Med.	2006;3:37–46.		94.		 Athanasiadis	L,	Papaharitou	S,	Salpiggidis	G,	Tsimtsiou	Z,	Nakopoulou	E,	Kirana	P,	et	al.	Educating	physicians	to	treat	erectile	dysfunction	patients:	development	and	evaluation	of	a	course	on	communication	and	management	strategies.	J	Sex	Med.	2006;3:47–55.		95.		 den	Boeft	M,	Huisman	D,	Morton	L,	Lucassen	P,	van	der	Wouden	JC,	Westerman	MJ,	et	al.	Negotiating	explanations:	doctor–patient	communication	with	patients	with	medically	unexplained	symptoms—a	qualitative	analysis.	Fam	Pract.	2017;34:107–13.		96.		 Johansen	M-L,	Risor	MB.	What	is	the	problem	with	medically	unexplained	symptoms	for	GPs?	A	meta	-synthesis	of	qualitative	studies.	Patient	Educ	Couns.	2017;100:647–54.		97.		 Giroldi	E,	Veldhuijzen	W,	de	Leve	T,	van	der	Weijden	T,	Bueving	H,	van	der	Vleuten	C.	“I	still	have	no	idea	why	this	patient	was	here”:	An	exploration	of	the	difficulties	GP	trainees	experience	when	gathering	information.	Patient	Educ	Couns.	2015;98:837–42.		98.		 Giroldi	E,	Veldhuijzen	W,	Geelen	K,	Muris	J,	Bareman	F,	Bueving	H,	et	al.	Developing	skilled	doctor–patient	communication	in	the	workplace:	a	qualitative	study	of	the	experiences	of	trainees	and	clinical	supervisors.	Adv	Heal	Sci	Educ.	2017;22:1263–78.		99.		 NHG	en	Interfacultair	Overleg	Huisartsgeneeskunde.	Nationale	Onderzoeksagenda	Huisartsgeneeskunde.	2018.		100.		 Zegers	M,	Heijmans	M,	Rijken	M.	Ondersteuningsbehoeften	van	(ex-)	kankerpatiënten.	Huisarts	Wet.	2010;171:2010.		101.	 FaMe-net.	Inclusion	Criteria	in	ICPC	[Internet].	2018.	Available	from:	https://www.transhis.nl/over/icpc-nl/wat-is-icpc/criteria-voor-opname-in-icpc/	102.	 Vork	L,	Weerts	ZZRM,	Mujagic	Z,	Kruimel	JW,	Hesselink	MAM,	Muris	JWM,	et	al.	Rome	III	vs	Rome	IV	criteria	for	irritable	bowel	syndrome:	A	comparison	of	clinical	characteristics	in	a	large	cohort	study.	Neurogastroenterol	Motil.	2017;e13189.			 	
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Summary 	Provoked	vulvodynia	(PVD)	is	a	chronic	pain	syndrome	of	the	vulva	in	which	the	pain	persists	for	more	than	three	months	and	for	which	no	somatic	cause	can	be	found.	The	vulvar	pain	is	provoked	by	touching	the	vestibulum	and	the	introitus	of	the	vagina	or	by	touch	during	and	following	penetration	of	the	vagina.		The	main	aim	of	this	PhD	project	is	to	gain	insight	about	whether	and	how	GPs	involve	PVD	in	their	diagnostic	management	when	women	present	themselves	with	vulvovaginal	complaints.	Given	the	gap	between	the	low	prevalence	of	PVD	in	general	practice	and	it’s	higher	prevalence	(including	a	need	for	help)	in	the	general	population,	and	given	the	lack	of	knowledge	about	this	biopsychosocial	pain	condition	in	a	sexual	context,	we	wanted	to	know	whether	PVD	is	visible	in	clinical	practice,	what	kind	of	barriers	and	facilitators	general	practitioners	(GPs)	and	women	with	PVD	experience,	and	how	GPs	can	be	supported	in	their	diagnostic	process.	Research	on	PVD	in	primary	care	is	very	limited	and	much	knowledge	is	based	upon	research	in	secondary	and	tertiary	care.	This	provides	a	bias	because	these	women	with	PVD	comprise	a	select	group	that	already	has	been	diagnosed	adequately,	and	that	has	found	its	way	to	treatment.		Improvement	of	the	knowledge	and	skills	of	the	GP	on	this	issue	might	lead	to	improvement	of	the	quality	of	health	care	for	these	women,	as	an	early	diagnosis	and	an	adequate	management	in	primary	care	might	break	the	vicious	circle	of	both	the	chronic	pain	and	the	medicalization	of	the	problem.		
	
Chapter	1	presents	an	introduction	to	the	subject.	The	definition	of	PVD	is	clarified	and	the	epidemiology,	the	clinical	presentation	and	the	context	of	PVD	are	given.	It	shows	the	complexity	of	the	physical	complaints	of	PVD,	elicited	and	maintained	by	its	bio-psycho-social	context	of	which,	among	other	things,	somatic	and	psychological	comorbidity,	sexuality,	partner	responses,	shame,	low	self-esteem,	and	negative	genital	self-image	are	part	of.	Furthermore,	a	description	of	the	unmet	needs	and	impeding	factors	of	women	seeking	help	regarding	their	PVD	are	presented.	It	appears	that	health	care	seeking	of	women	with	PVD	is	not	as	self-evident	as	one	might	expect.	Quantitative	and	qualitative	research	demonstrates	barriers	to	both	physicians	and	patients	in	addressing	the	
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problem.	In	general,	GPs	find	it	difficult	to	address	sexual	issues	and	women	are	ashamed	of	the	psychologizing	of	their	problem	and	expect	a	somatic	solution.	Finally,	the	role	of	the	general	practitioner	(GP)	concerning	diagnosis	and	management	of	PVD	is	described.	Some	studies	in	general	practice	show	that	PVD	as	a	condition	is	present	in	general	practice,	and	that	women	may	suffer	from	it	although	at	times	hidden	as	recurrent	or	unexplained	vulvo-vaginal	symptoms.	The	studied	GPs	lacked	the	knowledge	and	skills	to	diagnose	and	manage	this	problem.	It	is	unknown	if	this	applies	to	the	Dutch	GPs.		In	chapter	2	we	explored	the	relationship	between	specific	vulvovaginal	symptoms,	which	could	be	suggestive	of	PVD	(e.g.	genital	pain,	painful	intercourse),	and	comorbidities	known	from	studies	in	secondary	and	tertiary	line	health	care,	such	as	pain	syndromes,	psychological	diagnoses	and	uro-genital	infections.	The	presence	of	these	specific	vulvovaginal	symptoms	in	the	context	of	these	comorbidities	could	assist	GPs	to	recognise	and	identify	PVD	at	an	earlier	stage.	Therefore	we	wanted	to	know	whether	women	between	15-50	years	old,	who	are	visiting	a	GP	with	specific	vulvovaginal	complaints	suggestive	of	PVD,	have	a	higher	probability	of	certain	specified	comorbidities	than	women	of	a	similar	age	without	PVD.	Due	to	the	fact	that	PVD	is	not	included	in	the	International	Classification	of	Primary	Care,	it	was	necessary	to	make	use	off	indirect	characteristics	of	PVD.	A	retrospective	cohort	analysis	of	data	from	a	primary	care	database	shows	that	premenopausal	women	with	symptoms	suggestive	of	PVD	more	often	are	diagnosed	with	vulvovaginal	candidiasis	and	Irritable	bowel	syndrome.	Women	with	symptoms	suggestive	of	PVD	are	also	more	likely	to	be	diagnosed	with	complaints	of	muscle	pain,	general	weakness,	insomnia,	depressive	disorder	and	anxiety.	Possibly,	GPs	might	make	a	diagnosis	of	vulvovaginal	candidiasis	or	irritable	bowel	disease	-	of	which	the	diagnosis	is	only	based	upon	clinical	manifestations	-	in	many	women	in	whom	a	diagnosis	of	PVD	would	be	more	appropriate.		
Chapter	3	focuses	on	the	question	whether	the	relationship	between	vulvovaginal	candidiasis	(VVC)	and	PVD	found	in	our	own	and	in	other	studies,	might	also	be	explained	by	the	fact	that	some	women	with	VVC	possibly	are	diagnosed	incorrectly,	in	fact	masking	a	subgroup	of	women	with	PVD.		
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To	test	this	hypothesis	we	analysed	data	prospectively	collected	in	2014	in	Dutch	general	practices	of	the	NIVEL	Primary	Care	Database	in	which	we	distinguished	women	with	an	uncertain	diagnosis	of	VVC	–	i.e.	with	the	occurrence	of	recurrent	episodes	and	persisting	complaints,	despite	treatment	-	from	women	with	certain	VVC	–	i.e.	when	the	patients	history	and	physical	exam	displayed	itching	and	non-smelling,	white	crumbling	discharge	in	combination	with	a	red	swollen	vulva	or	vaginal	wall.	Uncertain	VVC	was	found	to	account	for	28%	of	the	entire	group	of	women,	a	proportion	that	is	in	line	with	international	studies.	As	we	hypothesized,	factors	known	to	be	associated	with	PVD	were	more	prevalent	in	women	with	uncertain	VVC	compared	with	women	with	certain	VVC,	indicating	that	uncertain	vulvovaginal	candidiasis	could	be	a	marker	of	PVD.	We	concluded	that	GPs	should	reconsider	their	diagnostics	and	management	when	women	present	recurrent	and	persistent	vulvovaginal	complaints,	especially	if	accompanied	by	dyspareunia,	functional	syndromes,	micturition	symptoms	and	psychological	conditions.		
Chapter	4	describes	the	state	of	the	art	of	the	exact	relationship	between	VVC	and	PVD.	After	all,	knowing	that	an	uncertain	diagnosis	of	VVC	could	be	a	marker	of	PVD	does	not	exclude	the	generally	suggested	hypothesis	that	VVC	might	cause	PVD.		Therefore	we	conducted	a	systematic	review	of	the	literature	published	over	the	last	fifteen	years.	The	key	findings	show	that,	contrary	to	what	is	suggested,	there	is	no	evidence	of	a	relationship	between	actual	VVC	and	PVD.	We	found	that	all	population	studies	used	an	invalid	self-reported	diagnosis	of	VVC,	that	pathophysiological	in-vitro	studies	were	not	conclusive,	and	that	most	included	studies	were	of	low	methodological	quality.	Based	on	the	current	available	evidence,	an	unequivocal	conclusion	about	the	relationship	between	VVC	and	PVD	cannot	be	drawn.	The	hypothesis	that	an	uncertain	diagnosis	of	VVC	may	be	a	marker	of	PVD	is	therefore	still	justifiable.		In	order	to	improve	the	recognition	of	PVD,	it	is	important	to	know	more	precisely	the	diagnostic	considerations	of	GPs	when	consulted	by	women	with	vulvovaginal	complaints.	Given	that	VVC	and	PVD	have	an	overlap	of	symptoms,	this	might	confront	GPs	with	uncertainty.	Therefore,	in	Chapter	5	we	explore	which	barriers	and	facilitators	are	affecting	the	diagnostic	process	of	GPs	who	are	confronted	with	(persistent	and	recurrent)	vulvovaginal	complaints.		
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We	conducted	a	qualitative	focus	group	study	among	17	Dutch	GPs,	5	men	and	12	women.	Barriers	were:	the	reluctance	of	discussing	sexuality,	the	male	gender	of	the	GP,	GPs’	negative	emotional	responses	when	faced	with	professional	uncertainty,	alongside	lack	of	education	about	PVD.	The	female	gender	of	the	GP	and	understanding	that	patients	can	benefit	from	asking	about	sexual	health	issues	were	found	to	be	facilitating	factors.		
Chapter	6	focuses	on	the	question	whether	the	current	management	of	vulvovaginal	complaints	by	GPs	is	in	accordance	with	the	needs	and	expectations	of	women	with	PVD.	Which	barriers	and	facilitators	affect	women	with	PVD	and	what	do	they	expect	and	experience	when	they	consult	a	GP	about	their	vulvovaginal	complaints?	This	knowledge	may	help	the	GP	to	improve	their	approach	of	women	in	both	the	diagnostics	as	well	as	the	management	of	PVD.	The	results	of	in-depth	interviews	with	12	women	with	PVD,	conclusively	diagnosed	by	a	sexologist	or	gynaecologist,	show	that	empathy	of	the	GP,	and	involvement	of	the	women	in	decision-making	and	referral	were	important	factors	in	the	appreciation	of	the	consultation	for	women	with	PVD	who	were	referred	to	a	specialist.	The	communication	with	and	the	competence	of	the	GP	ultimately	proved	more	important	in	the	contact	with	the	woman	than	the	gender	of	the	GP.	Because	women	were	reluctant	to	start	a	conversation	about	sexuality	they	expected	a	proactive	attitude	in	this	from	their	GP.	
	
Chapter	7	gives	an	overview	of	all	the	studies	and	discusses	the	most	important	themes	that	are	generated	by	it.		Given	all	studies,	PVD	might	be	considered	in	general	practice	-	whether	or	not	concealed	by	undefined	vulvovaginal	complaints	and	other	comorbidities	-	as	one	option	in	the	differential	diagnosis	of	vulvovaginal	complaints.	However,	the	diagnostic	management	of	PVD	by	GPs	is	problematic	for	some	reasons.	Firstly,	because	PVD	may	be	seen	as	an	example	of	medically	unexplained	symptoms	(MUS),	which	in	general	is	considered	as	difficult	by	GPs.	Secondly,	because	the	symptoms	of	PVD	among	other	things	arise	in	a	sexual	context	about	which	GPs	lack	knowledge	and	skills.	Thirdly,	managing	MUS	and	addressing	sexual	issues	might	provoke	a	feeling	of	uncertainty	in	GPs.		
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Therefore,	the	following	three	themes	are	further	discussed	in	this	chapter:	the	management	of	medically	unexplained	symptoms	(MUS);	addressing	sexual	health	in	general	practice;	and	coping	with	professional	uncertainty.	Implications	for	practice,	education	and	research	are	given.	We	conclude	that	women	finally	will	benefit	from	GPs	who	dare	to	explore	the	biopsychosocial	dimensions	of	the	complaint	including	sexual	and	relational	aspects.	GPs	will	be	supported	by	the	knowledge	that	women	with	PVD	expect	GPs	to	initiate	discussing	about	sexuality,	given	that	the	GPs	will	show	empathy	and	take	her	seriously.	Also,	an	approach	that	is	applied	at	MUS	in	general,	and	which	has	to	be	expanded	by	a	sexual	and	relational	context,	will	be	supportive	to	GPs.	Provided	that	the	GP	has	sufficient	knowledge	about	PVD,	ultimately,	it	will	be	the	quality	of	the	doctor-patient	relationship,	in	which	there	is	patient	involvement	in	decision-making	and	referral	and	in	which	the	complaints	of	the	women	with	PVD	are	met	with	empathy,	that	will	be	of	decisive	significance	to	meet	her	needs.		 	
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Samenvatting 
	
Provoked	vulvodynia	(PVD)	is	een	vorm	van	vulvodynie,	dat	wil	zeggen,	een	chronisch	pijnsyndroom	van	de	vulva	waarbij	de	pijn	langer	dan	drie	maanden	bestaat	en	waarvoor	geen	somatische	oorzaak	te	vinden	is.	De	vulvaire	pijn	wordt	uitgelokt	door	het	aanraken	van	het	vestibulum	of	de	introïtus	van	de	vagina	of	door	aanraking	van	de	vagina	tijdens	en	na	penetratie.	Het	doel	van	dit	proefschrift	is	om	te	onderzoeken	of	en	hoe	huisartsen	PVD	betrekken	bij	hun	diagnostiek	zodra	vrouwen	zich	presenteren	met	vulvovaginale	klachten.	Gezien	de	kloof	tussen	de	lage	prevalentie	van	PVD	in	de	huisartspraktijk	en	de	veel	hogere	prevalentie	van	5-10%	(inclusief	een	behoefte	aan	hulp)	in	de	algemene	bevolking,	en	mede	gezien	het	gebrek	aan	kennis	bij	huisartsen	over	deze	biopsychosociale	pijnconditie	in	een	seksuele	context,	willen	we	weten	of	PVD	zich	voordoet	in	de	dagelijkse	klinische	praktijk,	welke	belemmeringen	en	mogelijkheden	huisartsen	en	vrouwen	met	PVD	in	het	consult	ervaren,	en	hoe	huisartsen	kunnen	worden	ondersteund	in	de	aanpak	van	hun	diagnostiek.		Onderzoek	naar	PVD	in	de	eerste	lijn	is	tot	nu	toe	zeer	beperkt	en	veel	kennis	is	gebaseerd	op	onderzoek	in	de	tweede	en	derde	lijn.	Dit	geeft	een	vertekening	omdat	deze	vrouwen	met	PVD	een	selecte	groep	vormen	die	al	voldoende	is	gediagnosticeerd	en	die	zijn	weg	naar	behandeling	heeft	gevonden.	Verbetering	van	de	kennis	en	vaardigheden	van	de	huisarts	over	PVD	zou	kunnen	leiden	tot	verbetering	van	de	kwaliteit	van	de	zorg	voor	deze	vrouwen,	omdat	door	een	vroege	diagnose	en	een	adequate	aanpak	in	de	eerste	lijn	de	vicieuze	cirkel	van	zowel	de	chronische	pijn	als	de	medicalisering	van	het	probleem	doorbroken	zou	kunnen	worden.		
Hoofdstuk	1	geeft	een	inleiding	op	het	onderwerp.	De	definitie	van	PVD	wordt	verhelderd	en	de	epidemiologie,	de	klinische	presentatie	en	de	context	van	PVD	worden	besproken.	Het	toont	de	complexiteit	van	de	lichamelijke	klachten	van	PVD,	uitgelokt	en	onderhouden	door	haar	biopsychosociale	context,	waar,	onder	andere,	somatische	en	psychologische	comorbiditeit,	seksualiteit,	partnerreacties,	schaamte,	laag	zelfbeeld	en	een	negatief	genitaal	zelfbeeld,	deel	van	uitmaken.		
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Verder	wordt	een	beschrijving	gegeven	van	de	belemmeringen	en	onvervulde	behoeften	onder	vrouwen	die	hulp	zoeken	voor	hun	PVD.	Het	lijkt	erop	dat	het	zoeken	naar	hulp	voor	vrouwen	met	PVD	niet	zo	vanzelfsprekend	is	als	men	zou	verwachten.		Kwantitatief	en	kwalitatief	onderzoek	toont	aan	dat	er	barrières	zijn	voor	zowel	artsen	als	patiënten	om	het	probleem	bespreekbaar	te	maken.	In	het	algemeen	vinden	huisartsen	het	lastig	seksualiteit	bespreekbaar	te	maken	en	schamen	vrouwen	zich	voor	de	psychologisering	van	hun	probleem	en	verwachten	een	somatische	oplossing.	Ten	slotte	wordt	de	rol	van	de	huisarts	bij	de	diagnostiek	en	de	aanpak	van	PVD	beschreven.	Enkele	studies	in	de	huisartspraktijk	laten	zien	dat	PVD	als	aandoening	zich	voor	kan	doen	in	de	huisartspraktijk,	waarschijnlijk	soms	gecamoufleerd	als	terugkerende	of	onverklaarbare	vulvovaginale	symptomen.	De	onderzochte	huisartsen	blijken	de	kennis	en	vaardigheden	te	missen	om	dit	probleem	te	diagnosticeren	en	aan	te	pakken.	Het	is	onbekend	of	dit	ook	van	toepassing	is	in	Nederland.		In	hoofdstuk	2	hebben	we	de	relatie	onderzocht	tussen	specifieke	vulvovaginale	symptomen	die	kunnen	wijzen	op	PVD	(bijvoorbeeld	genitale	pijn,	pijnlijke	geslachtsgemeenschap)	en	comorbiditeit	zoals	die	bekend	is	uit	studies	in	de	tweede-	en	derdelijn	gezondheidszorg,	zoals	pijnsyndromen,	psychologische	aandoeningen	en	urogenitale	infecties.	De	aanwezigheid	van	deze	specifieke	vulvovaginale	symptomen	in	de	context	van	deze	comorbiditeit	zou	de	huisartsen	kunnen	helpen	om	PVD	in	een	eerder	stadium	te	signaleren	en	vast	te	stellen.	Daarom	wilden	we	weten	of	vrouwen	tussen	de	15	en	50	jaar,	die	een	huisarts	bezoeken	met	specifieke	vulvovaginale	klachten	die	op	PVD	kunnen	wijzen,	een	hogere	kans	hebben	op	bepaalde	comorbiditeit	dan	vrouwen	van	een	vergelijkbare	leeftijd	zonder	PVD.	Omdat	PVD	niet	is	opgenomen	in	het	internationaal	classificatiesysteem	van	eerstelijnszorg	(ICPC),	was	het	noodzakelijk	voor	het	onderzoek	gebruik	te	maken	van	indirecte	kenmerken	van	PVD.	Een	retrospectieve	cohortanalyse	van	gegevens	uit	een	database	van	de	eerstelijnszorg	toont	aan	dat	premenopauzale	vrouwen	met	symptomen	die	op	PVD	kunnen	wijzen,	vaker	worden	gediagnostiseerd	met	vulvovaginale	candidiasis	en	het	prikkelbare	darmsyndroom.	Vrouwen	met	symptomen	die	kunnen	wijzen	op	PVD	worden	ook	vaker	gediagnosticeerd	met	klachten	over	spierpijn,	moeheid,	slapeloosheid,	depressieve	stoornis	en	angst.	Mogelijk	dat	huisartsen	een	diagnose	van	vulvovaginale	candidiasis	of	prikkelbare	darmaandoening	stellen	-	waarvan	de	diagnose	veelal	alleen	gebaseerd	is	op	
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klinische	manifestaties	-	bij	een	deel	van	de	vrouwen	bij	wie	een	diagnose	van	PVD	beter	op	zijn	plaats	zou	kunnen	zijn.		
Hoofdstuk	3	richt	zich	op	de	vraag	of	de	relatie	tussen	vulvovaginale	candidiasis	(VVC)	en	PVD,	die	gevonden	werd	in	ons	eigen	en	in	andere	onderzoeken,	ook	zou	kunnen	worden	verklaard	doordat	sommige	vrouwen	met	VVC	mogelijk	de	verkeerde	diagnose	krijgen,	waardoor	in	feite	een	subgroep	van	vrouwen	met	PVD	wordt	gemaskeerd.	Om	deze	hypothese	te	toetsen,	hebben	we	de	gegevens	geanalyseerd	die	in	2014	prospectief	werden	verzameld	door	huisartspraktijken	van	de	NIVEL	Database,	waarin	we	vrouwen	onderscheidden	met	een	onzekere	diagnose	van	VVC	–	dwz	met	het	voorkomen	van	terugkerende	episodes	en	aanhoudende	klachten,	ondanks	de	behandeling	-	,	van	vrouwen	met	zekere	VVC	-	dwz	wanneer	de	voorgeschiedenis	en	het	lichamelijk	onderzoek	van	de	vrouw	jeuk	en	niet-ruikende,	witte	afbrokkelende	afscheiding	vertoonden	in	combinatie	met	een	rode	gezwollen	vulva	of	vaginawand.	Onzekere	VVC	bleek	28%	van	de	totale	groep	vrouwen	te	vertegenwoordigen,	een	percentage	dat	overeenstemt	met	internationale	studies.	Zoals	we	veronderstelden,	kwamen	factoren	waarvan	bekend	is	dat	deze	geassocieerd	zijn	met	PVD	meer	voor	bij	vrouwen	met	onzekere	VVC	vergeleken	met	vrouwen	met	zekere	VVC.	Dit	zou	kunnen	betekenen	dat	onzekere	vulvovaginale	candidiasis	een	teken	van	PVD	zou	kunnen	zijn.	We	concluderen	dat	huisartsen	hun	diagnostiek	en	aanpak	zouden	moeten	heroverwegen	wanneer	vrouwen	recidiverende	en	aanhoudende	vulvovaginale	klachten	vertonen,	vooral	als	ze	gepaard	gaan	met	dyspareunie,	functionele	syndromen,	mictieklachten	en	psychische	aandoeningen.		
Hoofdstuk	4	beschrijft	de	stand	van	zaken	van	de	exacte	relatie	tussen	VVC	en	PVD.	De	wetenschap	dat	een	onzekere	diagnose	van	VVC	een	teken	van	PVD	zou	kunnen	zijn,	sluit	namelijk	de	algemeen	veronderstelde	hypothese	dat	VVC	PVD	kan	veroorzaken	niet	uit.	We	hebben	daarom	een	systematische	review	verricht	over	de	literatuur	die	de	afgelopen	vijftien	jaar	over	deze	relatie	is	gepubliceerd.	De	belangrijkste	bevindingen	laten	zien	dat,	in	tegenstelling	tot	wat	vaak	wordt	gesuggereerd,	er	geen	bewijs	is	voor	een	verband	tussen	VVC	en	PVD.	We	vonden	dat	alle	populatiestudies	een	–	ontoereikende	-	zelfdiagnose	van	VVC	gebruikten,	dat	de	pathofysiologische	in-vitro	
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onderzoeken	niet	overtuigend	waren,	en	dat	de	meeste	inbegrepen	studies	van	lage	methodologische	kwaliteit	waren.	Op	basis	van	het	huidige	beschikbare	bewijs	kan	geen	eenduidige	conclusie	over	de	relatie	tussen	VVC	en	PVD	worden	getrokken.		De	hypothese	dat	een	onzekere	diagnose	van	VVC	een	teken	van	PVD	kan	zijn,	is	daarom	nog	steeds	te	rechtvaardigen.		Om	de	herkenning	van	PVD	door	huisartsen	te	verbeteren,	is	het	belangrijk	om	hun	diagnostische	overwegingen	te	kennen	wanneer	zij	worden	geconsulteerd	door	vrouwen	met	recidiverende	vulvovaginale	klachten.	Aangezien	VVC	en	PVD	een	overlap	van	symptomen	hebben,	kan	dit	de	diagnostiek	van	huisartsen	bemoeilijken.	Daarom	onderzoeken	we	in	hoofdstuk	5	welke	belemmeringen	en	mogelijkheden	van	invloed	zijn	op	het	diagnostisch	proces	van	huisartsen	die	geconfronteerd	worden	met	vrouwen	met	aanhoudende	en	terugkerende	vulvovaginale	klachten.	We	voerden	een	focusgroepstudie	uit	bij	17	huisartsen,	5	mannen	en	12	vrouwen.	Belemmeringen	onder	de	huisartsen	waren:	de	terughoudendheid	om	seksualiteit	te	bespreken,	het	mannelijke	geslacht	van	de	huisarts,	de	negatieve	emotionele	reacties	van	de	huisarts	bij	professionele	onzekerheid,	naast	een	gebrek	aan	scholing	over	PVD.	Het	vrouwelijk	geslacht	van	de	huisarts	en	de	wetenschap	dat	patiënten	baat	kunnen	hebben	bij	vragen	naar	seksuele	gezondheidsproblemen,	bleken	faciliterende	factoren	te	zijn.			
Hoofdstuk	6	richt	zich	op	de	vraag	of	de	huidige	aanpak	van	vulvovaginale	klachten	door	huisartsen	in	overeenstemming	is	met	de	behoeften	en	verwachtingen	van	vrouwen	met	PVD.	Welke	belemmeringen	en	mogelijkheden	ervaren	vrouwen	met	PVD	en	wat	verwachten	ze	wanneer	ze	een	huisarts	raadplegen	over	hun	vulvovaginale	klachten?	Deze	kennis	kan	de	huisarts	helpen	in	de	bejegening	van	vrouwen	bij	de	diagnostiek	en	aanpak	van	PVD.	De	resultaten	van	diepte-interviews	met	12	vrouwen	met	PVD,	gediagnosticeerd	door	een	seksuoloog	of	gynaecoloog,	tonen	aan	dat	empathie	van	de	huisarts	en	de	betrokkenheid	van	vrouwen	bij	de	besluitvorming	en	doorverwijzing,	belangrijke	factoren	waren	in	de	waardering	van	het	consult	voor	vrouwen	met	een	PVD	die	werden	doorverwezen	naar	een	specialist.	De	communicatie	met	en	de	competentie	van	de	huisarts	bleken	uiteindelijk	belangrijker	in	het	contact	met	de	vrouw	dan	het	geslacht	
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van	de	huisarts.	Omdat	vrouwen	terughoudend	waren	om	een	gesprek	over	seksualiteit	te	beginnen,	verwachtten	ze	hierin	een	proactieve	houding	van	hun	huisarts.		
Hoofdstuk	7	vat	alle	onderzoeken	samen	en	bespreekt	de	belangrijkste	thema’s	die	door	deze	studies	naar	voren	worden	gebracht.		Naar	ons	idee	kan	PVD	in	de	huisartspraktijk	overwogen	worden	als	een	optie	in	de	differentiaal	diagnostiek	van	vulvovaginale	klachten,	zij	het	dat	PVD	aanvankelijk	gemaskeerd	kan	zijn	door	onduidelijke	vulvovaginale	klachten	en	andere	comorbiditeit.	De	diagnostiek	van	PVD	door	huisartsen	is	om	een	aantal	redenen	lastig.	Ten	eerste	omdat	PVD	gezien	kan	worden	als	een	voorbeeld	van	somatisch	onvoldoende	verklaarde	lichamelijke	klachten	(SOLK)	die	in	het	algemeen	door	huisartsen	als	moeilijk	worden	ervaren.	Ten	tweede,	omdat	de	symptomen	van	PVD	zich	onder	meer	voordoen	in	een	seksuele	context	waarover	huisartsen	kennis	en	vaardigheden	missen.	Ten	derde	kan	de	aanpak	van	SOLK	en	seksuele	problemen	een	gevoel	van	onzekerheid	oproepen	bij	huisartsen.	Daarom	worden	in	dit	hoofdstuk	de	volgende	drie	thema’s	nader	besproken:	de	aanpak	van	SOLK;	het	bespreekbaar	maken	van	seksualiteit	in	de	huisartspraktijk;	en	het	omgaan	met	professionele	onzekerheid.	Implicaties	voor	de	praktijk,	het	onderwijs	en	wetenschappelijk	onderzoek	worden	gegeven.	Tenslotte	concluderen	we	dat	vrouwen	met	vulvovaginale	klachten	baat	zullen	hebben	bij	huisartsen	die	de	biopsychosociale	dimensies	van	de	klacht	durven	te	verkennen,	inclusief	seksuele	en	relationele	aspecten.	Huisartsen	worden	daarin	ondersteund	door	de	constatering	dat	vrouwen	met	PVD	van	huisartsen	verwachten	dat	ze	seksualiteit	bespreekbaar	maken,	zolang	de	huisarts	empathie	toont		en	haar	serieus	neemt.	Ook	een	aanpak	die	in	het	algemeen	wordt	toegepast	bij	SOLK	kan	de	huisarts	hierbij	ondersteunen.	Mits	de	huisarts	voldoende	kennis	heeft	over	PVD,		zal	uiteindelijk	de	kwaliteit	van	de	arts-patiëntrelatie,	-	waarbij	er	sprake	is	van	betrokkenheid	van	de	vrouw	bij	de	besluitvorming	en	eventuele	doorverwijzing,	en	van	een	persoonsgerichte	houding	van	de	huisarts	-,	van	doorslaggevende	betekenis	zijn.			 	
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Dankwoord 	Dit	proefschrift	kwam	tot	stand	door	samenwerking	met	velen.	Op	deze	plek	wil	ik	graag	mijn	dank	hiervoor	uitspreken.		Allereerst	ben	ik	de	vrouwen	en	de	huisartsen	dankbaar	die	tijd	en	moeite	hebben	genomen	de	studentes	en	mij	te	woord	te	staan.	Deelname	aan	wetenschappelijk	onderzoek	is	zeker	niet	vanzelfsprekend	en	ik	waardeer	dit	dan	ook	zeer.	Het	zijn	jullie	ervaringen	die	de	basis	waren	voor	mijn	twee	kwalitatieve	onderzoeken.	De	toegang	tot	de	vrouwen	kwam	tot	stand	via	enkele	seksuologen	NVVS,	gynaecologen	en	bekkenfysiotherapeuten,	veel	dank	voor	jullie	inzet.	Ook	wil	ik	de	onzichtbare	en	anonieme	deelname	van	honderden	huisartsen	aan	de	databases	van	het	NIVEL	en	TransHIS	noemen.	Dagelijks	noteren	zij	secuur	hun	consulten	waardoor	een	schat	aan	informatie	vrij	komt	waar	velen,	zoals	ik,	uit	hebben	mogen	putten.	Erg	veel	dank	voor	jullie	inspanning.		Prof.	dr.	A.L.M.	Lagro-Janssen,	beste	Toine.	Toen	ik	wat	ging	mijmeren	over	onderzoek	naar	vulvodynie,	was	er	in	Nederland,	gezien	jouw	zeer	gewaardeerde	inzet	voor	de	vrouwengezondheidszorg,	eigenlijk	maar	één	hoogleraar	binnen	de	huisartsgeneeskunde	waar	ik	me	toe	kon	wenden.	Maar	dreigde	jouw	emeritaat	geen	roet	in	het	eten	te	gaan	gooien,	en	kon	dat	wel	zonder	financiering?	Gelukkig	zei	je	onmiddellijk	en	volmondig	ja	op	mijn	verzoek,	van	onmogelijkheden	wilde	je	niet	weten,	je	zag	vooral	ook	kansen.	Wel	stelde	je	me	de	vraag	of	ik	wist	waarvoor	ik	het	allemaal	wilde	doen,	want	zonder	punt	aan	de	horizon	zou	het	een	zeer	moeizame	weg	worden.	Tot	op	de	dag	van	vandaag	heeft	mij	die	vraag	het	meest	geholpen.		Met	tomeloze	inzet	en	creatieve	flexibiliteit	wist	jij	mijn	grilligheden	in	mijn	situatie	als	buitenpromovendus	te	sturen	en	tot	een	goed	eind	te	brengen.	Heel	veel	dank	hiervoor.		Prof.	dr.	E.T.M.	Laan,	beste	Ellen.	We	kennen	elkaar	al	vele	jaren	vanuit	de	seksuologie	in	Nederland	en	je	geldt	zonder	enige	twijfel	binnen	deze	wereld	als	mijn	gouden	standaard	waar	het	zowel	dit	onderwerp	als	jouw	wetenschappelijke	statuur	betreft.	Met	jouw	deelname	kreeg	het	huisartsgeneeskundige	karakter	van	het	onderzoek	
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seksuologische	verbreding	en	verdieping.	Jouw	kritische	bevraging	tot	aan	het	gaatje	scherpte	mij	in	mijn	denken	en	schrijven	al	leek	dat	niet	altijd	zichtbaar.	Schuren	geeft	glans.	Ik	dank	je	zeer	voor	je	geduld,	je	reflectie	en	de	samenwerking.		Dr.	P.L.B.J.	Lucassen,	beste	Peter.	Jouw	boek	over	kwalitatief	onderzoek	in	de	huisartspraktijk	was	mij	al	bekend	(en	ook	gelezen!)	en	het	was	daarom	een	eer	en	waar	genoegen	toen	je	aan	het	team	werd	toegevoegd.	Helaas	hebben	we	elkaar	weinig	gesproken,	veel	ging	via	digitale	uitwisseling,	maar	ik	heb	veel	geleerd	over	de	mogelijkheden	van	dit	type	onderzoek.	Door	jouw	basale	vragen	over	PVD	werd	ik	gedwongen	me	te	verplaatsen	van	de	huisartsexpert	naar	de	huisarts	die	er	minder	mee	bekend	is,	mijn	aanvankelijke	blinde	vlek.	Erg	veel	dank	voor	je	geduldige	uitleg	en	behoedzame	benadering.		Dr.	T.A.M.	Teunissen,	beste	Doreth.	Voor	vele	redenen	was	jouw	rol	in	het	team	belangrijk.	Als	hoofd	van	de	NHG	kaderopleiding	uro-gynaecologie	wist	je	wat	er	nodig	was	aan	scholing	aan	huisartsen	en	had	je	toegang	tot	kaderhuisartsen.	Daarnaast	begeleidde	je	de	studenten	die	in	het	kader	van	hun	wetenschapsstage	geneeskunde	participeerden	in	ons	onderzoek.	En	tot	slot,	niet	onbelangrijk,	ben	je	ook	praktiserend	huisarts.	Vanuit	dit	perspectief	keek	je	met	nuchterheid	en	praktische	relativering	naar	ons	onderzoek.	Mijn	grote	dank	voor	je	veelzijdige	bijdrage.			Prof.	dr.	A.E.M.	Speckens,	prof.	dr.	W.C.M.	Weijmar	Schultz,	prof.	dr.	H.E.	van	der		Horst,	geachte	leden	van	de	manuscriptcommissie.	Ik	dank	u	voor	uw	kritische	lezing	van	het	manuscript	waarna	ik	–	weliswaar	niet	vereist	–	nog	enige	aanpassingen	heb	gemaakt.	Ik	meen	dat	het	daardoor	aan	kwaliteit	heeft	gewonnen,	waarvoor	mijn	dank.			Beste	Anne	Kaptheijns,	Daphne	van	Moorsel,	Esther	Kalicharan,	Renee	Steinmann,	Suzanne	van	de	Pasch,	studenten	geneeskunde,	en	Merel	Makker,	student	psychologie.	Wat	een	power	hebben	jullie!	Slim,	proactief,	sociaal	vaardig	en	flexibel	-	zonder	het	kaas	van	je	brood	te	laten	eten	-,	voegden	jullie	je	kortdurend	in	ons	onderzoeksteam.	Heel	erg	bedankt	voor	jullie	belangrijke	bijdrage	in	het	vergaren	en	interpreteren	van	de	data	en	het	meedenken	in	de	analyses.		
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Beste	Marianne	Vergeer,	arts-seksuoloog,	en	Gé	Donkers,	huisarts-onderzoeker.	Wat	fijn	dat	ik	een	beroep	op	jullie	expertise	kon	doen	als	moderator	voor	de	focusgroepen	met	huisartsen.	De	praktische	omstandigheden	noopten	soms	tot	improvisatie,	veel	dank	voor	jullie	flexibiliteit	en	inzet.		Dear	Charlotte	Otten,	being	an	English	native	speaker	with	a	Dutch	background,	as	well	as	being	a	sexologist	yourself,	you	were	very	helpful	in	checking	my	English	of	both	the	verbatims	in	the	qualitative	studies	and	the	General	discussion.	You	were	so	polite	to	compliment	me,	but	all	credit	goes	to	you.	Thnx!		Beste	collega’s,	vrienden,	familie.	Hier	passen	even	geen	namen,	sorry.	Al	jullie	persoonlijke	merites	zijn	mij	bekend	en	waardeer	ik	zeer,	jullie	werden	en	worden	gezien,	maar	het	is	teveel	om	allen	hier	publiekelijk	te	schetsen.	Echt	heel	veel	dank	voor	al	die	kleine	en	grote	gebaren,	Whatsappjes,	gezellige	avondjes	uit,	zomaar-wat-opmerkingen,	aanmoedigingen,	engelengeduld,	correcties,	kaartjes	en	knuffels.	Het	zit	allemaal	in	dit	boekje.	Echt.		Marjo	Ramakers,	Bert-Jan	de	Boer,	lieve	paranimfen.	In	jullie	beiden	vond	ik	de	gemeenschappelijke	thematiek	die	ik	aan	het	concept	‘paranimf’	wilde	toedichten.	Marjo	vanuit	de	Nederlandse	Wetenschappelijke	Vereniging	voor	Seksuologie,	Bert	Jan	vanuit	de	huisartsgeneeskunde:	beiden	waren	jullie	mijn	wortels	in	de	seksuologie	waardoor	ik	mij	destijds	binnen	beide	groepen	kon	ontwikkelen.	Jullie	steun	was	altijd	onvoorwaardelijk	en	zodra	jullie	mij	grenzen	gaven	dan	was	het	menens	(en	was	ik	zelfs	bereid	te	luisteren	:)).	Ik	ben	erg	trots	dat	jullie	naast	me	staan,	veel	dank	voor	al	die	jaren!		Noud,	Tijn	en	Bente,	lieve	kinderen.	‘Wat	is	een	vulva?’,	‘Waarom	koos	je	voor	dit	onderwerp?’	‘Waarom	mogen	wij	geen	vragen	stellen	tijdens	jouw	promotie?’	Wat	ben	ik	blij	met	jullie	en	met	jullie	vragen.	Wat	een	genot	jullie	te	hebben	zien	ontwikkelen	tot	waar	jullie	nu	staan.	Blijf	vragen!	We	gaan	samen	nog	hele	mooie	jaren	tegemoet.		Chris,	allerliefste.	Nooit	vanuit	een	belofte,	altijd	vanuit	een	verlangen.	Alweer	25	jaar.	Jou	bedanken	doet	jou	tekort	maar	is	zo	noodzakelijk.	Met	veel	plezier	leef	ik	samen	met	je	verder.	
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